data_2l91_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l91 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 CA--C 1.514 -0.406 0 N-CA-C 109.728 -0.471 . . . . 1.65 109.728 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 91.4 t -67.3 -45.31 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 108.448 -0.945 . . . . 1.07 108.448 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.418 ' O ' ' CG2' ' A' ' 700' ' ' VAL . 71.6 t -64.51 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.342 -0.985 . . . . 1.29 108.342 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 17.7 tp -60.69 -43.61 97.54 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.576 -0.284 . . . . 2.15 111.321 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 72.5 mt -66.46 -46.6 75.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.064 -0.717 . . . . 1.78 109.064 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 80.0 p -61.4 -36.78 81.24 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.415 -0.587 . . . . 0.18 109.415 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 696' ' ' VAL . 41.0 t -65.65 -46.92 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 107.977 -1.12 . . . . 1.44 107.977 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 6.3 mtp -59.94 -35.55 75.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.344 -0.984 . . . . 2.97 108.344 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.79 -44.07 81.63 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.57 -1.012 . . . . 0.16 110.57 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.72 96.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 1.03 110.232 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.67 -44.68 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.829 -0.748 . . . . 1.37 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.68 -44.49 96.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.89 -0.324 . . . . 2.3 110.374 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.99 -42.03 97.61 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.045 0.45 . . . . 2.33 110.259 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 89.2 mt -62.77 -41.5 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.804 -0.635 . . . . 1.93 111.021 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.29 -40.61 87.31 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.654 -0.978 . . . . 0.18 110.654 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 17.8 mt -77.68 -25.18 49.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 117.39 0.595 . . . . 2.0 110.693 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -48.44 -60.7 4.06 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 1.15 111.978 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.73 -30.81 40.97 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.875 1.716 . . . . 0.78 112.354 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 716' ' ' ALA . 19.2 mt -68.04 -42.84 79.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.547 -0.909 . . . . 1.62 108.547 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 61.0 mt -65.4 -44.52 87.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.839 -0.43 . . . . 1.59 109.839 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.65 -46.33 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.376 -0.602 . . . . 1.77 109.376 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -63.39 -47.35 82.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.442 -1.318 . . . . 4.47 107.442 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -56.24 -43.51 78.71 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.904 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.498 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 6.3 mt -64.48 -42.66 95.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.643 -0.253 . . . . 2.13 110.54 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 722' ' ' HIS . 80.6 mt -65.18 -45.6 84.21 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.212 -1.033 . . . . 1.54 108.212 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 12.7 mm -65.55 -46.96 88.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 N-CA-C 108.825 -0.806 . . . . 2.03 108.825 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.608 ' N ' ' O ' ' A' ' 716' ' ' ALA . 31.8 m -60.35 -42.23 95.3 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.393 -1.336 . . . . 1.76 107.393 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.498 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 1.3 mm -65.67 -43.58 93.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.83 -0.748 . . . . 1.7 111.392 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 718' ' ' LEU . 46.6 m80 . . . . . 0 C--N 1.343 0.318 0 CA-C-N 115.334 -0.848 . . . . 3.18 109.311 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.17 -44.77 97.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.162 0.506 . . . . 1.0 109.826 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.417 ' O ' ' OG ' ' A' ' 699' ' ' SER . 78.7 t -63.81 -43.79 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.375 -0.829 . . . . 1.0 109.583 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.1 -41.93 99.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.939 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.14 -42.96 96.58 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.294 0.569 . . . . 1.0 110.018 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 67.2 p -63.78 -34.9 78.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.33 -0.85 . . . . 1.0 109.94 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.27 -44.85 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.27 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 60.9 mtt -63.22 -39.16 93.83 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.49 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.27 99.35 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.35 97.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.633 0.254 . . . . 1.0 111.075 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.37 -44.06 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.414 -0.515 . . . . 1.0 110.684 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.52 -42.7 99.21 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.538 -0.301 . . . . 1.0 111.315 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.57 -40.35 96.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.284 0.564 . . . . 1.0 111.162 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.02 -42.84 96.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.941 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.95 -40.12 89.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.01 -35.21 76.4 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 122.707 0.403 . . . . 1.0 111.536 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -49.61 -60.56 4.75 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 120.233 -0.587 . . . . 1.0 111.926 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.49 -41.08 76.09 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.122 1.215 . . . . 1.0 112.434 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.23 -44.1 89.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.686 -0.487 . . . . 1.0 109.686 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.19 -43.79 90.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.093 0.473 . . . . 1.0 109.906 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.85 -44.8 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.909 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -65.14 -46.56 80.42 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.46 -38.41 87.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.541 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 721' ' ' ILE . 58.8 tp -62.99 -47.13 84.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.139 -0.319 . . . . 1.0 110.139 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.72 -44.34 90.5 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.13 -0.628 . . . . 1.0 110.111 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.5 mm -65.94 -44.46 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 716' ' ' ALA . 79.3 m -62.95 -44.91 94.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.2 mm -64.44 -43.58 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.472 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.593 -179.627 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 120.726 0.298 . . . . 1.0 110.317 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.62 -47.43 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.374 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.436 ' O ' ' OG ' ' A' ' 699' ' ' SER . 29.7 m -66.62 -37.61 79.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.033 -0.667 . . . . 1.0 109.535 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 39.6 mt -63.07 -42.6 99.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.422 -0.511 . . . . 1.0 111.766 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.35 -42.76 96.07 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.366 0.603 . . . . 1.0 109.746 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 74.3 p -63.6 -34.33 77.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.21 -0.904 . . . . 1.0 109.943 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.41 -45.77 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.188 0.518 . . . . 1.0 109.67 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.59 -38.57 91.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.674 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.79 99.61 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.01 85.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.762 0.315 . . . . 1.0 110.643 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.6 mt -62.77 -44.11 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.002 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.74 -42.03 99.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.091 -0.644 . . . . 1.0 110.779 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.76 -42.01 99.48 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.823 -0.351 . . . . 1.0 111.066 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.08 -41.58 93.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.597 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -71.11 -43.79 55.71 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 110.587 -1.005 . . . . 1.0 110.587 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.53 -37.42 84.97 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.873 0.469 . . . . 1.0 110.679 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . 0.404 ' CB ' ' CD ' ' A' ' 711' ' ' PRO . . . -40.54 -62.58 0.92 Allowed Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.502 -0.772 . . . . 1.0 112.374 -177.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 710' ' ' ALA . 20.2 Cg_endo -61.34 -34.51 87.11 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.802 1.668 . . . . 1.0 113.128 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.71 -43.18 89.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.94 -44.04 90.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.945 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.75 -44.88 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.701 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -65.24 -47.65 76.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.627 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 720' ' ' THR . . . -60.61 -42.49 96.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.398 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 721' ' ' ILE . 38.7 mt -63.6 -43.38 97.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.339 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.55 -44.33 94.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.298 -0.961 . . . . 1.0 109.292 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.74 -44.88 89.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.914 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 716' ' ' ALA . 20.1 m -63.46 -45.8 89.15 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 717' ' ' LEU . 79.3 mt -64.37 -43.1 97.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.538 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 9.6 m80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.6 -179.86 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.73 -43.99 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.437 ' O ' ' OG ' ' A' ' 699' ' ' SER . 77.3 t -63.48 -42.96 98.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.957 -1.02 . . . . 1.0 109.235 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.4 tp -62.62 -42.74 99.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.379 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.14 -43.07 96.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.331 0.586 . . . . 1.0 109.655 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.6 p -63.48 -34.55 78.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.332 -0.849 . . . . 1.0 109.81 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.67 -44.76 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.55 -39.0 93.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.243 -0.889 . . . . 1.0 109.42 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.27 -41.75 99.47 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.705 -0.958 . . . . 1.0 110.705 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.72 -38.5 91.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.702 0.287 . . . . 1.0 110.898 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.05 -43.46 99.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.342 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.64 -42.61 99.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.699 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.0 -41.77 98.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.88 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.14 -42.94 98.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.42 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.91 -47.08 77.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.794 -0.922 . . . . 1.0 110.794 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.35 -36.8 79.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.868 0.467 . . . . 1.0 111.418 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -36.27 -61.39 0.6 Allowed Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.79 -30.81 78.28 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.954 1.769 . . . . 1.0 113.322 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.13 -43.87 90.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.107 -0.637 . . . . 1.0 109.54 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.35 -42.93 95.99 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.216 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.79 -44.9 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -65.39 -46.48 79.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.446 ' O ' ' CG2' ' A' ' 720' ' ' THR . . . -57.89 -47.85 81.56 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.459 -0.791 . . . . 1.0 110.344 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.82 -44.25 93.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.563 -0.455 . . . . 1.0 110.789 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 82.8 mt -65.13 -45.03 86.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.431 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 5.3 tp -71.4 -42.33 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.094 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 716' ' ' ALA . 67.8 p -66.7 -40.41 88.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.684 -0.807 . . . . 1.0 108.852 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.41 -40.3 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.676 0.751 . . . . 1.0 111.211 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 10.9 m80 . . . . . 0 C--N 1.321 -0.637 0 C-N-CA 119.935 -0.706 . . . . 1.0 109.67 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.515 -0.398 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.12 -44.28 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.57 0.7 . . . . 1.0 109.229 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 699' ' ' SER . 78.2 t -63.71 -42.92 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.822 -1.081 . . . . 1.0 109.167 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.19 -42.94 99.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.387 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.96 -42.86 97.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.356 0.598 . . . . 1.0 109.755 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 73.4 p -63.61 -33.58 75.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.002 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.64 -45.22 92.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 99.0 mmm -63.57 -37.83 88.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.377 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.08 99.11 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.581 -1.008 . . . . 1.0 110.581 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.88 92.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.769 0.318 . . . . 1.0 110.72 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.56 -43.97 98.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.337 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.31 -42.79 99.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.776 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.2 -41.99 98.87 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.551 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.8 -42.84 97.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.92 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.21 -43.1 81.52 Favored Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.79 -37.31 81.86 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.939 0.496 . . . . 1.0 111.109 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -41.44 -61.57 1.36 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.592 -0.731 . . . . 1.0 112.623 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.11 -32.95 74.63 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.766 1.644 . . . . 1.0 112.749 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.6 mt -66.37 -43.78 84.97 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.14 -43.97 90.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.058 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.98 -45.01 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.972 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -63.89 -46.5 84.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.48 -39.75 88.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.779 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 721' ' ' ILE . 58.9 tp -63.41 -46.33 86.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.68 -45.1 88.09 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 120.178 -0.609 . . . . 1.0 110.167 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 31.0 mm -66.28 -44.35 91.19 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 716' ' ' ALA . 78.8 m -62.83 -44.09 97.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 717' ' ' LEU . 2.2 mm -64.59 -43.59 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.789 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.5 m80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.069 -179.275 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.08 -43.73 97.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 O-C-N 123.699 0.624 . . . . 1.0 109.616 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.417 ' O ' ' OG ' ' A' ' 699' ' ' SER . 77.4 t -62.91 -43.47 98.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.614 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.23 -40.97 98.95 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.185 -0.606 . . . . 1.0 112.11 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.94 -43.24 96.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.441 0.639 . . . . 1.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 70.9 p -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.327 -0.852 . . . . 1.0 109.443 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.86 -45.72 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.523 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.7 ttp -62.05 -40.02 94.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.154 -0.93 . . . . 1.0 109.718 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.2 -40.67 99.28 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.71 -36.8 84.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.749 0.309 . . . . 1.0 110.479 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.64 -43.73 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.971 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.43 -41.41 98.7 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.906 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.24 -41.72 98.68 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.826 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 30.8 mm -63.43 -43.45 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.72 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.95 -46.81 64.03 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.392 -0.683 . . . . 1.0 111.392 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.39 -35.27 77.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.838 0.352 . . . . 1.0 111.123 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -40.47 -62.04 1.04 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 115.882 -0.599 . . . . 1.0 112.421 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.53 -32.49 70.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.882 1.721 . . . . 1.0 112.575 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.57 -43.36 90.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.5 -43.7 93.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.794 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.71 -44.91 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.059 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -65.02 -46.36 81.67 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.0 -41.91 97.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.287 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.7 mt -63.68 -43.79 95.64 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.723 -0.391 . . . . 1.0 109.991 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.38 -44.79 90.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.79 -0.764 . . . . 1.0 109.831 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 93.1 mt -66.27 -44.81 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 716' ' ' ALA . 99.9 m -63.66 -45.09 91.74 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.0 mm -64.23 -43.64 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.199 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.6 m80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.731 -179.695 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 65.7 t -64.92 -44.39 96.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.608 0.718 . . . . 1.0 109.204 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.446 ' O ' ' OG ' ' A' ' 699' ' ' SER . 77.1 t -63.4 -42.77 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.689 -1.141 . . . . 1.0 109.349 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.16 -44.24 97.06 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.147 0.425 . . . . 1.0 112.147 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.38 -42.5 96.11 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -62.36 -35.38 78.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.779 . . . . 1.0 109.779 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 66.3 t -66.66 -45.93 87.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.493 0.663 . . . . 1.0 109.331 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 63.4 mtt -62.83 -38.52 91.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.139 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.03 -41.2 99.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.83 84.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.665 0.269 . . . . 1.0 110.471 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.6 mt -62.84 -43.99 99.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.905 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.5 -42.1 99.27 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.056 -0.658 . . . . 1.0 110.969 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.65 -42.03 98.33 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.72 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.27 -40.79 90.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.964 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -73.27 -44.55 34.33 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.739 -0.944 . . . . 1.0 110.739 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.25 -36.83 80.05 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.629 0.372 . . . . 1.0 111.936 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -47.5 -59.79 5.05 Favored Pre-proline 0 N--CA 1.464 0.275 0 C-N-CA 120.057 -0.657 . . . . 1.0 111.405 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -53.23 -40.3 77.94 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.43 1.42 . . . . 1.0 112.644 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.24 -44.67 87.45 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.563 -0.455 . . . . 1.0 109.936 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.77 -42.96 94.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.533 -0.467 . . . . 1.0 109.932 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.12 -44.74 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -65.68 -46.82 77.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.441 ' O ' ' CG2' ' A' ' 720' ' ' THR . . . -60.9 -41.11 95.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.29 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.479 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 35.4 mt -63.16 -44.34 95.78 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.104 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.73 -45.01 88.29 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 119.943 -0.703 . . . . 1.0 109.991 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.8 mm -66.86 -44.82 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.346 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 716' ' ' ALA . 66.5 p -67.45 -39.66 85.38 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 119.217 -0.993 . . . . 1.0 108.706 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.8 mm -64.65 -43.41 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 119.962 -0.695 . . . . 1.0 110.639 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.2 m80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.333 -0.848 . . . . 1.0 110.647 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.0 -45.04 97.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.441 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 699' ' ' SER . 75.9 t -63.86 -43.11 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.052 -0.977 . . . . 1.0 109.43 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.41 -43.02 99.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.562 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.34 -43.09 95.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.222 0.534 . . . . 1.0 109.56 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 75.7 p -63.96 -34.09 77.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.793 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 73.6 t -65.77 -44.69 93.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.8 mtp -63.61 -38.97 93.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.297 -0.865 . . . . 1.0 109.619 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.78 -41.85 98.74 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.12 93.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.655 0.264 . . . . 1.0 110.844 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.26 -43.83 98.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.494 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.16 -42.18 99.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.654 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.94 -42.28 99.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.875 0.369 . . . . 1.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.427 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 96.0 mt -62.23 -40.85 89.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.55 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -72.83 -42.27 46.43 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.63 -37.34 84.64 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 122.921 0.488 . . . . 1.0 111.588 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -51.17 -59.91 6.74 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 120.285 -0.566 . . . . 1.0 112.172 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . 0.427 ' CD ' ' O ' ' A' ' 707' ' ' ILE . 43.5 Cg_exo -53.02 -41.04 74.5 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.542 1.495 . . . . 1.0 112.18 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.27 -43.93 89.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.73 -43.45 93.36 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.834 -0.432 . . . . 1.0 109.834 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . 0.422 HG22 HD13 ' A' ' 714' ' ' ILE . 94.9 mt -64.42 -44.89 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.601 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 79.5 t90 -65.72 -47.01 76.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 720' ' ' THR . . . -61.75 -39.13 90.54 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.933 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 60.0 tp -63.03 -45.98 89.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . 0.534 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 87.6 mt -65.13 -46.02 82.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.283 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.8 -44.46 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.284 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 716' ' ' ALA . 61.6 p -66.13 -36.13 82.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.307 -0.957 . . . . 1.0 108.605 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 2.3 mm -66.56 -39.48 84.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.976 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . 0.534 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 40.5 m80 . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 115.36 -0.837 . . . . 1.0 111.225 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.54 -45.39 98.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.63 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.445 ' O ' ' OG ' ' A' ' 699' ' ' SER . 74.7 t -63.85 -43.67 97.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.446 -0.797 . . . . 1.0 109.392 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.25 -42.05 99.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.267 0.469 . . . . 1.0 112.267 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.04 -42.76 96.96 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.256 0.55 . . . . 1.0 109.806 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.9 p -63.25 -34.08 76.88 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.002 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.61 -45.21 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.643 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.27 -38.1 89.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.485 -0.779 . . . . 1.0 109.775 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.3 -42.24 99.3 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.561 -1.016 . . . . 1.0 110.561 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.93 96.15 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.673 0.237 . . . . 1.0 110.675 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.74 -42.93 98.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 121.867 0.841 . . . . 1.0 110.008 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.16 -41.56 98.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.985 -0.686 . . . . 1.0 110.876 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.98 -40.52 97.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.773 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.27 -43.16 98.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.578 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.76 -46.08 62.5 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.716 -0.954 . . . . 1.0 110.716 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.29 -35.75 78.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.163 0.506 . . . . 1.0 111.185 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -40.06 -61.95 1.01 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.429 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.04 -32.33 75.76 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.811 1.674 . . . . 1.0 112.73 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.06 -43.57 87.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.04 -43.66 91.63 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.965 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.7 -44.82 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.96 -0.564 . . . . 1.0 109.748 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -65.5 -46.56 79.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -59.73 -42.06 92.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.111 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 721' ' ' ILE . 37.7 mt -63.63 -44.09 94.92 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.238 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.74 -45.35 86.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.956 -0.698 . . . . 1.0 110.024 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.42 -44.61 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 716' ' ' ALA . 97.6 m -63.51 -44.9 92.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.536 -0.913 . . . . 1.0 108.536 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.5 -43.13 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.666 -0.697 . . . . 1.0 111.3 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 8.2 m80 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.755 -179.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.448 -0.572 0 N-CA-C 109.333 -0.618 . . . . 1.0 109.333 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.05 -45.15 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.382 0.611 . . . . 1.0 109.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 699' ' ' SER . 76.4 t -64.11 -42.99 97.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.995 -1.002 . . . . 1.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 51.7 tp -62.61 -43.03 99.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.71 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.99 -43.02 96.94 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.259 0.552 . . . . 1.0 109.748 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.6 p -63.23 -34.32 77.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.856 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 76.4 t -65.44 -45.3 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.638 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.9 mmm -63.93 -37.98 89.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.441 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.49 -42.38 98.98 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.546 -1.022 . . . . 1.0 110.546 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.3 90.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.713 0.292 . . . . 1.0 110.866 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.94 -43.55 99.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.472 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.33 -42.19 99.18 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.784 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.0 mt -62.89 -41.51 99.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.354 . . . . 1.0 110.705 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.3 -43.25 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.291 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.86 -43.57 73.44 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.49 -37.14 82.41 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 122.879 0.472 . . . . 1.0 110.954 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -41.45 -61.96 1.23 Allowed Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.782 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.27 -33.09 72.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.782 1.654 . . . . 1.0 112.672 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.19 -43.95 85.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.45 -44.21 87.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.155 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.18 -44.68 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.282 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -66.08 -46.54 77.34 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.54 -37.98 85.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.848 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 721' ' ' ILE . 58.6 tp -63.54 -44.15 95.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . 0.557 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 84.4 mt -64.63 -43.62 93.13 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 97.9 mt -65.25 -41.74 92.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 CA-C-O 123.64 1.686 . . . . 1.0 107.962 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 716' ' ' ALA . 99.0 m -68.29 -41.23 81.28 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 117.978 -1.489 . . . . 1.0 108.629 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.2 mm -64.71 -44.13 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 119.802 -0.759 . . . . 1.0 111.339 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 43.1 m80 . . . . . 0 N--CA 1.466 0.335 0 CA-C-N 115.274 -0.876 . . . . 1.0 110.442 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.73 -45.47 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.439 ' O ' ' OG ' ' A' ' 699' ' ' SER . 77.3 t -64.04 -43.38 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.165 -0.925 . . . . 1.0 109.156 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.65 -43.71 98.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.841 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.44 -42.56 95.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.136 0.493 . . . . 1.0 109.7 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 78.0 p -63.21 -34.8 78.42 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.883 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.63 -45.43 92.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.2 ttp -62.05 -39.56 92.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.587 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.96 -42.43 98.29 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.898 -0.881 . . . . 1.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.92 95.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.586 0.231 . . . . 1.0 110.716 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.37 -44.04 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.399 -0.521 . . . . 1.0 110.36 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.25 -43.09 99.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.714 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.8 -41.19 99.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.153 0.502 . . . . 1.0 111.855 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.7 -39.98 87.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.351 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.41 -42.88 63.7 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.612 -0.995 . . . . 1.0 110.612 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.47 -37.88 83.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.278 0.561 . . . . 1.0 110.631 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -36.55 -62.31 0.54 Allowed Pre-proline 0 C--N 1.333 -0.118 0 CA-C-N 115.618 -0.719 . . . . 1.0 112.096 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.03 -31.19 83.78 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.654 1.569 . . . . 1.0 113.256 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.72 -44.11 87.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.48 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.29 -42.84 96.21 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.293 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.95 -44.9 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -65.91 -45.91 80.23 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.273 -0.639 . . . . 1.0 109.273 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 720' ' ' THR . . . -57.96 -47.65 82.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.372 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.462 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 83.1 mt -64.26 -43.73 93.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.75 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.06 -44.89 87.52 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.139 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 5.1 tp -71.4 -41.88 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 108.925 -0.769 . . . . 1.0 108.925 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 716' ' ' ALA . 96.9 m -63.6 -44.86 92.78 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.42 -43.33 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.021 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.294 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.9 t -63.23 -45.2 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.322 0.582 . . . . 1.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.44 ' O ' ' OG ' ' A' ' 699' ' ' SER . 78.4 t -63.9 -43.17 97.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.48 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 40.4 mt -62.84 -42.48 99.76 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.497 -0.481 . . . . 1.0 112.057 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.26 -42.61 96.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.25 0.548 . . . . 1.0 109.805 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -63.28 -34.61 78.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.893 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.44 -45.65 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.695 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 99.0 mmm -64.94 -37.51 87.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.644 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.38 -43.14 99.49 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.86 77.69 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.092 -0.643 . . . . 1.0 110.823 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.96 -43.11 98.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.062 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.83 -42.08 99.58 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.088 -0.645 . . . . 1.0 111.892 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.79 -40.27 96.25 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.648 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.425 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 36.8 mm -64.55 -34.14 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.858 0.361 . . . . 1.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -77.5 -43.94 14.22 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.021 -1.085 . . . . 1.0 111.024 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.26 -36.56 81.84 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.76 0.424 . . . . 1.0 111.969 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -50.72 -60.04 6.23 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.079 -0.649 . . . . 1.0 111.768 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 707' ' ' ILE . 42.8 Cg_exo -53.07 -41.29 72.83 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.296 1.331 . . . . 1.0 112.113 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.31 -44.12 88.89 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.59 -43.46 93.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.607 -0.437 . . . . 1.0 110.007 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.58 -44.79 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.7 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -66.33 -46.12 77.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 720' ' ' THR . . . -61.82 -38.59 88.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.661 -0.7 . . . . 1.0 109.655 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.09 -45.56 91.54 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . 0.533 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 86.7 mt -63.59 -43.36 97.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.23 -0.588 . . . . 1.0 109.499 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.63 -44.26 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 716' ' ' ALA . 74.3 p -64.12 -41.21 97.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.042 -1.063 . . . . 1.0 108.404 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 81.7 mt -64.46 -43.4 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 119.57 -0.852 . . . . 1.0 111.706 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 52.0 m80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.547 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.75 -45.1 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.298 -0.63 . . . . 1.0 109.298 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.434 ' O ' ' OG ' ' A' ' 699' ' ' SER . 77.0 t -64.05 -43.15 97.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.961 -1.018 . . . . 1.0 109.282 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.49 -42.99 99.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.598 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.32 -43.17 95.52 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.183 0.516 . . . . 1.0 109.671 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -63.28 -34.95 78.79 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.825 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.81 -45.39 91.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.0 ttp -61.92 -39.42 91.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.136 -0.938 . . . . 1.0 109.571 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.53 -40.78 99.56 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.41 87.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.497 0.189 . . . . 1.0 111.016 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 31.6 mm -62.95 -44.12 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.434 -0.507 . . . . 1.0 110.771 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.71 -41.98 99.42 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.932 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.29 -42.53 99.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.811 0.339 . . . . 1.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.43 -43.25 98.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.197 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.52 -43.9 75.02 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.42 -36.88 82.14 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.869 0.468 . . . . 1.0 111.115 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -40.12 -62.19 0.96 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.83 -0.623 . . . . 1.0 112.435 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.02 -33.65 82.5 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.657 1.571 . . . . 1.0 113.036 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.66 -42.94 90.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.45 -43.69 93.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.883 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.78 -44.9 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.888 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -65.96 -45.96 79.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -55.46 -47.65 75.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.275 -0.875 . . . . 1.0 109.857 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 721' ' ' ILE . 40.3 mt -63.69 -43.3 97.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.539 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.44 -44.89 89.72 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 120.171 -0.611 . . . . 1.0 111.243 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 14.1 pt -73.17 -41.85 58.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 94.8 m -64.14 -43.55 94.88 Favored 'General case' 0 C--O 1.265 1.876 0 CA-C-O 122.346 1.07 . . . . 1.0 108.616 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 717' ' ' LEU . 76.9 mt -66.0 -44.43 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 117.802 -1.559 . . . . 1.0 111.702 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 10.3 m80 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.083 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.89 -43.29 93.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.806 0.812 . . . . 1.0 109.571 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.05 -39.74 85.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.48 -1.236 . . . . 1.0 109.693 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.98 -43.05 96.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.833 -0.621 . . . . 1.0 111.684 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -65.36 -42.23 92.98 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.319 -0.622 . . . . 1.0 109.319 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 59.3 p -62.98 -35.05 78.91 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.678 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.44 -44.53 90.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.333 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 5.7 ttp -61.89 -39.26 91.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.29 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.92 -41.67 98.62 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.13 96.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.775 0.321 . . . . 1.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.0 -43.72 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.26 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.41 -42.32 99.35 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.659 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.58 -42.38 99.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 1.0 110.446 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.23 -43.35 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.62 -44.88 69.31 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.414 -1.074 . . . . 1.0 110.414 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.05 -38.04 82.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.138 0.494 . . . . 1.0 110.99 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -37.13 -61.77 0.65 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.726 -0.67 . . . . 1.0 112.315 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.79 -31.25 78.35 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.764 1.643 . . . . 1.0 113.192 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.5 -44.45 86.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.3 -0.56 . . . . 1.0 109.525 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.45 -42.84 95.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.099 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.26 -45.09 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 120.297 -0.561 . . . . 1.0 109.872 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . 0.407 ' CE3' ' CD1' ' A' ' 719' ' ' ILE . 1.5 t90 -65.98 -46.53 77.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.15 -43.4 95.76 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.352 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 721' ' ' ILE . 38.0 mt -63.39 -43.95 96.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.297 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.58 -44.57 90.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.749 -0.78 . . . . 1.0 109.679 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . 0.407 ' CD1' ' CE3' ' A' ' 715' ' ' TRP . 93.3 mt -66.32 -45.01 90.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.756 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 716' ' ' ALA . 97.3 m -63.84 -44.74 92.28 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.0 mm -64.18 -43.59 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.984 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 9.6 m80 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.545 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.86 -45.42 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-O 121.42 0.629 . . . . 1.0 109.734 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 699' ' ' SER . 79.3 t -64.29 -43.08 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.001 -1.0 . . . . 1.0 109.382 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 51.9 tp -61.93 -42.47 99.13 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.87 -0.605 . . . . 1.0 112.031 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.19 -42.15 89.22 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.178 0.513 . . . . 1.0 110.926 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 68.8 p -61.73 -39.39 91.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.445 -0.798 . . . . 1.0 111.633 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.27 -40.31 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 119.67 -0.812 . . . . 1.0 109.498 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 56.0 ttp -61.23 -39.5 90.52 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.2 -40.81 98.33 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 110.595 -1.002 . . . . 1.0 110.595 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.52 91.37 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.689 -0.404 . . . . 1.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.96 -44.52 99.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 120.452 -0.499 . . . . 1.0 110.272 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.21 -43.16 99.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.628 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.58 -40.29 96.43 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.75 0.31 . . . . 1.0 111.142 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.455 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 85.2 mt -62.28 -41.54 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.84 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.31 -44.71 64.17 Favored Glycine 0 N--CA 1.471 0.996 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 8.9 mp -69.07 -35.47 76.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.501 -0.35 . . . . 1.0 111.936 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -50.5 -59.83 6.52 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 119.445 -0.902 . . . . 1.0 111.644 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . 0.455 ' CD ' ' O ' ' A' ' 707' ' ' ILE . 38.7 Cg_exo -53.16 -41.04 74.99 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.538 1.492 . . . . 1.0 112.308 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.52 -44.07 88.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.499 -0.556 . . . . 1.0 109.499 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.6 -43.82 92.6 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.475 -0.49 . . . . 1.0 109.876 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.53 -44.84 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.76 -45.84 87.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.979 -0.748 . . . . 1.0 108.979 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -59.38 -40.52 86.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.999 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.9 mt -63.16 -43.7 97.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.426 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.86 -43.93 94.62 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.413 -0.915 . . . . 1.0 109.021 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . 0.453 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.1 mm -65.11 -45.24 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 716' ' ' ALA . 19.7 m -64.92 -46.61 80.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.953 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 717' ' ' LEU . 82.7 mt -65.52 -44.19 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . 0.453 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 1.7 p-80 . . . . . 0 N--CA 1.467 0.39 0 C-N-CA 119.799 -0.76 . . . . 1.0 110.512 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.81 -45.09 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.772 0.796 . . . . 1.0 109.334 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.436 ' O ' ' OG ' ' A' ' 699' ' ' SER . 76.2 t -63.32 -43.09 98.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.207 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.26 -43.04 99.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.642 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.04 -43.19 96.29 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.143 0.497 . . . . 1.0 109.724 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 72.8 p -63.4 -34.61 78.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.466 -0.788 . . . . 1.0 109.883 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.67 -45.27 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 53.4 ttp -61.71 -39.91 93.17 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.345 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.42 -42.42 99.06 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.28 92.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.834 0.826 . . . . 1.0 110.341 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.12 -43.76 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 119.763 -0.775 . . . . 1.0 109.943 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.05 -43.81 98.03 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.94 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.54 -41.2 98.73 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.631 0.253 . . . . 1.0 110.598 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.43 -43.0 98.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.31 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.39 -40.84 94.63 Favored Glycine 0 N--CA 1.468 0.783 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.06 -35.15 76.23 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.715 0.406 . . . . 1.0 111.757 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -48.62 -60.54 4.39 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.201 -0.6 . . . . 1.0 111.862 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -53.49 -41.44 73.3 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.235 1.29 . . . . 1.0 112.529 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.68 -43.3 94.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.631 -0.428 . . . . 1.0 109.891 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.43 -43.9 92.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.403 -0.519 . . . . 1.0 110.249 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.69 -44.77 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -64.35 -48.65 74.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.438 -0.579 . . . . 1.0 109.438 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -58.76 -41.74 87.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.987 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 721' ' ' ILE . 37.2 mt -63.69 -44.17 94.47 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.731 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.47 -45.43 87.39 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.796 -0.762 . . . . 1.0 110.034 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . 0.529 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 1.7 mp -66.78 -45.3 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.11 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 716' ' ' ALA . 98.8 m -64.87 -45.95 83.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.11 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.474 ' N ' ' O ' ' A' ' 717' ' ' LEU . 82.6 mt -65.61 -43.97 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.156 0.799 . . . . 1.0 113.156 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 1.9 p-80 . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 119.306 -0.958 . . . . 1.0 110.266 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.73 -44.82 98.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 699' ' ' SER . 75.6 t -64.06 -43.56 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.643 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.37 -41.89 98.83 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.276 0.472 . . . . 1.0 112.276 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.88 -42.87 97.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.325 0.583 . . . . 1.0 109.728 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.2 p -64.04 -34.05 77.15 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.253 -0.885 . . . . 1.0 109.801 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.54 -45.55 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.659 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.9 mmm -64.52 -38.48 91.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.629 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.59 -41.2 99.53 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.456 -1.058 . . . . 1.0 110.456 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.78 84.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.806 0.336 . . . . 1.0 110.555 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.7 mt -62.8 -43.92 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.454 -0.499 . . . . 1.0 110.954 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.51 -42.02 99.22 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.185 -0.606 . . . . 1.0 110.743 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.25 -42.44 99.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 1.0 110.551 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.35 -43.27 98.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.229 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.83 -43.81 72.53 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.718 -0.953 . . . . 1.0 110.718 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.41 -37.38 82.97 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 122.79 0.436 . . . . 1.0 111.067 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -40.28 -62.2 0.98 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.602 -0.726 . . . . 1.0 112.529 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.24 -32.85 73.22 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.672 1.581 . . . . 1.0 112.573 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.01 -43.52 87.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.1 -43.89 90.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.087 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.7 mt -64.03 -44.58 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.751 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -65.26 -46.46 80.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -58.16 -43.89 87.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.125 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 721' ' ' ILE . 80.2 mt -63.85 -42.89 97.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.633 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.1 -44.37 89.04 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.693 -0.803 . . . . 1.0 109.733 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . 0.545 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.5 mm -66.37 -45.39 89.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.881 -0.785 . . . . 1.0 108.881 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 716' ' ' ALA . 38.3 m -64.69 -44.64 89.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.14 -0.936 . . . . 1.0 110.912 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 717' ' ' LEU . 81.0 mt -67.26 -41.73 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 112.991 0.738 . . . . 1.0 112.991 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . 0.545 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 2.6 p-80 . . . . . 0 C--N 1.313 -0.992 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.191 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.0 -43.92 96.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 699' ' ' SER . 76.4 t -63.62 -42.99 97.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.189 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.33 -42.91 99.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.351 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.96 -43.28 96.25 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.294 0.569 . . . . 1.0 109.572 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 76.4 p -63.72 -34.44 77.88 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.352 -0.84 . . . . 1.0 109.893 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 76.3 t -65.47 -45.06 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.6 ttp -61.76 -39.69 92.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.252 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.74 99.35 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.427 -1.069 . . . . 1.0 110.427 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.74 -36.23 82.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.713 0.292 . . . . 1.0 110.418 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.85 -44.1 99.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.551 -0.459 . . . . 1.0 110.757 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.4 -42.07 98.77 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.653 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 51.7 tp -62.48 -43.99 97.47 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.403 0.52 . . . . 1.0 112.403 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 21.2 tt -67.28 -38.41 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.211 -0.596 . . . . 1.0 111.749 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.2 -44.97 73.69 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.35 -35.28 77.51 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.954 0.502 . . . . 1.0 111.07 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -41.03 -61.87 1.18 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.925 -0.58 . . . . 1.0 112.559 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.15 -33.07 82.89 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.756 1.637 . . . . 1.0 112.918 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.36 -43.17 91.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.76 -44.13 91.07 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.085 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.5 mm -64.85 -44.72 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 80.8 t90 -65.74 -47.03 76.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.478 ' O ' ' OG1' ' A' ' 720' ' ' THR . . . -60.33 -42.25 95.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.255 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.7 mt -63.07 -43.11 99.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.714 -0.395 . . . . 1.0 110.236 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . 0.432 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 85.3 mt -64.17 -44.91 90.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.81 -0.756 . . . . 1.0 109.515 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.37 -45.25 89.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.774 -0.648 . . . . 1.0 109.642 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 716' ' ' ALA . 19.7 m -64.29 -44.17 92.52 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.4 mm -64.59 -42.23 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.943 0.878 . . . . 1.0 110.819 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . 0.432 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 11.7 m80 . . . . . 0 CA--C 1.553 1.067 0 CA-C-N 114.995 -1.002 . . . . 1.0 110.487 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.245 0.86 0 CA-C-O 122.09 0.948 . . . . 1.0 109.579 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -44.49 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.31 -0.859 . . . . 1.0 109.229 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' A' ' 699' ' ' SER . 73.5 t -63.13 -43.52 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.115 -0.948 . . . . 1.0 109.609 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.31 -42.08 98.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.993 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.05 -43.16 96.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.282 0.563 . . . . 1.0 109.581 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 78.0 p -63.65 -34.82 78.68 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.661 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 73.3 t -65.39 -45.35 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.2 ttp -61.86 -39.73 92.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.334 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.69 -42.37 98.69 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.745 -0.942 . . . . 1.0 110.745 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.91 96.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.636 0.255 . . . . 1.0 111.376 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.49 -41.56 92.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 82.0 mt -61.67 -42.05 98.38 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.979 -0.688 . . . . 1.0 110.446 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.82 -41.6 99.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.752 0.311 . . . . 1.0 111.199 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . 0.404 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 31.1 mm -63.46 -43.2 98.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.371 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.55 -42.27 81.53 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 110.956 -0.857 . . . . 1.0 110.956 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.5 mt -68.3 -35.86 78.47 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.974 0.51 . . . . 1.0 111.74 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -49.59 -60.37 5.08 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.091 -0.644 . . . . 1.0 111.921 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . 0.404 ' CD ' ' O ' ' A' ' 707' ' ' ILE . 38.5 Cg_exo -53.76 -40.93 78.13 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.443 1.429 . . . . 1.0 112.399 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.19 -44.16 89.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.0 -43.61 91.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.563 -0.455 . . . . 1.0 109.928 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.7 -44.76 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.837 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -66.51 -46.86 74.84 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.41 -40.07 89.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.843 -0.617 . . . . 1.0 109.703 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 59.2 tp -63.64 -46.21 86.7 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.66 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.19 -44.36 92.23 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.248 -0.581 . . . . 1.0 109.935 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.3 mm -65.82 -43.95 93.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 716' ' ' ALA . 95.4 m -62.58 -45.24 93.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.35 -43.32 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 119.742 -0.783 . . . . 1.0 111.754 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.0 m80 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.542 -179.615 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 109.219 -0.659 . . . . 1.0 109.219 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 69.5 t -64.45 -45.2 96.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.503 0.668 . . . . 1.0 109.489 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.421 ' O ' ' OG ' ' A' ' 699' ' ' SER . 78.3 t -64.32 -43.06 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.955 -1.02 . . . . 1.0 109.336 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.2 -43.16 99.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.802 -0.635 . . . . 1.0 111.594 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.13 -43.0 96.62 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.423 0.63 . . . . 1.0 109.562 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 74.1 p -64.08 -34.38 77.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.231 -0.895 . . . . 1.0 109.782 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.2 -45.17 94.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 61.3 mtt -63.45 -38.48 91.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.439 -0.8 . . . . 1.0 109.348 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.12 -41.68 99.69 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.232 -1.147 . . . . 1.0 110.232 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.66 94.61 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.636 0.255 . . . . 1.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.37 -43.91 98.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.59 0.71 . . . . 1.0 110.053 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.99 -43.34 99.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.601 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.06 -43.17 99.41 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.285 0.476 . . . . 1.0 112.285 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 14.6 tt -65.33 -31.93 56.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.045 -0.662 . . . . 1.0 111.176 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.94 -45.75 71.35 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.624 -0.991 . . . . 1.0 110.624 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.68 -36.87 81.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 1.0 111.266 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -37.78 -62.05 0.69 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.982 -0.554 . . . . 1.0 112.311 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.57 -31.65 79.85 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.924 1.749 . . . . 1.0 112.502 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.8 -43.72 71.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.504 -0.479 . . . . 1.0 109.928 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.17 -45.05 86.48 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.935 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.26 -41.96 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 119.873 -0.731 . . . . 1.0 109.704 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -63.7 -47.28 81.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.887 -0.782 . . . . 1.0 108.887 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.43 -38.95 85.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 721' ' ' ILE . 58.9 tp -63.17 -45.44 91.81 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.16 -44.2 89.3 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 121.298 0.571 . . . . 1.0 109.895 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . 0.555 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.2 mm -65.05 -44.41 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 716' ' ' ALA . 98.9 m -63.91 -45.9 87.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.443 177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.7 mm -65.89 -43.99 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 113.826 1.047 . . . . 1.0 113.826 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . 0.555 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 2.2 p-80 . . . . . 0 C--N 1.328 -0.353 0 C-N-CA 119.782 -0.767 . . . . 1.0 110.754 -178.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.6 t -63.72 -45.41 97.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.989 -0.55 . . . . 1.0 109.876 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.422 ' O ' ' OG ' ' A' ' 699' ' ' SER . 74.6 t -64.01 -43.52 97.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.329 -0.85 . . . . 1.0 109.852 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.428 ' N ' HD23 ' A' ' 697' ' ' LEU . 0.9 OUTLIER -62.92 -41.13 99.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.046 -0.525 . . . . 1.0 112.184 -179.031 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.38 -42.27 88.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.238 0.542 . . . . 1.0 110.852 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.3 p -62.07 -39.63 93.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.68 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 16.2 m -69.82 -41.39 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 119.386 -0.926 . . . . 1.0 109.632 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.22 -39.0 88.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.92 -40.55 99.01 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.66 -36.87 82.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.511 0.196 . . . . 1.0 111.006 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 38.6 mm -60.93 -44.02 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 122.293 1.044 . . . . 1.0 109.547 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 46.4 tp -64.23 -44.21 92.59 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.674 -1.266 . . . . 1.0 112.404 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.06 -41.18 99.41 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 45.2 pt -65.38 -38.69 83.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.482 -0.487 . . . . 1.0 111.62 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.13 -40.98 92.82 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.414 -1.074 . . . . 1.0 110.414 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 97.0 mt -68.58 -35.27 77.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.42 -0.39 . . . . 1.0 111.505 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -48.67 -60.91 3.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.03 -0.668 . . . . 1.0 112.075 -176.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -53.88 -40.63 79.79 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.351 1.367 . . . . 1.0 112.35 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.34 -43.85 89.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.78 -43.94 91.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.236 178.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.82 -44.69 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -65.23 -47.77 75.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 716' ' ' ALA . . . . . 0.477 ' O ' ' CG2' ' A' ' 720' ' ' THR . . . -61.96 -39.43 92.12 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.096 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.412 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 60.8 tp -62.97 -46.47 87.56 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.93 -44.86 88.1 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.133 -0.627 . . . . 1.0 110.282 178.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.5 mm -66.62 -44.4 89.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.426 179.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.477 ' CG2' ' O ' ' A' ' 716' ' ' ALA . 57.4 p -65.71 -39.79 91.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.412 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.96 -43.29 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 120.015 -0.674 . . . . 1.0 110.986 178.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.624 -0.716 . . . . 1.0 110.294 -179.844 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 CA--C 1.517 -0.332 0 N-CA-C 108.356 -1.44 . . . . 15.53 108.356 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . 0.632 ' O ' ' C ' ' A' ' 687' ' ' SER . 0.0 OUTLIER -80.2 27.86 0.32 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 118.235 -0.888 . . . . 15.29 111.374 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.632 ' C ' ' O ' ' A' ' 686' ' ' GLU . 2.6 t -37.25 134.52 0.71 Allowed Pre-proline 0 C--N 1.378 1.811 0 N-CA-C 100.882 -3.747 . . . . 12.45 100.882 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . 0.607 ' C ' ' O ' ' A' ' 687' ' ' SER . 80.2 Cg_exo -40.62 118.7 0.64 Allowed 'Trans proline' 0 C--N 1.302 -1.889 0 CA-C-N 123.062 2.129 . . . . 10.85 110.06 -169.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . 0.62 ' CB ' ' HZ3' ' A' ' 689' ' ' LYS . 0.0 OUTLIER -74.17 -2.68 25.74 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 112.153 -2.294 . . . . 9.9 106.941 -176.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 688' ' ' PRO . . . -115.86 62.57 0.36 Allowed Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 105.144 -3.182 . . . . 5.28 105.144 172.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . 0.517 ' HD3' ' C ' ' A' ' 689' ' ' LYS . 15.0 Cg_exo -51.38 126.17 18.58 Favored 'Trans proline' 0 CA--C 1.485 -1.952 1 N-CA-C 98.717 -5.147 . . . . 4.89 98.717 177.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . 0.584 ' O ' ' CG2' ' A' ' 696' ' ' VAL . 67.4 m-20 -65.56 -22.22 66.68 Favored 'General case' 0 N--CA 1.406 -2.635 0 N-CA-C 106.107 -1.812 . . . . 2.13 106.107 -175.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 697' ' ' LEU . 50.2 mt -65.45 -55.21 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 114.95 -1.023 . . . . 1.79 111.662 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 21.0 mt -62.92 -43.83 97.74 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.728 -0.471 . . . . 1.65 109.728 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 91.4 t -67.3 -45.31 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 108.448 -0.945 . . . . 1.07 108.448 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.584 ' CG2' ' O ' ' A' ' 692' ' ' ASP . 71.6 t -64.51 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.342 -0.985 . . . . 1.29 108.342 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 693' ' ' ILE . 17.7 tp -60.69 -43.61 97.54 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.576 -0.284 . . . . 2.15 111.321 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 72.5 mt -66.46 -46.6 75.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.064 -0.717 . . . . 1.78 109.064 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 80.0 p -61.4 -36.78 81.24 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.415 -0.587 . . . . 0.18 109.415 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 696' ' ' VAL . 41.0 t -65.65 -46.92 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 107.977 -1.12 . . . . 1.44 107.977 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 6.3 mtp -59.94 -35.55 75.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.344 -0.984 . . . . 2.97 108.344 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.79 -44.07 81.63 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.57 -1.012 . . . . 0.16 110.57 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.72 96.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 1.03 110.232 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.67 -44.68 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.829 -0.748 . . . . 1.37 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.68 -44.49 96.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.89 -0.324 . . . . 2.3 110.374 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.99 -42.03 97.61 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.045 0.45 . . . . 2.33 110.259 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 89.2 mt -62.77 -41.5 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.804 -0.635 . . . . 1.93 111.021 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.29 -40.61 87.31 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.654 -0.978 . . . . 0.18 110.654 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 17.8 mt -77.68 -25.18 49.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 117.39 0.595 . . . . 2.0 110.693 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -48.44 -60.7 4.06 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 1.15 111.978 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.73 -30.81 40.97 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.875 1.716 . . . . 0.78 112.354 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 716' ' ' ALA . 19.2 mt -68.04 -42.84 79.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.547 -0.909 . . . . 1.62 108.547 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 61.0 mt -65.4 -44.52 87.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.839 -0.43 . . . . 1.59 109.839 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.65 -46.33 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.376 -0.602 . . . . 1.77 109.376 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -63.39 -47.35 82.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.442 -1.318 . . . . 4.47 107.442 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -56.24 -43.51 78.71 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.904 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.498 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 6.3 mt -64.48 -42.66 95.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.643 -0.253 . . . . 2.13 110.54 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 722' ' ' HIS . 80.6 mt -65.18 -45.6 84.21 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.212 -1.033 . . . . 1.54 108.212 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . 0.723 ' O ' ' N ' ' A' ' 723' ' ' ASP . 12.7 mm -65.55 -46.96 88.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 N-CA-C 108.825 -0.806 . . . . 2.03 108.825 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.608 ' N ' ' O ' ' A' ' 716' ' ' ALA . 31.8 m -60.35 -42.23 95.3 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.393 -1.336 . . . . 1.76 107.393 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.498 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 1.3 mm -65.67 -43.58 93.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.83 -0.748 . . . . 1.7 111.392 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 718' ' ' LEU . 46.6 m80 -76.1 -41.26 50.88 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 115.334 -0.848 . . . . 3.18 109.311 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.723 ' N ' ' O ' ' A' ' 719' ' ' ILE . 11.5 t0 -70.39 -52.65 20.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.979 -1.119 . . . . 2.6 107.979 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 720' ' ' THR . 10.8 ttp85 -68.88 148.07 50.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 102.296 -3.224 . . . . 8.29 102.296 173.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 726' ' ' GLU . 0.0 OUTLIER -167.63 -4.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.104 -1.438 . . . . 8.8 109.74 -175.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 725' ' ' LYS . 60.4 tt0 101.66 172.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.673 -1.232 . . . . 8.63 107.673 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 726' ' ' GLU . 2.8 m-85 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.09 -0.957 . . . . 12.13 109.51 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo . . . . . 0 N--CA 1.484 0.927 0 N-CA-C 109.829 -0.874 . . . . 1.0 109.829 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.89 -38.06 87.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.97 0.414 . . . . 1.0 110.333 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.465 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 0.0 OUTLIER -164.78 -48.15 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.674 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 687' ' ' SER . 21.8 Cg_exo -62.54 145.67 95.43 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.049 1.832 . . . . 1.0 111.498 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.08 144.9 50.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.672 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . 0.524 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -97.25 -47.78 2.14 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.273 -0.731 . . . . 1.0 111.273 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 52.3 Cg_exo -54.15 -38.06 87.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.669 2.246 . . . . 1.0 112.346 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -81.34 106.09 13.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.617 0.722 . . . . 1.0 110.757 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.04 -43.17 92.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.732 -1.122 . . . . 1.0 110.965 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.13 -38.69 89.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.297 -0.865 . . . . 1.0 109.99 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.17 -44.77 97.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.162 0.506 . . . . 1.0 109.826 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.417 ' O ' ' OG ' ' A' ' 699' ' ' SER . 78.7 t -63.81 -43.79 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.375 -0.829 . . . . 1.0 109.583 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.1 -41.93 99.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.939 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.14 -42.96 96.58 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.294 0.569 . . . . 1.0 110.018 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 67.2 p -63.78 -34.9 78.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.33 -0.85 . . . . 1.0 109.94 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.27 -44.85 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.27 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 60.9 mtt -63.22 -39.16 93.83 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.49 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.27 99.35 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.35 97.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.633 0.254 . . . . 1.0 111.075 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.37 -44.06 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.414 -0.515 . . . . 1.0 110.684 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.52 -42.7 99.21 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.538 -0.301 . . . . 1.0 111.315 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.57 -40.35 96.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.284 0.564 . . . . 1.0 111.162 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.02 -42.84 96.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.941 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.95 -40.12 89.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.01 -35.21 76.4 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 122.707 0.403 . . . . 1.0 111.536 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -49.61 -60.56 4.75 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 120.233 -0.587 . . . . 1.0 111.926 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.49 -41.08 76.09 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.122 1.215 . . . . 1.0 112.434 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.23 -44.1 89.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.686 -0.487 . . . . 1.0 109.686 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.19 -43.79 90.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.093 0.473 . . . . 1.0 109.906 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.85 -44.8 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.909 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -65.14 -46.56 80.42 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.46 -38.41 87.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.541 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 721' ' ' ILE . 58.8 tp -62.99 -47.13 84.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.139 -0.319 . . . . 1.0 110.139 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.72 -44.34 90.5 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.13 -0.628 . . . . 1.0 110.111 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.5 mm -65.94 -44.46 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 716' ' ' ALA . 79.3 m -62.95 -44.91 94.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.2 mm -64.44 -43.58 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.472 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -60.37 -39.41 87.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.593 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.24 141.77 39.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.996 0.427 . . . . 1.0 110.561 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -96.93 136.53 37.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.224 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -102.77 145.56 29.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.508 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.99 -38.97 89.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.496 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.915 -1.04 . . . . 1.0 110.515 -179.935 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . 0.431 ' H2 ' ' H ' ' A' ' 686' ' ' GLU . 9.3 Cg_endo . . . . . 0 N--CA 1.484 0.957 0 N-CA-C 109.528 -0.989 . . . . 1.0 109.528 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . 0.431 ' H ' ' H2 ' ' A' ' 685' ' ' PRO . 83.7 tt0 -65.94 -38.87 89.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.446 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 43.7 t -143.58 73.19 17.34 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -61.55 145.23 97.97 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.819 2.346 . . . . 1.0 112.034 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -67.74 133.91 50.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.517 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . 0.441 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -172.14 -52.7 0.04 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.026 -0.83 . . . . 1.0 111.026 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 22.3 Cg_exo -61.62 145.14 97.86 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.565 2.177 . . . . 1.0 111.922 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -95.29 -6.03 42.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.306 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 47.1 mm -67.93 -43.61 85.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.835 0.826 . . . . 1.0 109.975 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.83 -39.32 93.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.698 -1.137 . . . . 1.0 110.317 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.62 -47.43 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.374 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.436 ' O ' ' OG ' ' A' ' 699' ' ' SER . 29.7 m -66.62 -37.61 79.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.033 -0.667 . . . . 1.0 109.535 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 39.6 mt -63.07 -42.6 99.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.422 -0.511 . . . . 1.0 111.766 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.35 -42.76 96.07 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.366 0.603 . . . . 1.0 109.746 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 74.3 p -63.6 -34.33 77.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.21 -0.904 . . . . 1.0 109.943 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.41 -45.77 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.188 0.518 . . . . 1.0 109.67 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.59 -38.57 91.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.674 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.79 99.61 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.01 85.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.762 0.315 . . . . 1.0 110.643 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.6 mt -62.77 -44.11 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.002 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.74 -42.03 99.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.091 -0.644 . . . . 1.0 110.779 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.76 -42.01 99.48 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.823 -0.351 . . . . 1.0 111.066 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.08 -41.58 93.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.597 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -71.11 -43.79 55.71 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 110.587 -1.005 . . . . 1.0 110.587 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.53 -37.42 84.97 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.873 0.469 . . . . 1.0 110.679 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . 0.404 ' CB ' ' CD ' ' A' ' 711' ' ' PRO . . . -40.54 -62.58 0.92 Allowed Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.502 -0.772 . . . . 1.0 112.374 -177.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 710' ' ' ALA . 20.2 Cg_endo -61.34 -34.51 87.11 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.802 1.668 . . . . 1.0 113.128 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.71 -43.18 89.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.94 -44.04 90.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.945 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.75 -44.88 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.701 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -65.24 -47.65 76.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.627 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 720' ' ' THR . . . -60.61 -42.49 96.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.398 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 721' ' ' ILE . 38.7 mt -63.6 -43.38 97.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.339 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.55 -44.33 94.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.298 -0.961 . . . . 1.0 109.292 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.74 -44.88 89.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.914 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 716' ' ' ALA . 20.1 m -63.46 -45.8 89.15 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 717' ' ' LEU . 79.3 mt -64.37 -43.1 97.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.538 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -59.96 -40.39 88.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.6 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -72.51 -29.27 63.46 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.596 0.712 . . . . 1.0 109.934 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -66.22 -44.94 82.39 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 118.917 -1.113 . . . . 1.0 110.188 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -69.25 136.35 51.83 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.591 -0.732 . . . . 1.0 110.503 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.32 -38.76 88.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.704 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.069 -0.967 . . . . 1.0 110.601 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . 0.414 ' H2 ' ' H ' ' A' ' 686' ' ' GLU . 12.0 Cg_exo . . . . . 0 N--CA 1.484 0.954 0 N-CA-C 109.519 -0.993 . . . . 1.0 109.519 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . 0.414 ' H ' ' H2 ' ' A' ' 685' ' ' PRO . 80.2 mm-40 -118.62 131.89 56.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.363 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 4.9 t -139.07 73.31 38.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.633 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.61 145.46 97.65 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.84 2.36 . . . . 1.0 112.065 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.02 144.78 50.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.464 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -115.25 -166.3 14.96 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.045 -0.822 . . . . 1.0 111.045 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -61.66 146.0 97.12 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.983 2.455 . . . . 1.0 112.051 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -67.92 144.07 55.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.464 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 693' ' ' ILE . 95.0 mt -64.29 -43.28 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.278 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.14 -40.12 94.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.351 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.73 -43.99 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.437 ' O ' ' OG ' ' A' ' 699' ' ' SER . 77.3 t -63.48 -42.96 98.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.957 -1.02 . . . . 1.0 109.235 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.4 tp -62.62 -42.74 99.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.379 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.14 -43.07 96.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.331 0.586 . . . . 1.0 109.655 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.6 p -63.48 -34.55 78.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.332 -0.849 . . . . 1.0 109.81 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.67 -44.76 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.55 -39.0 93.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.243 -0.889 . . . . 1.0 109.42 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.27 -41.75 99.47 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.705 -0.958 . . . . 1.0 110.705 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.72 -38.5 91.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.702 0.287 . . . . 1.0 110.898 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.05 -43.46 99.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.342 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.64 -42.61 99.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.699 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.0 -41.77 98.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.88 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.14 -42.94 98.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.42 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.91 -47.08 77.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.794 -0.922 . . . . 1.0 110.794 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.35 -36.8 79.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.868 0.467 . . . . 1.0 111.418 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -36.27 -61.39 0.6 Allowed Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.79 -30.81 78.28 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.954 1.769 . . . . 1.0 113.322 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.13 -43.87 90.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.107 -0.637 . . . . 1.0 109.54 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.35 -42.93 95.99 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.216 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.79 -44.9 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -65.39 -46.48 79.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.446 ' O ' ' CG2' ' A' ' 720' ' ' THR . . . -57.89 -47.85 81.56 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.459 -0.791 . . . . 1.0 110.344 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.82 -44.25 93.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.563 -0.455 . . . . 1.0 110.789 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 82.8 mt -65.13 -45.03 86.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.431 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 5.3 tp -71.4 -42.33 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.094 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 716' ' ' ALA . 67.8 p -66.7 -40.41 88.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.684 -0.807 . . . . 1.0 108.852 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.41 -40.3 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.676 0.751 . . . . 1.0 111.211 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 10.9 m80 -63.07 -35.89 81.74 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.935 -0.706 . . . . 1.0 109.67 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -75.22 -39.31 60.16 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.49 0.662 . . . . 1.0 110.552 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -66.96 134.75 52.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.142 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.61 144.13 49.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.74 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.06 -38.76 89.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.406 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 117.976 -1.012 . . . . 1.0 110.526 179.826 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . 0.418 ' H2 ' ' H ' ' A' ' 686' ' ' GLU . 10.3 Cg_endo . . . . . 0 N--CA 1.484 0.937 0 N-CA-C 109.408 -1.035 . . . . 1.0 109.408 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . 0.418 ' H ' ' H2 ' ' A' ' 685' ' ' PRO . 79.9 mm-40 -65.89 -38.63 89.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.485 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 1.4 m 65.06 59.41 1.31 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.714 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -72.38 154.76 55.97 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.963 2.442 . . . . 1.0 112.557 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.09 144.15 50.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.293 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . 0.479 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . 56.12 52.36 49.83 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.011 -0.835 . . . . 1.0 111.011 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 36.5 Cg_endo -65.58 -21.35 59.66 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.954 2.436 . . . . 1.0 111.997 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -67.29 143.88 56.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.471 0.653 . . . . 1.0 110.618 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.98 -42.33 79.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.641 0.734 . . . . 1.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.25 -39.16 91.97 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.077 -0.965 . . . . 1.0 108.713 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.12 -44.28 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.57 0.7 . . . . 1.0 109.229 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 699' ' ' SER . 78.2 t -63.71 -42.92 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.822 -1.081 . . . . 1.0 109.167 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.19 -42.94 99.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.387 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.96 -42.86 97.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.356 0.598 . . . . 1.0 109.755 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 73.4 p -63.61 -33.58 75.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.002 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.64 -45.22 92.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 99.0 mmm -63.57 -37.83 88.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.377 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.08 99.11 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.581 -1.008 . . . . 1.0 110.581 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.88 92.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.769 0.318 . . . . 1.0 110.72 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.56 -43.97 98.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.337 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.31 -42.79 99.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.776 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.2 -41.99 98.87 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.551 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.8 -42.84 97.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.92 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.21 -43.1 81.52 Favored Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.79 -37.31 81.86 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.939 0.496 . . . . 1.0 111.109 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -41.44 -61.57 1.36 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.592 -0.731 . . . . 1.0 112.623 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.11 -32.95 74.63 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.766 1.644 . . . . 1.0 112.749 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.6 mt -66.37 -43.78 84.97 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.14 -43.97 90.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.058 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.98 -45.01 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.972 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -63.89 -46.5 84.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.48 -39.75 88.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.779 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 721' ' ' ILE . 58.9 tp -63.41 -46.33 86.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.68 -45.1 88.09 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 120.178 -0.609 . . . . 1.0 110.167 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 31.0 mm -66.28 -44.35 91.19 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 716' ' ' ALA . 78.8 m -62.83 -44.09 97.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 717' ' ' LEU . 2.2 mm -64.59 -43.59 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.789 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.507 ' O ' ' C ' ' A' ' 723' ' ' ASP . 7.5 m80 -64.1 -35.61 81.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.069 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 722' ' ' HIS . 99.5 m-20 -8.77 -72.1 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.999 0.812 . . . . 1.0 112.803 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 722' ' ' HIS . 85.6 mtp180 -79.23 144.61 34.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.647 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 727' ' ' PHE . 64.5 mttp -112.49 145.49 40.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.548 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 727' ' ' PHE . 97.3 mt-10 45.67 -89.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.613 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 725' ' ' LYS . 96.5 m-85 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.562 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 N--CA 1.483 0.903 0 N-CA-C 109.605 -0.96 . . . . 1.0 109.605 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.79 137.86 58.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.605 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 10.2 p -155.49 72.49 5.48 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.549 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -61.72 145.85 97.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.799 2.333 . . . . 1.0 111.942 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -106.13 146.32 30.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.263 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 139.43 -67.79 0.5 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.788 -0.925 . . . . 1.0 110.788 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.51 -22.2 59.1 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.378 2.052 . . . . 1.0 112.09 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -68.02 -41.06 82.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 97.1 mt -67.48 -42.7 87.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.095 -0.957 . . . . 1.0 110.559 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.62 -36.56 83.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.016 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.08 -43.73 97.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 O-C-N 123.699 0.624 . . . . 1.0 109.616 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.417 ' O ' ' OG ' ' A' ' 699' ' ' SER . 77.4 t -62.91 -43.47 98.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.614 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.23 -40.97 98.95 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.185 -0.606 . . . . 1.0 112.11 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.94 -43.24 96.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.441 0.639 . . . . 1.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 70.9 p -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.327 -0.852 . . . . 1.0 109.443 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.86 -45.72 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.523 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.7 ttp -62.05 -40.02 94.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.154 -0.93 . . . . 1.0 109.718 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.2 -40.67 99.28 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.71 -36.8 84.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.749 0.309 . . . . 1.0 110.479 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.64 -43.73 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.971 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.43 -41.41 98.7 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.906 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.24 -41.72 98.68 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.826 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 30.8 mm -63.43 -43.45 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.72 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.95 -46.81 64.03 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.392 -0.683 . . . . 1.0 111.392 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.39 -35.27 77.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.838 0.352 . . . . 1.0 111.123 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -40.47 -62.04 1.04 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 115.882 -0.599 . . . . 1.0 112.421 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.53 -32.49 70.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.882 1.721 . . . . 1.0 112.575 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.57 -43.36 90.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.5 -43.7 93.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.794 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.71 -44.91 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.059 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -65.02 -46.36 81.67 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.0 -41.91 97.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.287 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.7 mt -63.68 -43.79 95.64 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.723 -0.391 . . . . 1.0 109.991 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.38 -44.79 90.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.79 -0.764 . . . . 1.0 109.831 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 93.1 mt -66.27 -44.81 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 716' ' ' ALA . 99.9 m -63.66 -45.09 91.74 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.0 mm -64.23 -43.64 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.199 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -59.84 -39.57 85.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.731 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -167.91 163.98 13.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.42 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 726' ' ' GLU . 99.8 mtt180 -131.93 140.09 48.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.58 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 38.26 23.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.44 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 724' ' ' ARG . 97.0 mt-10 -140.81 148.74 41.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 1.0 110.715 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.611 179.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . 0.414 ' H2 ' ' H ' ' A' ' 686' ' ' GLU . 11.6 Cg_exo . . . . . 0 N--CA 1.484 0.958 0 N-CA-C 109.569 -0.973 . . . . 1.0 109.569 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . 0.414 ' H ' ' H2 ' ' A' ' 685' ' ' PRO . 97.4 mt-10 -65.89 -38.81 89.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.581 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 688' ' ' PRO . 0.4 OUTLIER -57.19 179.99 0.12 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.279 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 687' ' ' SER . 22.9 Cg_exo -61.7 145.28 97.56 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.138 1.892 . . . . 1.0 112.087 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.02 142.01 38.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 1.0 109.976 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . 0.482 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -108.69 -51.19 0.71 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 21.7 Cg_exo -61.72 144.85 97.56 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.664 2.242 . . . . 1.0 111.794 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -90.02 -19.0 24.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.341 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.72 -43.69 89.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.336 0.588 . . . . 1.0 110.232 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.15 -37.57 85.73 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 65.7 t -64.92 -44.39 96.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.608 0.718 . . . . 1.0 109.204 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.446 ' O ' ' OG ' ' A' ' 699' ' ' SER . 77.1 t -63.4 -42.77 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.689 -1.141 . . . . 1.0 109.349 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.16 -44.24 97.06 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.147 0.425 . . . . 1.0 112.147 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.38 -42.5 96.11 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -62.36 -35.38 78.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.779 . . . . 1.0 109.779 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 66.3 t -66.66 -45.93 87.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.493 0.663 . . . . 1.0 109.331 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 63.4 mtt -62.83 -38.52 91.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.139 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.03 -41.2 99.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.83 84.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.665 0.269 . . . . 1.0 110.471 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.6 mt -62.84 -43.99 99.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.905 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.5 -42.1 99.27 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.056 -0.658 . . . . 1.0 110.969 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.65 -42.03 98.33 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.72 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.27 -40.79 90.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.964 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -73.27 -44.55 34.33 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.739 -0.944 . . . . 1.0 110.739 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.25 -36.83 80.05 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.629 0.372 . . . . 1.0 111.936 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -47.5 -59.79 5.05 Favored Pre-proline 0 N--CA 1.464 0.275 0 C-N-CA 120.057 -0.657 . . . . 1.0 111.405 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -53.23 -40.3 77.94 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.43 1.42 . . . . 1.0 112.644 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.24 -44.67 87.45 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.563 -0.455 . . . . 1.0 109.936 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.77 -42.96 94.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.533 -0.467 . . . . 1.0 109.932 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.12 -44.74 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -65.68 -46.82 77.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.441 ' O ' ' CG2' ' A' ' 720' ' ' THR . . . -60.9 -41.11 95.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.29 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.479 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 35.4 mt -63.16 -44.34 95.78 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.104 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.73 -45.01 88.29 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 119.943 -0.703 . . . . 1.0 109.991 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.8 mm -66.86 -44.82 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.346 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 716' ' ' ALA . 66.5 p -67.45 -39.66 85.38 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 119.217 -0.993 . . . . 1.0 108.706 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.8 mm -64.65 -43.41 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 119.962 -0.695 . . . . 1.0 110.639 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -60.27 -39.38 86.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.333 -0.848 . . . . 1.0 110.647 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -74.01 -19.24 60.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.506 -0.316 . . . . 1.0 110.389 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' A' ' 721' ' ' ILE . 94.9 mtt-85 -102.71 136.83 41.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 1.0 110.59 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.18 -42.04 99.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.537 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 56.62 76.38 0.3 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.205 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.993 -1.003 . . . . 1.0 110.598 -179.796 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 N--CA 1.484 0.922 0 N-CA-C 109.575 -0.971 . . . . 1.0 109.575 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.66 126.21 54.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.616 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 70.1 m -139.95 72.75 34.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.533 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.51 145.19 98.12 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.911 2.407 . . . . 1.0 112.081 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.14 145.62 50.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.355 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -151.13 -56.31 0.01 OUTLIER Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.889 -0.672 . . . . 1.0 111.451 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -61.34 144.06 98.24 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.309 2.006 . . . . 1.0 112.073 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -98.13 -4.45 35.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.412 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 694' ' ' LEU . 20.7 tt -69.9 -41.51 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.994 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . 0.468 ' N ' ' CG2' ' A' ' 693' ' ' ILE . 90.9 mt -62.93 -40.27 97.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.437 -0.801 . . . . 1.0 109.204 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.0 -45.04 97.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.441 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 699' ' ' SER . 75.9 t -63.86 -43.11 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.052 -0.977 . . . . 1.0 109.43 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.41 -43.02 99.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.562 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.34 -43.09 95.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.222 0.534 . . . . 1.0 109.56 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 75.7 p -63.96 -34.09 77.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.793 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 73.6 t -65.77 -44.69 93.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.8 mtp -63.61 -38.97 93.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.297 -0.865 . . . . 1.0 109.619 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.78 -41.85 98.74 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.12 93.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.655 0.264 . . . . 1.0 110.844 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.26 -43.83 98.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.494 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.16 -42.18 99.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.654 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.94 -42.28 99.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.875 0.369 . . . . 1.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.427 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 96.0 mt -62.23 -40.85 89.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.55 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -72.83 -42.27 46.43 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.63 -37.34 84.64 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 122.921 0.488 . . . . 1.0 111.588 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -51.17 -59.91 6.74 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 120.285 -0.566 . . . . 1.0 112.172 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . 0.427 ' CD ' ' O ' ' A' ' 707' ' ' ILE . 43.5 Cg_exo -53.02 -41.04 74.5 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.542 1.495 . . . . 1.0 112.18 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.27 -43.93 89.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.73 -43.45 93.36 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.834 -0.432 . . . . 1.0 109.834 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . 0.422 HG22 HD13 ' A' ' 714' ' ' ILE . 94.9 mt -64.42 -44.89 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.601 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 79.5 t90 -65.72 -47.01 76.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 720' ' ' THR . . . -61.75 -39.13 90.54 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.933 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 60.0 tp -63.03 -45.98 89.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . 0.534 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 87.6 mt -65.13 -46.02 82.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.283 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.8 -44.46 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.284 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 716' ' ' ALA . 61.6 p -66.13 -36.13 82.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.307 -0.957 . . . . 1.0 108.605 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 2.3 mm -66.56 -39.48 84.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.976 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 725' ' ' LYS . 40.5 m80 -66.88 -34.64 78.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.36 -0.837 . . . . 1.0 111.225 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 722' ' ' HIS . 98.2 m-20 -8.89 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 124.336 1.023 . . . . 1.0 113.231 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -63.08 -43.33 98.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.039 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 722' ' ' HIS . 87.2 tttt -68.29 132.9 47.92 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.98 -41.94 90.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.336 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' A' ' 727' ' ' PHE . 52.0 p90 . . . . . 0 C--O 1.221 -0.395 0 CA-C-O 117.974 -1.012 . . . . 1.0 110.475 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.483 0.907 0 N-CA-C 109.609 -0.958 . . . . 1.0 109.609 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.0 -38.93 89.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.416 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.49 161.8 70.96 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.414 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.82 152.47 63.83 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.929 2.419 . . . . 1.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -141.26 151.19 43.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.793 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 167.02 -173.04 42.28 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.8 -38.68 85.5 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.782 2.321 . . . . 1.0 111.975 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 66.1 t0 67.6 -48.22 0.51 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.664 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.03 -43.85 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.018 0.437 . . . . 1.0 110.472 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.94 -38.74 92.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.723 -0.672 . . . . 1.0 109.447 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.54 -45.39 98.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.63 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.445 ' O ' ' OG ' ' A' ' 699' ' ' SER . 74.7 t -63.85 -43.67 97.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.446 -0.797 . . . . 1.0 109.392 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.25 -42.05 99.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.267 0.469 . . . . 1.0 112.267 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.04 -42.76 96.96 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.256 0.55 . . . . 1.0 109.806 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.9 p -63.25 -34.08 76.88 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.002 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.61 -45.21 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.643 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.27 -38.1 89.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.485 -0.779 . . . . 1.0 109.775 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.3 -42.24 99.3 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.561 -1.016 . . . . 1.0 110.561 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.93 96.15 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.673 0.237 . . . . 1.0 110.675 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.74 -42.93 98.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 121.867 0.841 . . . . 1.0 110.008 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.16 -41.56 98.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.985 -0.686 . . . . 1.0 110.876 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.98 -40.52 97.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.773 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.27 -43.16 98.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.578 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.76 -46.08 62.5 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.716 -0.954 . . . . 1.0 110.716 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.29 -35.75 78.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.163 0.506 . . . . 1.0 111.185 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -40.06 -61.95 1.01 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.429 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.04 -32.33 75.76 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.811 1.674 . . . . 1.0 112.73 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.06 -43.57 87.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.04 -43.66 91.63 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.965 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.7 -44.82 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.96 -0.564 . . . . 1.0 109.748 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -65.5 -46.56 79.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -59.73 -42.06 92.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.111 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 721' ' ' ILE . 37.7 mt -63.63 -44.09 94.92 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.238 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.74 -45.35 86.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.956 -0.698 . . . . 1.0 110.024 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.42 -44.61 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 716' ' ' ALA . 97.6 m -63.51 -44.9 92.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.536 -0.913 . . . . 1.0 108.536 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.5 -43.13 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.666 -0.697 . . . . 1.0 111.3 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -61.93 -36.33 81.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.755 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -86.64 112.45 21.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 1.0 110.91 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -124.41 133.68 53.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.042 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.53 133.41 50.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.607 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -115.54 126.91 54.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.377 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.553 -179.835 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 N--CA 1.483 0.896 0 N-CA-C 109.612 -0.957 . . . . 1.0 109.612 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -96.79 -7.99 32.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.816 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.562 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 0.0 OUTLIER -62.4 -43.55 85.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.123 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 687' ' ' SER . 22.7 Cg_exo -61.38 144.72 98.49 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.555 2.17 . . . . 1.0 112.027 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.39 -41.89 98.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.768 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -151.95 84.89 0.15 Allowed Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.08 153.11 46.46 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.073 1.849 . . . . 1.0 112.501 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -97.33 -4.48 38.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.559 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.4 mt -65.4 -43.65 94.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-O 121.296 0.57 . . . . 1.0 110.164 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.87 -40.0 96.16 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.315 -0.857 . . . . 1.0 109.333 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.05 -45.15 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.382 0.611 . . . . 1.0 109.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 699' ' ' SER . 76.4 t -64.11 -42.99 97.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.995 -1.002 . . . . 1.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 51.7 tp -62.61 -43.03 99.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.71 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.99 -43.02 96.94 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.259 0.552 . . . . 1.0 109.748 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.6 p -63.23 -34.32 77.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.856 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 76.4 t -65.44 -45.3 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.638 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.9 mmm -63.93 -37.98 89.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.441 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.49 -42.38 98.98 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.546 -1.022 . . . . 1.0 110.546 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.3 90.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.713 0.292 . . . . 1.0 110.866 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.94 -43.55 99.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.472 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.33 -42.19 99.18 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.784 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.0 mt -62.89 -41.51 99.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.354 . . . . 1.0 110.705 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.3 -43.25 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.291 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.86 -43.57 73.44 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.49 -37.14 82.41 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 122.879 0.472 . . . . 1.0 110.954 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -41.45 -61.96 1.23 Allowed Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.782 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.27 -33.09 72.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.782 1.654 . . . . 1.0 112.672 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.19 -43.95 85.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.45 -44.21 87.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.155 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.18 -44.68 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.282 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -66.08 -46.54 77.34 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.54 -37.98 85.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.848 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 721' ' ' ILE . 58.6 tp -63.54 -44.15 95.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . 0.557 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 84.4 mt -64.63 -43.62 93.13 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 97.9 mt -65.25 -41.74 92.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 CA-C-O 123.64 1.686 . . . . 1.0 107.962 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 716' ' ' ALA . 99.0 m -68.29 -41.23 81.28 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 117.978 -1.489 . . . . 1.0 108.629 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.2 mm -64.71 -44.13 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 119.802 -0.759 . . . . 1.0 111.339 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 43.1 m80 -63.17 -40.62 98.08 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.274 -0.876 . . . . 1.0 110.442 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -67.92 -41.26 82.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.781 0.324 . . . . 1.0 110.256 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -62.76 -43.03 99.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.423 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -71.26 136.61 48.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.238 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.63 -39.22 93.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.911 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . 0.54 ' O ' ' CD2' ' A' ' 727' ' ' PHE . 81.8 t80 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 N--CA 1.483 0.897 0 N-CA-C 109.584 -0.968 . . . . 1.0 109.584 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -114.19 125.71 54.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.301 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 9.5 p -177.23 73.05 0.23 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.59 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.62 145.6 97.5 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.932 2.421 . . . . 1.0 111.97 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -110.86 146.07 37.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.389 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 145.26 -160.53 28.08 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.16 145.42 98.75 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.538 2.158 . . . . 1.0 111.671 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -98.75 -3.18 36.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.573 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.82 -43.76 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.426 0.631 . . . . 1.0 109.886 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.04 -39.91 96.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.503 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.73 -45.47 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.439 ' O ' ' OG ' ' A' ' 699' ' ' SER . 77.3 t -64.04 -43.38 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.165 -0.925 . . . . 1.0 109.156 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.65 -43.71 98.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.841 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.44 -42.56 95.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.136 0.493 . . . . 1.0 109.7 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 78.0 p -63.21 -34.8 78.42 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.883 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.63 -45.43 92.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.2 ttp -62.05 -39.56 92.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.587 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.96 -42.43 98.29 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.898 -0.881 . . . . 1.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.92 95.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.586 0.231 . . . . 1.0 110.716 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.37 -44.04 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.399 -0.521 . . . . 1.0 110.36 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.25 -43.09 99.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.714 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.8 -41.19 99.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.153 0.502 . . . . 1.0 111.855 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.7 -39.98 87.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.351 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.41 -42.88 63.7 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.612 -0.995 . . . . 1.0 110.612 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.47 -37.88 83.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.278 0.561 . . . . 1.0 110.631 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -36.55 -62.31 0.54 Allowed Pre-proline 0 C--N 1.333 -0.118 0 CA-C-N 115.618 -0.719 . . . . 1.0 112.096 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.03 -31.19 83.78 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.654 1.569 . . . . 1.0 113.256 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.72 -44.11 87.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.48 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.29 -42.84 96.21 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.293 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.95 -44.9 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -65.91 -45.91 80.23 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.273 -0.639 . . . . 1.0 109.273 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 720' ' ' THR . . . -57.96 -47.65 82.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.372 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.462 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 83.1 mt -64.26 -43.73 93.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.75 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.06 -44.89 87.52 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.139 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 5.1 tp -71.4 -41.88 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 108.925 -0.769 . . . . 1.0 108.925 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 716' ' ' ALA . 96.9 m -63.6 -44.86 92.78 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.42 -43.33 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.021 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -60.73 -38.34 84.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -77.34 143.33 38.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.466 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -138.85 152.24 47.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.607 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -127.28 144.63 51.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.565 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -116.86 127.41 54.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.519 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.03 -0.986 . . . . 1.0 110.562 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 N--CA 1.483 0.907 0 N-CA-C 109.569 -0.973 . . . . 1.0 109.569 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . 0.418 ' O ' ' OG ' ' A' ' 687' ' ' SER . 83.8 tt0 -114.12 125.94 54.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.398 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 686' ' ' GLU . 2.7 m 176.4 73.93 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.538 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.49 145.27 98.09 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.842 2.361 . . . . 1.0 111.962 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -127.05 145.01 50.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.618 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 167.43 71.54 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.939 -0.865 . . . . 1.0 110.939 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.73 145.36 97.41 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.744 2.296 . . . . 1.0 111.943 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -95.58 -7.58 37.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.131 0.491 . . . . 1.0 110.039 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 32.3 mm -65.66 -43.47 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.665 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.63 -40.23 96.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.463 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.9 t -63.23 -45.2 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.322 0.582 . . . . 1.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.44 ' O ' ' OG ' ' A' ' 699' ' ' SER . 78.4 t -63.9 -43.17 97.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.48 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 40.4 mt -62.84 -42.48 99.76 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.497 -0.481 . . . . 1.0 112.057 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.26 -42.61 96.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.25 0.548 . . . . 1.0 109.805 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -63.28 -34.61 78.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.893 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.44 -45.65 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.695 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 99.0 mmm -64.94 -37.51 87.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.644 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.38 -43.14 99.49 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.86 77.69 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.092 -0.643 . . . . 1.0 110.823 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.96 -43.11 98.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.062 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.83 -42.08 99.58 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.088 -0.645 . . . . 1.0 111.892 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.79 -40.27 96.25 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.648 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.425 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 36.8 mm -64.55 -34.14 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.858 0.361 . . . . 1.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -77.5 -43.94 14.22 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.021 -1.085 . . . . 1.0 111.024 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.26 -36.56 81.84 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.76 0.424 . . . . 1.0 111.969 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -50.72 -60.04 6.23 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.079 -0.649 . . . . 1.0 111.768 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 707' ' ' ILE . 42.8 Cg_exo -53.07 -41.29 72.83 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.296 1.331 . . . . 1.0 112.113 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.31 -44.12 88.89 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.59 -43.46 93.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.607 -0.437 . . . . 1.0 110.007 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.58 -44.79 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.7 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -66.33 -46.12 77.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 720' ' ' THR . . . -61.82 -38.59 88.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.661 -0.7 . . . . 1.0 109.655 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.09 -45.56 91.54 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . 0.533 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 86.7 mt -63.59 -43.36 97.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.23 -0.588 . . . . 1.0 109.499 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.63 -44.26 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 716' ' ' ALA . 74.3 p -64.12 -41.21 97.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.042 -1.063 . . . . 1.0 108.404 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 81.7 mt -64.46 -43.4 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 119.57 -0.852 . . . . 1.0 111.706 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 52.0 m80 -65.18 -37.73 88.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.547 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -85.23 114.54 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 1.0 110.784 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -73.48 146.05 45.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.555 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.93 -41.92 99.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 727' ' ' PHE . 83.9 tt0 -109.75 117.26 33.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.435 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . 0.443 ' C ' ' O ' ' A' ' 726' ' ' GLU . 88.0 m-85 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.961 -1.019 . . . . 1.0 111.567 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.484 0.957 0 N-CA-C 109.659 -0.939 . . . . 1.0 109.659 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -65.98 -38.51 88.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.409 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 62.1 m -131.89 78.05 70.76 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.53 145.0 98.21 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.593 2.195 . . . . 1.0 112.004 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . 0.41 ' O ' ' CD1' ' A' ' 694' ' ' LEU . 88.7 tttt -62.21 -44.21 97.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.537 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 43.98 69.5 0.68 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.71 -38.02 91.51 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.966 2.444 . . . . 1.0 112.294 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.89 -42.41 90.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.367 0.603 . . . . 1.0 110.046 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 94.8 mt -65.55 -43.27 94.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.353 -0.839 . . . . 1.0 110.031 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 689' ' ' LYS . 88.8 mt -62.65 -39.96 95.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.996 -1.002 . . . . 1.0 109.53 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.75 -45.1 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.298 -0.63 . . . . 1.0 109.298 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.434 ' O ' ' OG ' ' A' ' 699' ' ' SER . 77.0 t -64.05 -43.15 97.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.961 -1.018 . . . . 1.0 109.282 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.49 -42.99 99.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.598 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.32 -43.17 95.52 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.183 0.516 . . . . 1.0 109.671 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -63.28 -34.95 78.79 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.825 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.81 -45.39 91.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.0 ttp -61.92 -39.42 91.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.136 -0.938 . . . . 1.0 109.571 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.53 -40.78 99.56 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.41 87.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.497 0.189 . . . . 1.0 111.016 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 31.6 mm -62.95 -44.12 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.434 -0.507 . . . . 1.0 110.771 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.71 -41.98 99.42 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.932 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.29 -42.53 99.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.811 0.339 . . . . 1.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.43 -43.25 98.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.197 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.52 -43.9 75.02 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.42 -36.88 82.14 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.869 0.468 . . . . 1.0 111.115 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -40.12 -62.19 0.96 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.83 -0.623 . . . . 1.0 112.435 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.02 -33.65 82.5 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.657 1.571 . . . . 1.0 113.036 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.66 -42.94 90.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.45 -43.69 93.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.883 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.78 -44.9 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.888 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -65.96 -45.96 79.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -55.46 -47.65 75.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.275 -0.875 . . . . 1.0 109.857 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 721' ' ' ILE . 40.3 mt -63.69 -43.3 97.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.539 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.44 -44.89 89.72 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 120.171 -0.611 . . . . 1.0 111.243 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 14.1 pt -73.17 -41.85 58.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 94.8 m -64.14 -43.55 94.88 Favored 'General case' 0 C--O 1.265 1.876 0 CA-C-O 122.346 1.07 . . . . 1.0 108.616 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 717' ' ' LEU . 76.9 mt -66.0 -44.43 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 117.802 -1.559 . . . . 1.0 111.702 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -59.38 -39.64 84.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.083 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -66.75 -39.09 87.77 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.78 0.324 . . . . 1.0 110.255 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -62.65 -42.9 99.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.395 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -62.41 -44.35 96.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.454 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 56.23 76.23 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.269 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . 0.491 ' CD2' ' OXT' ' A' ' 727' ' ' PHE . 55.2 p90 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.997 -1.002 . . . . 1.0 110.517 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 N--CA 1.484 0.956 0 N-CA-C 109.521 -0.992 . . . . 1.0 109.521 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.04 -38.92 89.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.579 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 74.9 m 44.11 59.47 12.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.785 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.2 153.74 56.75 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.937 2.425 . . . . 1.0 112.41 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -110.78 130.16 55.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.338 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 103.59 75.53 1.06 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.827 -0.909 . . . . 1.0 110.827 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.76 145.49 97.26 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.858 2.372 . . . . 1.0 111.606 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -94.84 -8.66 36.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.299 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.63 -43.19 93.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.633 0.73 . . . . 1.0 110.071 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.04 -37.17 86.73 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.788 -1.096 . . . . 1.0 109.737 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.89 -43.29 93.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.806 0.812 . . . . 1.0 109.571 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.05 -39.74 85.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.48 -1.236 . . . . 1.0 109.693 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.98 -43.05 96.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.833 -0.621 . . . . 1.0 111.684 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -65.36 -42.23 92.98 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.319 -0.622 . . . . 1.0 109.319 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 59.3 p -62.98 -35.05 78.91 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.678 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.44 -44.53 90.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.333 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 5.7 ttp -61.89 -39.26 91.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.29 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.92 -41.67 98.62 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.13 96.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.775 0.321 . . . . 1.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.0 -43.72 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.26 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.41 -42.32 99.35 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.659 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.58 -42.38 99.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 1.0 110.446 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.23 -43.35 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.62 -44.88 69.31 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.414 -1.074 . . . . 1.0 110.414 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.05 -38.04 82.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.138 0.494 . . . . 1.0 110.99 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -37.13 -61.77 0.65 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.726 -0.67 . . . . 1.0 112.315 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.79 -31.25 78.35 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.764 1.643 . . . . 1.0 113.192 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.5 -44.45 86.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.3 -0.56 . . . . 1.0 109.525 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.45 -42.84 95.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.099 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.26 -45.09 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 120.297 -0.561 . . . . 1.0 109.872 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . 0.407 ' CE3' ' CD1' ' A' ' 719' ' ' ILE . 1.5 t90 -65.98 -46.53 77.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.15 -43.4 95.76 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.352 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 721' ' ' ILE . 38.0 mt -63.39 -43.95 96.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.297 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.58 -44.57 90.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.749 -0.78 . . . . 1.0 109.679 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . 0.407 ' CD1' ' CE3' ' A' ' 715' ' ' TRP . 93.3 mt -66.32 -45.01 90.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.756 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 716' ' ' ALA . 97.3 m -63.84 -44.74 92.28 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.0 mm -64.18 -43.59 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.984 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -60.28 -40.09 89.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.545 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.95 -42.99 69.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.789 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 721' ' ' ILE . 99.9 mtt180 -130.36 140.6 50.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.842 0.353 . . . . 1.0 110.991 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.32 -42.08 98.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.634 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -135.63 148.25 48.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.702 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.987 -1.006 . . . . 1.0 110.613 -179.921 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.483 0.885 0 N-CA-C 109.576 -0.971 . . . . 1.0 109.576 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -65.98 -38.9 89.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.027 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 70.1 m -144.01 74.74 16.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.48 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.57 145.05 98.07 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.748 2.299 . . . . 1.0 112.004 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -68.75 133.68 48.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.683 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -144.83 -172.73 15.53 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -61.65 144.16 97.23 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.508 2.139 . . . . 1.0 111.888 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -97.73 -5.23 35.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.413 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.51 -43.74 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.408 0.623 . . . . 1.0 110.26 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.81 -40.06 96.19 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.274 -0.875 . . . . 1.0 109.563 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.86 -45.42 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-O 121.42 0.629 . . . . 1.0 109.734 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 699' ' ' SER . 79.3 t -64.29 -43.08 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.001 -1.0 . . . . 1.0 109.382 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 51.9 tp -61.93 -42.47 99.13 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.87 -0.605 . . . . 1.0 112.031 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.19 -42.15 89.22 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.178 0.513 . . . . 1.0 110.926 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 68.8 p -61.73 -39.39 91.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.445 -0.798 . . . . 1.0 111.633 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.27 -40.31 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 119.67 -0.812 . . . . 1.0 109.498 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 56.0 ttp -61.23 -39.5 90.52 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.2 -40.81 98.33 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 110.595 -1.002 . . . . 1.0 110.595 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.52 91.37 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.689 -0.404 . . . . 1.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.96 -44.52 99.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 120.452 -0.499 . . . . 1.0 110.272 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.21 -43.16 99.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.628 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.58 -40.29 96.43 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.75 0.31 . . . . 1.0 111.142 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.455 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 85.2 mt -62.28 -41.54 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.84 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.31 -44.71 64.17 Favored Glycine 0 N--CA 1.471 0.996 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 8.9 mp -69.07 -35.47 76.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.501 -0.35 . . . . 1.0 111.936 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -50.5 -59.83 6.52 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 119.445 -0.902 . . . . 1.0 111.644 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . 0.455 ' CD ' ' O ' ' A' ' 707' ' ' ILE . 38.7 Cg_exo -53.16 -41.04 74.99 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.538 1.492 . . . . 1.0 112.308 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.52 -44.07 88.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.499 -0.556 . . . . 1.0 109.499 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.6 -43.82 92.6 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.475 -0.49 . . . . 1.0 109.876 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.53 -44.84 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.76 -45.84 87.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.979 -0.748 . . . . 1.0 108.979 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -59.38 -40.52 86.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.999 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.9 mt -63.16 -43.7 97.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.426 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.86 -43.93 94.62 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.413 -0.915 . . . . 1.0 109.021 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . 0.453 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.1 mm -65.11 -45.24 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 716' ' ' ALA . 19.7 m -64.92 -46.61 80.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.953 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 717' ' ' LEU . 82.7 mt -65.52 -44.19 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.488 ' O ' ' C ' ' A' ' 723' ' ' ASP . 1.7 p-80 -67.69 -30.03 69.44 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 119.799 -0.76 . . . . 1.0 110.512 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.488 ' C ' ' O ' ' A' ' 722' ' ' HIS . 51.6 p-10 -7.05 126.27 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.154 0.908 . . . . 1.0 113.392 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -62.51 -42.87 99.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.348 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.5 146.61 48.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.637 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -109.21 124.11 50.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.521 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.554 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo . . . . . 0 N--CA 1.484 0.945 0 N-CA-C 109.56 -0.977 . . . . 1.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -64.97 138.35 58.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.98 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 32.1 m 54.48 73.01 0.96 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.59 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -61.69 145.25 97.6 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.747 2.298 . . . . 1.0 112.072 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.56 144.54 50.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.572 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -177.61 -70.14 0.06 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.77 -23.06 63.25 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.756 2.304 . . . . 1.0 112.144 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 693' ' ' ILE . 38.2 p-10 -71.83 -40.98 68.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.8 -0.637 . . . . 1.0 109.836 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . 0.548 ' N ' ' OD1' ' A' ' 692' ' ' ASP . 97.9 mt -65.44 -43.66 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.039 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.33 -37.05 84.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.307 -0.861 . . . . 1.0 109.129 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.81 -45.09 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.772 0.796 . . . . 1.0 109.334 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.436 ' O ' ' OG ' ' A' ' 699' ' ' SER . 76.2 t -63.32 -43.09 98.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.207 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.26 -43.04 99.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.642 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.04 -43.19 96.29 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.143 0.497 . . . . 1.0 109.724 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 72.8 p -63.4 -34.61 78.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.466 -0.788 . . . . 1.0 109.883 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.67 -45.27 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 53.4 ttp -61.71 -39.91 93.17 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.345 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.42 -42.42 99.06 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.28 92.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.834 0.826 . . . . 1.0 110.341 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.12 -43.76 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 119.763 -0.775 . . . . 1.0 109.943 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.05 -43.81 98.03 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.94 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.54 -41.2 98.73 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.631 0.253 . . . . 1.0 110.598 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.43 -43.0 98.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.31 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.39 -40.84 94.63 Favored Glycine 0 N--CA 1.468 0.783 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.06 -35.15 76.23 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.715 0.406 . . . . 1.0 111.757 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -48.62 -60.54 4.39 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.201 -0.6 . . . . 1.0 111.862 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -53.49 -41.44 73.3 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.235 1.29 . . . . 1.0 112.529 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.68 -43.3 94.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.631 -0.428 . . . . 1.0 109.891 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.43 -43.9 92.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.403 -0.519 . . . . 1.0 110.249 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.69 -44.77 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -64.35 -48.65 74.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.438 -0.579 . . . . 1.0 109.438 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -58.76 -41.74 87.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.987 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 721' ' ' ILE . 37.2 mt -63.69 -44.17 94.47 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.731 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.47 -45.43 87.39 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.796 -0.762 . . . . 1.0 110.034 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . 0.529 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 1.7 mp -66.78 -45.3 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.11 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 716' ' ' ALA . 98.8 m -64.87 -45.95 83.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.11 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.474 ' N ' ' O ' ' A' ' 717' ' ' LEU . 82.6 mt -65.61 -43.97 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.156 0.799 . . . . 1.0 113.156 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 1.9 p-80 -65.64 -35.52 81.02 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.306 -0.958 . . . . 1.0 110.266 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 722' ' ' HIS . 64.6 t0 -66.83 -40.01 87.84 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.058 -0.349 . . . . 1.0 110.058 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -67.45 134.43 51.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.288 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 727' ' ' PHE . 98.8 mttt -63.04 -41.96 99.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.593 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 45.38 -88.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.671 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 725' ' ' LYS . 89.0 t80 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.047 -0.978 . . . . 1.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.482 0.829 0 N-CA-C 109.463 -1.014 . . . . 1.0 109.463 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -114.41 125.96 54.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.6 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 10.6 t -166.82 73.52 1.09 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.697 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.9 145.14 97.1 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.852 2.368 . . . . 1.0 111.964 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.35 -44.11 97.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.591 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . 97.97 55.87 1.11 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 41.4 Cg_endo -69.37 -11.8 32.17 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.77 2.313 . . . . 1.0 112.314 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -65.7 -40.54 92.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.17 0.509 . . . . 1.0 110.315 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 10.9 tp -70.18 -39.25 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.268 0.556 . . . . 1.0 109.968 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.34 -39.27 92.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.269 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.73 -44.82 98.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 699' ' ' SER . 75.6 t -64.06 -43.56 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.643 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.37 -41.89 98.83 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.276 0.472 . . . . 1.0 112.276 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.88 -42.87 97.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.325 0.583 . . . . 1.0 109.728 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.2 p -64.04 -34.05 77.15 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.253 -0.885 . . . . 1.0 109.801 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.54 -45.55 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.659 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.9 mmm -64.52 -38.48 91.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.629 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.59 -41.2 99.53 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.456 -1.058 . . . . 1.0 110.456 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.78 84.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.806 0.336 . . . . 1.0 110.555 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.7 mt -62.8 -43.92 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.454 -0.499 . . . . 1.0 110.954 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.51 -42.02 99.22 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.185 -0.606 . . . . 1.0 110.743 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.25 -42.44 99.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 1.0 110.551 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.35 -43.27 98.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.229 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.83 -43.81 72.53 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.718 -0.953 . . . . 1.0 110.718 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.41 -37.38 82.97 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 122.79 0.436 . . . . 1.0 111.067 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -40.28 -62.2 0.98 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.602 -0.726 . . . . 1.0 112.529 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.24 -32.85 73.22 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.672 1.581 . . . . 1.0 112.573 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.01 -43.52 87.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.1 -43.89 90.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.087 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.7 mt -64.03 -44.58 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.751 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -65.26 -46.46 80.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -58.16 -43.89 87.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.125 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 721' ' ' ILE . 80.2 mt -63.85 -42.89 97.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.633 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.1 -44.37 89.04 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.693 -0.803 . . . . 1.0 109.733 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . 0.545 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.5 mm -66.37 -45.39 89.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.881 -0.785 . . . . 1.0 108.881 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.428 ' O ' ' OD2' ' A' ' 723' ' ' ASP . 38.3 m -64.69 -44.64 89.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.14 -0.936 . . . . 1.0 110.912 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 717' ' ' LEU . 81.0 mt -67.26 -41.73 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 112.991 0.738 . . . . 1.0 112.991 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.545 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 2.6 p-80 -69.95 -26.67 64.23 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.191 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 722' ' ' HIS . 98.5 m-20 -9.76 -73.99 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.908 0.755 . . . . 1.0 113.02 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -126.45 132.78 51.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.188 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.03 142.37 41.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.376 -0.374 . . . . 1.0 110.505 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -89.96 139.36 30.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.535 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.061 -0.971 . . . . 1.0 110.661 179.91 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 N--CA 1.484 0.928 0 N-CA-C 109.538 -0.985 . . . . 1.0 109.538 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.01 137.96 58.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.61 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.435 ' CB ' ' CD ' ' A' ' 688' ' ' PRO . 0.1 OUTLIER -141.33 179.47 1.22 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.263 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 687' ' ' SER . 22.6 Cg_exo -61.75 144.94 97.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.137 1.892 . . . . 1.0 112.04 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.35 134.51 36.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.27 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -170.43 -167.16 30.45 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.84 146.98 96.19 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.105 2.536 . . . . 1.0 112.195 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -66.66 142.69 57.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.134 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.27 -43.36 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.386 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.1 -40.26 95.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.188 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.0 -43.92 96.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 699' ' ' SER . 76.4 t -63.62 -42.99 97.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.189 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.33 -42.91 99.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.351 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.96 -43.28 96.25 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.294 0.569 . . . . 1.0 109.572 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 76.4 p -63.72 -34.44 77.88 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.352 -0.84 . . . . 1.0 109.893 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 76.3 t -65.47 -45.06 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.6 ttp -61.76 -39.69 92.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.252 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.74 99.35 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.427 -1.069 . . . . 1.0 110.427 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.74 -36.23 82.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.713 0.292 . . . . 1.0 110.418 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.85 -44.1 99.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.551 -0.459 . . . . 1.0 110.757 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.4 -42.07 98.77 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.653 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 51.7 tp -62.48 -43.99 97.47 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.403 0.52 . . . . 1.0 112.403 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 21.2 tt -67.28 -38.41 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.211 -0.596 . . . . 1.0 111.749 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.2 -44.97 73.69 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.35 -35.28 77.51 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.954 0.502 . . . . 1.0 111.07 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -41.03 -61.87 1.18 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.925 -0.58 . . . . 1.0 112.559 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.15 -33.07 82.89 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.756 1.637 . . . . 1.0 112.918 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.36 -43.17 91.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.76 -44.13 91.07 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.085 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.5 mm -64.85 -44.72 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 80.8 t90 -65.74 -47.03 76.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.478 ' O ' ' OG1' ' A' ' 720' ' ' THR . . . -60.33 -42.25 95.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.255 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.7 mt -63.07 -43.11 99.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.714 -0.395 . . . . 1.0 110.236 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . 0.432 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 85.3 mt -64.17 -44.91 90.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.81 -0.756 . . . . 1.0 109.515 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.37 -45.25 89.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.774 -0.648 . . . . 1.0 109.642 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 716' ' ' ALA . 19.7 m -64.29 -44.17 92.52 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.4 mm -64.59 -42.23 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.943 0.878 . . . . 1.0 110.819 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.557 ' O ' ' CB ' ' A' ' 723' ' ' ASP . 11.7 m80 -61.47 -29.72 70.14 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.995 -1.002 . . . . 1.0 110.487 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 722' ' ' HIS . 48.1 t0 108.46 46.63 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.454 1.121 . . . . 1.0 109.296 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . 0.51 ' O ' ' CE1' ' A' ' 727' ' ' PHE . 99.8 mtt180 41.81 81.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.287 -0.965 . . . . 1.0 111.159 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -62.16 -43.86 97.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.318 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.38 -37.41 83.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.856 0.36 . . . . 1.0 111.079 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . 0.51 ' CE1' ' O ' ' A' ' 724' ' ' ARG . 73.3 m-85 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.433 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 687' ' ' SER . 12.3 Cg_exo . . . . . 0 N--CA 1.483 0.864 0 N-CA-C 109.608 -0.959 . . . . 1.0 109.608 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 46.82 -89.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.264 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 685' ' ' PRO . 0.0 OUTLIER -73.97 161.86 76.6 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.484 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.51 152.96 60.5 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.016 2.477 . . . . 1.0 112.392 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -63.09 -42.08 99.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.589 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . 0.44 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . 86.0 53.99 2.86 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 33.8 Cg_endo -65.7 -19.81 59.52 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.765 2.31 . . . . 1.0 111.362 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -67.41 -39.8 85.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.52 -42.29 89.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 122.173 0.987 . . . . 1.0 109.548 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.64 -38.0 89.45 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 122.09 0.948 . . . . 1.0 109.579 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -44.49 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.31 -0.859 . . . . 1.0 109.229 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' A' ' 699' ' ' SER . 73.5 t -63.13 -43.52 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.115 -0.948 . . . . 1.0 109.609 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.31 -42.08 98.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.993 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.05 -43.16 96.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.282 0.563 . . . . 1.0 109.581 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 78.0 p -63.65 -34.82 78.68 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.661 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 73.3 t -65.39 -45.35 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.2 ttp -61.86 -39.73 92.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.334 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.69 -42.37 98.69 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.745 -0.942 . . . . 1.0 110.745 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.91 96.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.636 0.255 . . . . 1.0 111.376 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.49 -41.56 92.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 82.0 mt -61.67 -42.05 98.38 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.979 -0.688 . . . . 1.0 110.446 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.82 -41.6 99.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.752 0.311 . . . . 1.0 111.199 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . 0.404 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 31.1 mm -63.46 -43.2 98.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.371 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.55 -42.27 81.53 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 110.956 -0.857 . . . . 1.0 110.956 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.5 mt -68.3 -35.86 78.47 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.974 0.51 . . . . 1.0 111.74 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -49.59 -60.37 5.08 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.091 -0.644 . . . . 1.0 111.921 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . 0.404 ' CD ' ' O ' ' A' ' 707' ' ' ILE . 38.5 Cg_exo -53.76 -40.93 78.13 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.443 1.429 . . . . 1.0 112.399 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.19 -44.16 89.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.0 -43.61 91.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.563 -0.455 . . . . 1.0 109.928 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.7 -44.76 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.837 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -66.51 -46.86 74.84 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.41 -40.07 89.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.843 -0.617 . . . . 1.0 109.703 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 59.2 tp -63.64 -46.21 86.7 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.66 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.19 -44.36 92.23 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.248 -0.581 . . . . 1.0 109.935 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.3 mm -65.82 -43.95 93.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 716' ' ' ALA . 95.4 m -62.58 -45.24 93.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.35 -43.32 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 119.742 -0.783 . . . . 1.0 111.754 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.545 ' O ' ' CB ' ' A' ' 723' ' ' ASP . 7.0 m80 -60.15 -38.86 84.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.542 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 722' ' ' HIS . 67.0 t0 117.54 117.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.72 1.263 . . . . 1.0 109.989 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -68.19 134.15 50.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -108.28 145.77 33.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 1.0 109.905 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.12 138.03 58.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.525 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 55.2 p90 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.412 -179.941 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.484 0.919 0 N-CA-C 109.606 -0.959 . . . . 1.0 109.606 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.87 148.05 50.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.289 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 6.3 m -126.07 81.7 66.14 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.634 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -61.32 144.91 98.76 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.36 2.04 . . . . 1.0 111.96 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 18.1 tttm 48.06 27.56 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.807 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -170.0 71.2 0.13 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.999 -0.84 . . . . 1.0 110.999 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.38 144.51 98.37 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.68 2.254 . . . . 1.0 112.042 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -96.74 -6.62 35.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.307 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.11 -43.62 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.163 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.1 mt -62.94 -39.48 94.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.244 -0.889 . . . . 1.0 109.219 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 69.5 t -64.45 -45.2 96.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.503 0.668 . . . . 1.0 109.489 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.421 ' O ' ' OG ' ' A' ' 699' ' ' SER . 78.3 t -64.32 -43.06 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.955 -1.02 . . . . 1.0 109.336 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.2 -43.16 99.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.802 -0.635 . . . . 1.0 111.594 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.13 -43.0 96.62 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.423 0.63 . . . . 1.0 109.562 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 74.1 p -64.08 -34.38 77.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.231 -0.895 . . . . 1.0 109.782 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.2 -45.17 94.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 61.3 mtt -63.45 -38.48 91.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.439 -0.8 . . . . 1.0 109.348 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.12 -41.68 99.69 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.232 -1.147 . . . . 1.0 110.232 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.66 94.61 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.636 0.255 . . . . 1.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.37 -43.91 98.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.59 0.71 . . . . 1.0 110.053 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.99 -43.34 99.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.601 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.06 -43.17 99.41 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.285 0.476 . . . . 1.0 112.285 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 14.6 tt -65.33 -31.93 56.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.045 -0.662 . . . . 1.0 111.176 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.94 -45.75 71.35 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.624 -0.991 . . . . 1.0 110.624 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.68 -36.87 81.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 1.0 111.266 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -37.78 -62.05 0.69 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.982 -0.554 . . . . 1.0 112.311 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.57 -31.65 79.85 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.924 1.749 . . . . 1.0 112.502 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.8 -43.72 71.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.504 -0.479 . . . . 1.0 109.928 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.17 -45.05 86.48 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.935 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.26 -41.96 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 119.873 -0.731 . . . . 1.0 109.704 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -63.7 -47.28 81.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.887 -0.782 . . . . 1.0 108.887 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.43 -38.95 85.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 721' ' ' ILE . 58.9 tp -63.17 -45.44 91.81 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.16 -44.2 89.3 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 121.298 0.571 . . . . 1.0 109.895 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . 0.555 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.2 mm -65.05 -44.41 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 716' ' ' ALA . 98.9 m -63.91 -45.9 87.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.443 177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.7 mm -65.89 -43.99 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 113.826 1.047 . . . . 1.0 113.826 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . 0.555 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 2.2 p-80 -64.68 -30.41 71.42 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.782 -0.767 . . . . 1.0 110.754 -178.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -87.92 110.5 20.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.918 0.39 . . . . 1.0 110.625 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -103.28 137.85 40.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.507 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.71 144.27 50.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.574 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -116.27 127.28 54.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.342 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.963 -1.018 . . . . 1.0 110.542 179.98 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 N--CA 1.484 0.95 0 N-CA-C 109.641 -0.946 . . . . 1.0 109.641 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.88 138.28 58.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.352 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 687' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 0.1 OUTLIER -99.7 -43.21 0.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.903 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 688' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 687' ' ' SER . 22.5 Cg_exo -61.56 145.16 98.0 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.521 2.148 . . . . 1.0 111.957 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.25 -41.93 99.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.548 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 160.88 177.6 34.13 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.55 -11.61 26.4 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 123.318 2.679 . . . . 1.0 112.746 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.06 -42.17 94.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.49 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.33 -39.38 76.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.207 0.527 . . . . 1.0 110.183 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.19 -39.59 93.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.211 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.6 t -63.72 -45.41 97.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.989 -0.55 . . . . 1.0 109.876 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.422 ' O ' ' OG ' ' A' ' 699' ' ' SER . 74.6 t -64.01 -43.52 97.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.329 -0.85 . . . . 1.0 109.852 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.428 ' N ' HD23 ' A' ' 697' ' ' LEU . 0.9 OUTLIER -62.92 -41.13 99.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.046 -0.525 . . . . 1.0 112.184 -179.031 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.38 -42.27 88.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.238 0.542 . . . . 1.0 110.852 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.3 p -62.07 -39.63 93.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.68 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 16.2 m -69.82 -41.39 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 119.386 -0.926 . . . . 1.0 109.632 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.22 -39.0 88.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.92 -40.55 99.01 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.66 -36.87 82.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.511 0.196 . . . . 1.0 111.006 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 38.6 mm -60.93 -44.02 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 122.293 1.044 . . . . 1.0 109.547 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 46.4 tp -64.23 -44.21 92.59 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.674 -1.266 . . . . 1.0 112.404 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.06 -41.18 99.41 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 45.2 pt -65.38 -38.69 83.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.482 -0.487 . . . . 1.0 111.62 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.13 -40.98 92.82 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.414 -1.074 . . . . 1.0 110.414 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 97.0 mt -68.58 -35.27 77.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.42 -0.39 . . . . 1.0 111.505 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 710' ' ' ALA . . . . . . . . . . . . . . . -48.67 -60.91 3.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.03 -0.668 . . . . 1.0 112.075 -176.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 711' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -53.88 -40.63 79.79 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.351 1.367 . . . . 1.0 112.35 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.34 -43.85 89.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.78 -43.94 91.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.236 178.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.82 -44.69 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -65.23 -47.77 75.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 716' ' ' ALA . . . . . 0.477 ' O ' ' CG2' ' A' ' 720' ' ' THR . . . -61.96 -39.43 92.12 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.096 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.412 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 60.8 tp -62.97 -46.47 87.56 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.93 -44.86 88.1 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.133 -0.627 . . . . 1.0 110.282 178.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.5 mm -66.62 -44.4 89.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.426 179.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.477 ' CG2' ' O ' ' A' ' 716' ' ' ALA . 57.4 p -65.71 -39.79 91.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.412 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.96 -43.29 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 120.015 -0.674 . . . . 1.0 110.986 178.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -59.82 -41.11 90.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.624 -0.716 . . . . 1.0 110.294 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 723' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 725' ' ' LYS . 64.7 t0 -67.38 -40.81 85.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.095 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 61.76 -42.41 0.14 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.27 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 723' ' ' ASP . 27.2 tttt 46.97 32.68 1.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.681 0.277 . . . . 1.0 110.472 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 726' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 725' ' ' LYS . 97.4 mt-10 55.53 158.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.858 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.026 -0.988 . . . . 1.0 110.552 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 CA--C 1.514 -0.406 0 N-CA-C 109.728 -0.471 . . . . 0.94 109.728 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 91.4 t -67.3 -45.31 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 108.448 -0.945 . . . . 0.18 108.448 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.8 ' O ' HG23 ' A' ' 700' ' ' VAL . 71.6 t -64.51 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.342 -0.985 . . . . 0.6 108.342 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 17.7 tp -60.69 -43.61 97.54 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.576 -0.284 . . . . 1.64 111.321 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 72.5 mt -66.46 -46.6 75.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.064 -0.717 . . . . 1.1 109.064 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 80.0 p -61.4 -36.78 81.24 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.415 -0.587 . . . . 0.17 109.415 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 696' ' ' VAL . 41.0 t -65.65 -46.92 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 107.977 -1.12 . . . . 0.82 107.977 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 6.3 mtp -59.94 -35.55 75.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.344 -0.984 . . . . 2.45 108.344 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.79 -44.07 81.63 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.57 -1.012 . . . . 0.14 110.57 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.72 96.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.14 110.232 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.67 -44.68 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.829 -0.748 . . . . 0.73 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.68 -44.49 96.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.89 -0.324 . . . . 1.68 110.374 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.99 -42.03 97.61 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.045 0.45 . . . . 1.82 110.259 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 89.2 mt -62.77 -41.5 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.804 -0.635 . . . . 1.37 111.021 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.29 -40.61 87.31 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.654 -0.978 . . . . 0.17 110.654 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 17.8 mt -77.68 -25.18 49.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 117.39 0.595 . . . . 1.36 110.693 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -48.44 -60.7 4.06 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.35 111.978 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 43.0 Cg_endo -66.73 -30.81 40.97 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.875 1.716 . . . . 0.4 112.354 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 712' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 716' ' ' ALA . 19.2 mt -68.04 -42.84 79.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 61.0 mt -65.4 -44.52 87.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.839 -0.43 . . . . 0.96 109.839 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.65 -46.33 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.376 -0.602 . . . . 1.09 109.376 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.815 ' CH2' HD11 ' A' ' 719' ' ' ILE . 8.7 t-105 -63.39 -47.35 82.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.442 -1.318 . . . . 3.42 107.442 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -56.24 -43.51 78.71 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.853 -0.612 . . . . 0.21 109.904 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.498 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 6.3 mt -64.48 -42.66 95.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.643 -0.253 . . . . 1.58 110.54 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 718' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 722' ' ' HIS . 80.6 mt -65.18 -45.6 84.21 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.212 -1.033 . . . . 0.88 108.212 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.815 HD11 ' CH2' ' A' ' 715' ' ' TRP . 12.7 mm -65.55 -46.96 88.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 N-CA-C 108.825 -0.806 . . . . 1.4 108.825 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 716' ' ' ALA . 31.8 m -60.35 -42.23 95.3 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.393 -1.336 . . . . 1.09 107.393 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.498 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 1.3 mm -65.67 -43.58 93.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.83 -0.748 . . . . 1.07 111.392 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 722' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 718' ' ' LEU . 46.6 m80 . . . . . 0 C--N 1.343 0.318 0 CA-C-N 115.334 -0.848 . . . . 2.49 109.311 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.17 -44.77 97.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.162 0.506 . . . . 1.0 109.826 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.776 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.7 t -63.81 -43.79 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.375 -0.829 . . . . 1.0 109.583 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.1 -41.93 99.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.939 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.14 -42.96 96.58 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.294 0.569 . . . . 1.0 110.018 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 67.2 p -63.78 -34.9 78.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.33 -0.85 . . . . 1.0 109.94 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 696' ' ' VAL . 77.9 t -65.27 -44.85 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.27 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 60.9 mtt -63.22 -39.16 93.83 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.49 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.27 99.35 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.35 97.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.633 0.254 . . . . 1.0 111.075 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.37 -44.06 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.414 -0.515 . . . . 1.0 110.684 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.52 -42.7 99.21 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.538 -0.301 . . . . 1.0 111.315 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.57 -40.35 96.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.284 0.564 . . . . 1.0 111.162 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.02 -42.84 96.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.941 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.95 -40.12 89.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.01 -35.21 76.4 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 122.707 0.403 . . . . 1.0 111.536 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.683 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -49.61 -60.56 4.75 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 120.233 -0.587 . . . . 1.0 111.926 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 40.4 Cg_exo -53.49 -41.08 76.09 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.122 1.215 . . . . 1.0 112.434 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.23 -44.1 89.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.686 -0.487 . . . . 1.0 109.686 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 713' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 713' ' ' LEU . 87.0 mt -65.19 -43.79 90.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.093 0.473 . . . . 1.0 109.906 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.85 -44.8 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.909 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -65.14 -46.56 80.42 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.46 -38.41 87.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.541 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.99 -47.13 84.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.139 -0.319 . . . . 1.0 110.139 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.72 -44.34 90.5 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.13 -0.628 . . . . 1.0 110.111 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.5 mm -65.94 -44.46 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 716' ' ' ALA . 79.3 m -62.95 -44.91 94.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.44 -43.58 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.472 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.593 -179.627 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 120.726 0.298 . . . . 1.0 110.317 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.62 -47.43 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.374 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 700' ' ' VAL . 29.7 m -66.62 -37.61 79.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.033 -0.667 . . . . 1.0 109.535 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 39.6 mt -63.07 -42.6 99.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.422 -0.511 . . . . 1.0 111.766 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.35 -42.76 96.07 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.366 0.603 . . . . 1.0 109.746 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 74.3 p -63.6 -34.33 77.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.21 -0.904 . . . . 1.0 109.943 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 696' ' ' VAL . 72.9 t -65.41 -45.77 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.188 0.518 . . . . 1.0 109.67 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.59 -38.57 91.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.674 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.79 99.61 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.01 85.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.762 0.315 . . . . 1.0 110.643 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.6 mt -62.77 -44.11 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.002 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.74 -42.03 99.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.091 -0.644 . . . . 1.0 110.779 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.76 -42.01 99.48 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.823 -0.351 . . . . 1.0 111.066 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.08 -41.58 93.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.597 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -71.11 -43.79 55.71 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 110.587 -1.005 . . . . 1.0 110.587 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.53 -37.42 84.97 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.873 0.469 . . . . 1.0 110.679 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.54 -62.58 0.92 Allowed Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.502 -0.772 . . . . 1.0 112.374 -177.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 20.2 Cg_endo -61.34 -34.51 87.11 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.802 1.668 . . . . 1.0 113.128 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 712' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.71 -43.18 89.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.94 -44.04 90.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.945 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.75 -44.88 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.701 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -65.24 -47.65 76.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.627 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.49 96.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.398 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 38.7 mt -63.6 -43.38 97.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.339 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 718' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 718' ' ' LEU . 85.0 mt -63.55 -44.33 94.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.298 -0.961 . . . . 1.0 109.292 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.74 -44.88 89.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.914 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 20.1 m -63.46 -45.8 89.15 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 79.3 mt -64.37 -43.1 97.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.538 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 9.6 m80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.6 -179.86 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 694' ' ' LEU . 90.9 mt . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.73 -43.99 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.3 t -63.48 -42.96 98.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.957 -1.02 . . . . 1.0 109.235 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.4 tp -62.62 -42.74 99.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.379 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.14 -43.07 96.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.331 0.586 . . . . 1.0 109.655 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.6 p -63.48 -34.55 78.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.332 -0.849 . . . . 1.0 109.81 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 696' ' ' VAL . 79.4 t -65.67 -44.76 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.55 -39.0 93.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.243 -0.889 . . . . 1.0 109.42 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.27 -41.75 99.47 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.705 -0.958 . . . . 1.0 110.705 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.72 -38.5 91.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.702 0.287 . . . . 1.0 110.898 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.05 -43.46 99.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.342 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.64 -42.61 99.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.699 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.0 -41.77 98.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.88 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.14 -42.94 98.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.42 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 708' ' ' GLY . . . . . 0.407 ' O ' HD13 ' A' ' 712' ' ' LEU . . . -65.91 -47.08 77.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.794 -0.922 . . . . 1.0 110.794 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.35 -36.8 79.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.868 0.467 . . . . 1.0 111.418 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.626 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -36.27 -61.39 0.6 Allowed Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.0 Cg_endo -62.79 -30.81 78.28 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.954 1.769 . . . . 1.0 113.322 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 712' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.13 -43.87 90.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.107 -0.637 . . . . 1.0 109.54 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 713' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 713' ' ' LEU . 11.2 mp -64.35 -42.93 95.99 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.216 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.79 -44.9 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.551 ' CZ2' HD13 ' A' ' 719' ' ' ILE . 66.9 t-105 -65.39 -46.48 79.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 720' ' ' THR . . . -57.89 -47.85 81.56 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.459 -0.791 . . . . 1.0 110.344 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.82 -44.25 93.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.563 -0.455 . . . . 1.0 110.789 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 718' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 82.8 mt -65.13 -45.03 86.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.431 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.551 HD13 ' CZ2' ' A' ' 715' ' ' TRP . 5.3 tp -71.4 -42.33 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.094 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 716' ' ' ALA . 67.8 p -66.7 -40.41 88.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.684 -0.807 . . . . 1.0 108.852 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.41 -40.3 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.676 0.751 . . . . 1.0 111.211 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 722' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 10.9 m80 . . . . . 0 C--N 1.321 -0.637 0 C-N-CA 119.935 -0.706 . . . . 1.0 109.67 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.2 mp . . . . . 0 CA--C 1.515 -0.398 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.12 -44.28 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.57 0.7 . . . . 1.0 109.229 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.2 t -63.71 -42.92 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.822 -1.081 . . . . 1.0 109.167 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.19 -42.94 99.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.387 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.96 -42.86 97.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.356 0.598 . . . . 1.0 109.755 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 73.4 p -63.61 -33.58 75.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.002 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.9 t -65.64 -45.22 92.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 99.0 mmm -63.57 -37.83 88.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.377 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.08 99.11 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.581 -1.008 . . . . 1.0 110.581 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.88 92.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.769 0.318 . . . . 1.0 110.72 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.56 -43.97 98.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.337 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.31 -42.79 99.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.776 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.2 -41.99 98.87 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.551 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.8 -42.84 97.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.92 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.21 -43.1 81.52 Favored Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.79 -37.31 81.86 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.939 0.496 . . . . 1.0 111.109 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.645 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -41.44 -61.57 1.36 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.592 -0.731 . . . . 1.0 112.623 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 27.6 Cg_endo -63.11 -32.95 74.63 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.766 1.644 . . . . 1.0 112.749 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 712' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 712' ' ' LEU . 90.6 mt -66.37 -43.78 84.97 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.14 -43.97 90.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.058 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 714' ' ' ILE . . . . . 0.48 ' O ' HD13 ' A' ' 718' ' ' LEU . 95.8 mt -64.98 -45.01 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.972 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -63.89 -46.5 84.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.48 -39.75 88.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.779 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.41 -46.33 86.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 718' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 714' ' ' ILE . 9.3 mp -64.68 -45.1 88.09 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 120.178 -0.609 . . . . 1.0 110.167 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 31.0 mm -66.28 -44.35 91.19 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 716' ' ' ALA . 78.8 m -62.83 -44.09 97.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.59 -43.59 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.789 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.5 m80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.069 -179.275 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 694' ' ' LEU . 90.8 mt . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.08 -43.73 97.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 O-C-N 123.699 0.624 . . . . 1.0 109.616 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.4 t -62.91 -43.47 98.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.614 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.23 -40.97 98.95 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.185 -0.606 . . . . 1.0 112.11 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.94 -43.24 96.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.441 0.639 . . . . 1.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 70.9 p -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.327 -0.852 . . . . 1.0 109.443 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.6 t -65.86 -45.72 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.523 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.7 ttp -62.05 -40.02 94.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.154 -0.93 . . . . 1.0 109.718 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.2 -40.67 99.28 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.71 -36.8 84.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.749 0.309 . . . . 1.0 110.479 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.64 -43.73 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.971 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.43 -41.41 98.7 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.906 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.24 -41.72 98.68 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.826 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 30.8 mm -63.43 -43.45 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.72 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.95 -46.81 64.03 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.392 -0.683 . . . . 1.0 111.392 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.39 -35.27 77.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.838 0.352 . . . . 1.0 111.123 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.647 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.47 -62.04 1.04 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 115.882 -0.599 . . . . 1.0 112.421 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.647 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 29.7 Cg_endo -63.53 -32.49 70.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.882 1.721 . . . . 1.0 112.575 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 712' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 712' ' ' LEU . 91.0 mt -65.57 -43.36 90.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.5 -43.7 93.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.794 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.71 -44.91 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.059 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.55 ' CD1' HD11 ' A' ' 719' ' ' ILE . 15.3 t-105 -65.02 -46.36 81.67 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.0 -41.91 97.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.287 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.7 mt -63.68 -43.79 95.64 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.723 -0.391 . . . . 1.0 109.991 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 718' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 718' ' ' LEU . 85.1 mt -64.38 -44.79 90.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.79 -0.764 . . . . 1.0 109.831 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.55 HD11 ' CD1' ' A' ' 715' ' ' TRP . 93.1 mt -66.27 -44.81 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 716' ' ' ALA . 99.9 m -63.66 -45.09 91.74 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.0 mm -64.23 -43.64 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.199 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.6 m80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.731 -179.695 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 698' ' ' LEU . 95.1 mt . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 65.7 t -64.92 -44.39 96.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.608 0.718 . . . . 1.0 109.204 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.753 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.1 t -63.4 -42.77 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.689 -1.141 . . . . 1.0 109.349 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.16 -44.24 97.06 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.147 0.425 . . . . 1.0 112.147 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 698' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 694' ' ' LEU . 4.5 mm? -64.38 -42.5 96.11 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -62.36 -35.38 78.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.779 . . . . 1.0 109.779 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 696' ' ' VAL . 66.3 t -66.66 -45.93 87.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.493 0.663 . . . . 1.0 109.331 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 63.4 mtt -62.83 -38.52 91.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.139 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.03 -41.2 99.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.83 84.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.665 0.269 . . . . 1.0 110.471 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.6 mt -62.84 -43.99 99.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.905 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.5 -42.1 99.27 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.056 -0.658 . . . . 1.0 110.969 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.65 -42.03 98.33 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.72 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.27 -40.79 90.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.964 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -73.27 -44.55 34.33 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.739 -0.944 . . . . 1.0 110.739 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.25 -36.83 80.05 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.629 0.372 . . . . 1.0 111.936 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.696 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -47.5 -59.79 5.05 Favored Pre-proline 0 N--CA 1.464 0.275 0 C-N-CA 120.057 -0.657 . . . . 1.0 111.405 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 35.5 Cg_exo -53.23 -40.3 77.94 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.43 1.42 . . . . 1.0 112.644 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.24 -44.67 87.45 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.563 -0.455 . . . . 1.0 109.936 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.77 -42.96 94.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.533 -0.467 . . . . 1.0 109.932 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.12 -44.74 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -65.68 -46.82 77.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.751 ' O ' HG23 ' A' ' 720' ' ' THR . . . -60.9 -41.11 95.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.29 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.479 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 35.4 mt -63.16 -44.34 95.78 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.104 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.73 -45.01 88.29 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 119.943 -0.703 . . . . 1.0 109.991 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.8 mm -66.86 -44.82 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.346 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 716' ' ' ALA . 66.5 p -67.45 -39.66 85.38 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 119.217 -0.993 . . . . 1.0 108.706 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.8 mm -64.65 -43.41 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 119.962 -0.695 . . . . 1.0 110.639 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.2 m80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.333 -0.848 . . . . 1.0 110.647 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.0 -45.04 97.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.441 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.807 ' O ' HG23 ' A' ' 700' ' ' VAL . 75.9 t -63.86 -43.11 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.052 -0.977 . . . . 1.0 109.43 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.41 -43.02 99.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.562 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.34 -43.09 95.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.222 0.534 . . . . 1.0 109.56 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 75.7 p -63.96 -34.09 77.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.793 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 696' ' ' VAL . 73.6 t -65.77 -44.69 93.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.8 mtp -63.61 -38.97 93.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.297 -0.865 . . . . 1.0 109.619 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.78 -41.85 98.74 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.12 93.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.655 0.264 . . . . 1.0 110.844 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.26 -43.83 98.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.494 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 705' ' ' LEU . 93.7 mt -62.16 -42.18 99.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.654 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.94 -42.28 99.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.875 0.369 . . . . 1.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.427 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 96.0 mt -62.23 -40.85 89.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.55 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -72.83 -42.27 46.43 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.63 -37.34 84.64 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 122.921 0.488 . . . . 1.0 111.588 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -51.17 -59.91 6.74 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 120.285 -0.566 . . . . 1.0 112.172 -176.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 43.5 Cg_exo -53.02 -41.04 74.5 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.542 1.495 . . . . 1.0 112.18 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.27 -43.93 89.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.73 -43.45 93.36 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.834 -0.432 . . . . 1.0 109.834 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.42 -44.89 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.601 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 79.5 t90 -65.72 -47.01 76.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.748 ' O ' HG23 ' A' ' 720' ' ' THR . . . -61.75 -39.13 90.54 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.933 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 60.0 tp -63.03 -45.98 89.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 718' ' ' LEU . . . . . 0.534 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 87.6 mt -65.13 -46.02 82.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.283 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.8 -44.46 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.284 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 716' ' ' ALA . 61.6 p -66.13 -36.13 82.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.307 -0.957 . . . . 1.0 108.605 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 2.3 mm -66.56 -39.48 84.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.976 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 722' ' ' HIS . . . . . 0.534 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 40.5 m80 . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 115.36 -0.837 . . . . 1.0 111.225 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 694' ' ' LEU . 94.4 mt . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.54 -45.39 98.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.63 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.732 ' O ' HG23 ' A' ' 700' ' ' VAL . 74.7 t -63.85 -43.67 97.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.446 -0.797 . . . . 1.0 109.392 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.25 -42.05 99.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.267 0.469 . . . . 1.0 112.267 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.04 -42.76 96.96 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.256 0.55 . . . . 1.0 109.806 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.9 p -63.25 -34.08 76.88 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.002 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 696' ' ' VAL . 75.7 t -65.61 -45.21 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.643 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.27 -38.1 89.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.485 -0.779 . . . . 1.0 109.775 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.3 -42.24 99.3 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.561 -1.016 . . . . 1.0 110.561 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.93 96.15 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.673 0.237 . . . . 1.0 110.675 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.74 -42.93 98.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 121.867 0.841 . . . . 1.0 110.008 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.16 -41.56 98.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.985 -0.686 . . . . 1.0 110.876 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.98 -40.52 97.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.773 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.27 -43.16 98.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.578 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.76 -46.08 62.5 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.716 -0.954 . . . . 1.0 110.716 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.29 -35.75 78.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.163 0.506 . . . . 1.0 111.185 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.06 -61.95 1.01 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.429 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.7 Cg_endo -63.04 -32.33 75.76 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.811 1.674 . . . . 1.0 112.73 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 712' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 712' ' ' LEU . 90.7 mt -66.06 -43.57 87.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.04 -43.66 91.63 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.965 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.7 -44.82 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.96 -0.564 . . . . 1.0 109.748 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.437 ' CZ2' HD11 ' A' ' 719' ' ' ILE . 76.9 t-105 -65.5 -46.56 79.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -59.73 -42.06 92.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.111 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.444 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 37.7 mt -63.63 -44.09 94.92 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.238 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.74 -45.35 86.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.956 -0.698 . . . . 1.0 110.024 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.437 HD11 ' CZ2' ' A' ' 715' ' ' TRP . 30.7 mm -66.42 -44.61 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 716' ' ' ALA . 97.6 m -63.51 -44.9 92.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.536 -0.913 . . . . 1.0 108.536 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.444 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.5 -43.13 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.666 -0.697 . . . . 1.0 111.3 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 8.2 m80 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.755 -179.663 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.448 -0.572 0 N-CA-C 109.333 -0.618 . . . . 1.0 109.333 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.05 -45.15 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.382 0.611 . . . . 1.0 109.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 700' ' ' VAL . 76.4 t -64.11 -42.99 97.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.995 -1.002 . . . . 1.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 51.7 tp -62.61 -43.03 99.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.71 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.99 -43.02 96.94 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.259 0.552 . . . . 1.0 109.748 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.6 p -63.23 -34.32 77.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.856 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.4 t -65.44 -45.3 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.638 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.9 mmm -63.93 -37.98 89.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.441 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.49 -42.38 98.98 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.546 -1.022 . . . . 1.0 110.546 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.3 90.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.713 0.292 . . . . 1.0 110.866 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.94 -43.55 99.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.472 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.33 -42.19 99.18 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.784 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.0 mt -62.89 -41.51 99.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.354 . . . . 1.0 110.705 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.3 -43.25 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.291 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.86 -43.57 73.44 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.49 -37.14 82.41 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 122.879 0.472 . . . . 1.0 110.954 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -41.45 -61.96 1.23 Allowed Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.782 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.4 Cg_endo -63.27 -33.09 72.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.782 1.654 . . . . 1.0 112.672 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.19 -43.95 85.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.45 -44.21 87.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.155 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.18 -44.68 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.282 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.577 ' NE1' HD11 ' A' ' 719' ' ' ILE . 58.3 t-105 -66.08 -46.54 77.34 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.54 -37.98 85.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.848 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 721' ' ' ILE . 58.6 tp -63.54 -44.15 95.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 718' ' ' LEU . . . . . 0.557 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 84.4 mt -64.63 -43.62 93.13 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.577 HD11 ' NE1' ' A' ' 715' ' ' TRP . 97.9 mt -65.25 -41.74 92.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 CA-C-O 123.64 1.686 . . . . 1.0 107.962 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 716' ' ' ALA . 99.0 m -68.29 -41.23 81.28 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 117.978 -1.489 . . . . 1.0 108.629 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.2 mm -64.71 -44.13 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 119.802 -0.759 . . . . 1.0 111.339 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 722' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 43.1 m80 . . . . . 0 N--CA 1.466 0.335 0 CA-C-N 115.274 -0.876 . . . . 1.0 110.442 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 698' ' ' LEU . 11.0 mp . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.73 -45.47 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.798 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.3 t -64.04 -43.38 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.165 -0.925 . . . . 1.0 109.156 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.65 -43.71 98.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.841 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 698' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 694' ' ' LEU . 9.9 mp -64.44 -42.56 95.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.136 0.493 . . . . 1.0 109.7 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 78.0 p -63.21 -34.8 78.42 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.883 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 696' ' ' VAL . 74.2 t -65.63 -45.43 92.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.2 ttp -62.05 -39.56 92.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.587 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.96 -42.43 98.29 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.898 -0.881 . . . . 1.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.92 95.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.586 0.231 . . . . 1.0 110.716 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.37 -44.04 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.399 -0.521 . . . . 1.0 110.36 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.25 -43.09 99.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.714 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.8 -41.19 99.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.153 0.502 . . . . 1.0 111.855 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.7 -39.98 87.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.351 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.41 -42.88 63.7 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.612 -0.995 . . . . 1.0 110.612 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 709' ' ' LEU . . . . . 0.411 HD23 HD12 ' A' ' 712' ' ' LEU . 96.7 mt -67.47 -37.88 83.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.278 0.561 . . . . 1.0 110.631 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.622 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -36.55 -62.31 0.54 Allowed Pre-proline 0 C--N 1.333 -0.118 0 CA-C-N 115.618 -0.719 . . . . 1.0 112.096 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.622 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.0 Cg_endo -62.03 -31.19 83.78 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.654 1.569 . . . . 1.0 113.256 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 712' ' ' LEU . . . . . 0.411 HD12 HD23 ' A' ' 709' ' ' LEU . 90.1 mt -65.72 -44.11 87.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.48 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 713' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 713' ' ' LEU . 11.2 mp -64.29 -42.84 96.21 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.293 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.95 -44.9 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -65.91 -45.91 80.23 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.273 -0.639 . . . . 1.0 109.273 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 720' ' ' THR . . . -57.96 -47.65 82.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.372 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.462 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 83.1 mt -64.26 -43.73 93.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.75 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.06 -44.89 87.52 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.139 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 5.1 tp -71.4 -41.88 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 108.925 -0.769 . . . . 1.0 108.925 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 716' ' ' ALA . 96.9 m -63.6 -44.86 92.78 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.42 -43.33 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.021 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.294 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 698' ' ' LEU . 89.9 mt . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.9 t -63.23 -45.2 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.322 0.582 . . . . 1.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.4 t -63.9 -43.17 97.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.48 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 40.4 mt -62.84 -42.48 99.76 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.497 -0.481 . . . . 1.0 112.057 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 698' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 694' ' ' LEU . 9.8 mp -64.26 -42.61 96.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.25 0.548 . . . . 1.0 109.805 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -63.28 -34.61 78.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.893 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 696' ' ' VAL . 71.6 t -65.44 -45.65 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.695 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 99.0 mmm -64.94 -37.51 87.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.644 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.38 -43.14 99.49 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.86 77.69 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.092 -0.643 . . . . 1.0 110.823 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.96 -43.11 98.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.062 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.83 -42.08 99.58 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.088 -0.645 . . . . 1.0 111.892 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.79 -40.27 96.25 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.648 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.425 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 36.8 mm -64.55 -34.14 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.858 0.361 . . . . 1.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -77.5 -43.94 14.22 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.021 -1.085 . . . . 1.0 111.024 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.26 -36.56 81.84 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.76 0.424 . . . . 1.0 111.969 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.716 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -50.72 -60.04 6.23 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.079 -0.649 . . . . 1.0 111.768 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 42.8 Cg_exo -53.07 -41.29 72.83 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.296 1.331 . . . . 1.0 112.113 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.31 -44.12 88.89 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.59 -43.46 93.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.607 -0.437 . . . . 1.0 110.007 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.58 -44.79 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.7 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.565 ' CE2' HD11 ' A' ' 719' ' ' ILE . 12.7 t90 -66.33 -46.12 77.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.862 ' O ' HG23 ' A' ' 720' ' ' THR . . . -61.82 -38.59 88.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.661 -0.7 . . . . 1.0 109.655 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.09 -45.56 91.54 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 718' ' ' LEU . . . . . 0.533 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 86.7 mt -63.59 -43.36 97.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.23 -0.588 . . . . 1.0 109.499 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.565 HD11 ' CE2' ' A' ' 715' ' ' TRP . 92.2 mt -64.63 -44.26 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.862 HG23 ' O ' ' A' ' 716' ' ' ALA . 74.3 p -64.12 -41.21 97.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.042 -1.063 . . . . 1.0 108.404 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 81.7 mt -64.46 -43.4 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 119.57 -0.852 . . . . 1.0 111.706 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 722' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 52.0 m80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.547 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.75 -45.1 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.298 -0.63 . . . . 1.0 109.298 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.0 t -64.05 -43.15 97.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.961 -1.018 . . . . 1.0 109.282 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.49 -42.99 99.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.598 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.32 -43.17 95.52 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.183 0.516 . . . . 1.0 109.671 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -63.28 -34.95 78.79 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.825 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 696' ' ' VAL . 74.7 t -65.81 -45.39 91.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.0 ttp -61.92 -39.42 91.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.136 -0.938 . . . . 1.0 109.571 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.53 -40.78 99.56 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.41 87.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.497 0.189 . . . . 1.0 111.016 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 31.6 mm -62.95 -44.12 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.434 -0.507 . . . . 1.0 110.771 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.71 -41.98 99.42 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.932 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.29 -42.53 99.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.811 0.339 . . . . 1.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.43 -43.25 98.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.197 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 708' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 712' ' ' LEU . . . -68.52 -43.9 75.02 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.42 -36.88 82.14 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.869 0.468 . . . . 1.0 111.115 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.64 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.12 -62.19 0.96 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.83 -0.623 . . . . 1.0 112.435 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 22.4 Cg_endo -62.02 -33.65 82.5 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.657 1.571 . . . . 1.0 113.036 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 712' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.66 -42.94 90.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 177.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.45 -43.69 93.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.883 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.78 -44.9 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.888 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -65.96 -45.96 79.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -55.46 -47.65 75.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.275 -0.875 . . . . 1.0 109.857 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 40.3 mt -63.69 -43.3 97.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.539 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.44 -44.89 89.72 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 120.171 -0.611 . . . . 1.0 111.243 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 719' ' ' ILE . 14.1 pt -73.17 -41.85 58.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 94.8 m -64.14 -43.55 94.88 Favored 'General case' 0 C--O 1.265 1.876 0 CA-C-O 122.346 1.07 . . . . 1.0 108.616 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.0 -44.43 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 117.802 -1.559 . . . . 1.0 111.702 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 10.3 m80 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.083 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.89 -43.29 93.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.806 0.812 . . . . 1.0 109.571 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.795 ' O ' HG23 ' A' ' 700' ' ' VAL . 71.1 t -66.05 -39.74 85.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.48 -1.236 . . . . 1.0 109.693 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.98 -43.05 96.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.833 -0.621 . . . . 1.0 111.684 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -65.36 -42.23 92.98 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.319 -0.622 . . . . 1.0 109.319 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 59.3 p -62.98 -35.05 78.91 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.678 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 696' ' ' VAL . 75.5 t -66.44 -44.53 90.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.333 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 5.7 ttp -61.89 -39.26 91.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.29 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.92 -41.67 98.62 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.13 96.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.775 0.321 . . . . 1.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.0 -43.72 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.26 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.41 -42.32 99.35 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.659 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.58 -42.38 99.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 1.0 110.446 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.23 -43.35 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.62 -44.88 69.31 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.414 -1.074 . . . . 1.0 110.414 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.05 -38.04 82.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.138 0.494 . . . . 1.0 110.99 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -37.13 -61.77 0.65 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.726 -0.67 . . . . 1.0 112.315 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.0 Cg_endo -62.79 -31.25 78.35 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.764 1.643 . . . . 1.0 113.192 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 712' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 712' ' ' LEU . 91.2 mt -65.5 -44.45 86.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.3 -0.56 . . . . 1.0 109.525 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 713' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 713' ' ' LEU . 11.2 mp -64.45 -42.84 95.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.099 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.26 -45.09 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 120.297 -0.561 . . . . 1.0 109.872 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.568 ' CD2' HD11 ' A' ' 719' ' ' ILE . 1.5 t90 -65.98 -46.53 77.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.15 -43.4 95.76 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.352 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 721' ' ' ILE . 38.0 mt -63.39 -43.95 96.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.297 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.58 -44.57 90.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.749 -0.78 . . . . 1.0 109.679 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.568 HD11 ' CD2' ' A' ' 715' ' ' TRP . 93.3 mt -66.32 -45.01 90.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.756 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 716' ' ' ALA . 97.3 m -63.84 -44.74 92.28 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.0 mm -64.18 -43.59 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.984 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 9.6 m80 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.545 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.0 mp . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.86 -45.42 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-O 121.42 0.629 . . . . 1.0 109.734 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 699' ' ' SER . 79.3 t -64.29 -43.08 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.001 -1.0 . . . . 1.0 109.382 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 51.9 tp -61.93 -42.47 99.13 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.87 -0.605 . . . . 1.0 112.031 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.19 -42.15 89.22 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.178 0.513 . . . . 1.0 110.926 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 68.8 p -61.73 -39.39 91.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.445 -0.798 . . . . 1.0 111.633 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.27 -40.31 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 119.67 -0.812 . . . . 1.0 109.498 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 56.0 ttp -61.23 -39.5 90.52 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.2 -40.81 98.33 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 110.595 -1.002 . . . . 1.0 110.595 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.52 91.37 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.689 -0.404 . . . . 1.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.96 -44.52 99.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 120.452 -0.499 . . . . 1.0 110.272 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.21 -43.16 99.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.628 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.58 -40.29 96.43 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.75 0.31 . . . . 1.0 111.142 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.455 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 85.2 mt -62.28 -41.54 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.84 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.31 -44.71 64.17 Favored Glycine 0 N--CA 1.471 0.996 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 8.9 mp -69.07 -35.47 76.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.501 -0.35 . . . . 1.0 111.936 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.678 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -50.5 -59.83 6.52 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 119.445 -0.902 . . . . 1.0 111.644 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 38.7 Cg_exo -53.16 -41.04 74.99 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.538 1.492 . . . . 1.0 112.308 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.52 -44.07 88.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.499 -0.556 . . . . 1.0 109.499 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.6 -43.82 92.6 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.475 -0.49 . . . . 1.0 109.876 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 714' ' ' ILE . . . . . 0.424 ' O ' HD13 ' A' ' 718' ' ' LEU . 95.5 mt -64.53 -44.84 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.483 ' CZ2' HD11 ' A' ' 719' ' ' ILE . 68.9 t-105 -63.76 -45.84 87.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.979 -0.748 . . . . 1.0 108.979 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.52 86.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.999 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.9 mt -63.16 -43.7 97.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.426 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 718' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 714' ' ' ILE . 8.8 mp -63.86 -43.93 94.62 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.413 -0.915 . . . . 1.0 109.021 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.483 HD11 ' CZ2' ' A' ' 715' ' ' TRP . 30.1 mm -65.11 -45.24 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.7 m -64.92 -46.61 80.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.953 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 717' ' ' LEU . 82.7 mt -65.52 -44.19 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 722' ' ' HIS . . . . . 0.453 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 1.7 p-80 . . . . . 0 N--CA 1.467 0.39 0 C-N-CA 119.799 -0.76 . . . . 1.0 110.512 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 694' ' ' LEU . 94.0 mt . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.81 -45.09 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.772 0.796 . . . . 1.0 109.334 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.764 ' O ' HG23 ' A' ' 700' ' ' VAL . 76.2 t -63.32 -43.09 98.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.207 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.26 -43.04 99.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.642 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.04 -43.19 96.29 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.143 0.497 . . . . 1.0 109.724 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 72.8 p -63.4 -34.61 78.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.466 -0.788 . . . . 1.0 109.883 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 696' ' ' VAL . 73.1 t -65.67 -45.27 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 53.4 ttp -61.71 -39.91 93.17 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.345 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.42 -42.42 99.06 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.28 92.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.834 0.826 . . . . 1.0 110.341 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.12 -43.76 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 119.763 -0.775 . . . . 1.0 109.943 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.05 -43.81 98.03 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.94 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.54 -41.2 98.73 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.631 0.253 . . . . 1.0 110.598 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.43 -43.0 98.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.31 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.39 -40.84 94.63 Favored Glycine 0 N--CA 1.468 0.783 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.06 -35.15 76.23 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.715 0.406 . . . . 1.0 111.757 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -48.62 -60.54 4.39 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.201 -0.6 . . . . 1.0 111.862 -177.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 39.3 Cg_exo -53.49 -41.44 73.3 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.235 1.29 . . . . 1.0 112.529 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 712' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -64.68 -43.3 94.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.631 -0.428 . . . . 1.0 109.891 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.43 -43.9 92.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.403 -0.519 . . . . 1.0 110.249 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.69 -44.77 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.41 ' O ' HD13 ' A' ' 719' ' ' ILE . 85.6 t90 -64.35 -48.65 74.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.438 -0.579 . . . . 1.0 109.438 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -58.76 -41.74 87.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.987 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 37.2 mt -63.69 -44.17 94.47 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.731 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 718' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 718' ' ' LEU . 88.7 mt -64.47 -45.43 87.39 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.796 -0.762 . . . . 1.0 110.034 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.535 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 1.7 mp -66.78 -45.3 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.11 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 716' ' ' ALA . 98.8 m -64.87 -45.95 83.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.11 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.61 -43.97 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.156 0.799 . . . . 1.0 113.156 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 722' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 1.9 p-80 . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 119.306 -0.958 . . . . 1.0 110.266 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.73 -44.82 98.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.755 ' O ' HG23 ' A' ' 700' ' ' VAL . 75.6 t -64.06 -43.56 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.643 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.37 -41.89 98.83 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.276 0.472 . . . . 1.0 112.276 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.88 -42.87 97.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.325 0.583 . . . . 1.0 109.728 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.2 p -64.04 -34.05 77.15 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.253 -0.885 . . . . 1.0 109.801 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 696' ' ' VAL . 72.5 t -65.54 -45.55 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.659 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.9 mmm -64.52 -38.48 91.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.629 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.59 -41.2 99.53 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.456 -1.058 . . . . 1.0 110.456 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.78 84.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.806 0.336 . . . . 1.0 110.555 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.7 mt -62.8 -43.92 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.454 -0.499 . . . . 1.0 110.954 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.51 -42.02 99.22 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.185 -0.606 . . . . 1.0 110.743 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.25 -42.44 99.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 1.0 110.551 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.35 -43.27 98.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.229 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.83 -43.81 72.53 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.718 -0.953 . . . . 1.0 110.718 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.41 -37.38 82.97 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 122.79 0.436 . . . . 1.0 111.067 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.645 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.28 -62.2 0.98 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.602 -0.726 . . . . 1.0 112.529 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.2 Cg_endo -63.24 -32.85 73.22 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.672 1.581 . . . . 1.0 112.573 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 712' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 712' ' ' LEU . 89.4 mt -66.01 -43.52 87.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.1 -43.89 90.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.087 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.7 mt -64.03 -44.58 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.751 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.514 ' CZ2' HD11 ' A' ' 719' ' ' ILE . 76.0 t-105 -65.26 -46.46 80.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -58.16 -43.89 87.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.125 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 721' ' ' ILE . 80.2 mt -63.85 -42.89 97.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.633 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.1 -44.37 89.04 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.693 -0.803 . . . . 1.0 109.733 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.548 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.5 mm -66.37 -45.39 89.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.881 -0.785 . . . . 1.0 108.881 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 716' ' ' ALA . 38.3 m -64.69 -44.64 89.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.14 -0.936 . . . . 1.0 110.912 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 717' ' ' LEU . 81.0 mt -67.26 -41.73 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 112.991 0.738 . . . . 1.0 112.991 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 722' ' ' HIS . . . . . 0.548 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 2.6 p-80 . . . . . 0 C--N 1.313 -0.992 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.191 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 694' ' ' LEU . 90.9 mt . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.0 -43.92 96.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.812 ' O ' HG23 ' A' ' 700' ' ' VAL . 76.4 t -63.62 -42.99 97.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.189 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.33 -42.91 99.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.351 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.96 -43.28 96.25 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.294 0.569 . . . . 1.0 109.572 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 76.4 p -63.72 -34.44 77.88 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.352 -0.84 . . . . 1.0 109.893 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.3 t -65.47 -45.06 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.6 ttp -61.76 -39.69 92.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.252 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.74 99.35 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.427 -1.069 . . . . 1.0 110.427 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.74 -36.23 82.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.713 0.292 . . . . 1.0 110.418 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.85 -44.1 99.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.551 -0.459 . . . . 1.0 110.757 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.4 -42.07 98.77 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.653 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 51.7 tp -62.48 -43.99 97.47 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.403 0.52 . . . . 1.0 112.403 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 21.2 tt -67.28 -38.41 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.211 -0.596 . . . . 1.0 111.749 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 708' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 712' ' ' LEU . . . -68.2 -44.97 73.69 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.35 -35.28 77.51 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.954 0.502 . . . . 1.0 111.07 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.642 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -41.03 -61.87 1.18 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.925 -0.58 . . . . 1.0 112.559 -177.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 23.1 Cg_endo -62.15 -33.07 82.89 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.756 1.637 . . . . 1.0 112.918 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 712' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.36 -43.17 91.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 177.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.76 -44.13 91.07 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.085 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.5 mm -64.85 -44.72 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 80.8 t90 -65.74 -47.03 76.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.25 95.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.255 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.7 mt -63.07 -43.11 99.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.714 -0.395 . . . . 1.0 110.236 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 718' ' ' LEU . . . . . 0.432 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 85.3 mt -64.17 -44.91 90.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.81 -0.756 . . . . 1.0 109.515 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.37 -45.25 89.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.774 -0.648 . . . . 1.0 109.642 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.7 m -64.29 -44.17 92.52 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.4 mm -64.59 -42.23 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.943 0.878 . . . . 1.0 110.819 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 722' ' ' HIS . . . . . 0.432 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 11.7 m80 . . . . . 0 CA--C 1.553 1.067 0 CA-C-N 114.995 -1.002 . . . . 1.0 110.487 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.0 mp . . . . . 0 C--O 1.245 0.86 0 CA-C-O 122.09 0.948 . . . . 1.0 109.579 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -44.49 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.31 -0.859 . . . . 1.0 109.229 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.791 ' O ' HG23 ' A' ' 700' ' ' VAL . 73.5 t -63.13 -43.52 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.115 -0.948 . . . . 1.0 109.609 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.31 -42.08 98.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.993 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.05 -43.16 96.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.282 0.563 . . . . 1.0 109.581 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 78.0 p -63.65 -34.82 78.68 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.661 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 696' ' ' VAL . 73.3 t -65.39 -45.35 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.2 ttp -61.86 -39.73 92.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.334 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.69 -42.37 98.69 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.745 -0.942 . . . . 1.0 110.745 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.91 96.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.636 0.255 . . . . 1.0 111.376 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.49 -41.56 92.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 82.0 mt -61.67 -42.05 98.38 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.979 -0.688 . . . . 1.0 110.446 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.82 -41.6 99.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.752 0.311 . . . . 1.0 111.199 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.404 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 31.1 mm -63.46 -43.2 98.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.371 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.55 -42.27 81.53 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 110.956 -0.857 . . . . 1.0 110.956 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.5 mt -68.3 -35.86 78.47 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.974 0.51 . . . . 1.0 111.74 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.699 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -49.59 -60.37 5.08 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.091 -0.644 . . . . 1.0 111.921 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 38.5 Cg_exo -53.76 -40.93 78.13 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.443 1.429 . . . . 1.0 112.399 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.19 -44.16 89.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.0 -43.61 91.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.563 -0.455 . . . . 1.0 109.928 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.7 -44.76 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.837 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -66.51 -46.86 74.84 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.41 -40.07 89.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.843 -0.617 . . . . 1.0 109.703 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 59.2 tp -63.64 -46.21 86.7 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.66 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 718' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 718' ' ' LEU . 86.5 mt -64.19 -44.36 92.23 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.248 -0.581 . . . . 1.0 109.935 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.3 mm -65.82 -43.95 93.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 716' ' ' ALA . 95.4 m -62.58 -45.24 93.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.35 -43.32 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 119.742 -0.783 . . . . 1.0 111.754 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.0 m80 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.542 -179.615 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 694' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 694' ' ' LEU . 92.1 mt . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 109.219 -0.659 . . . . 1.0 109.219 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 69.5 t -64.45 -45.2 96.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.503 0.668 . . . . 1.0 109.489 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.803 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.3 t -64.32 -43.06 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.955 -1.02 . . . . 1.0 109.336 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.2 -43.16 99.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.802 -0.635 . . . . 1.0 111.594 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.13 -43.0 96.62 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.423 0.63 . . . . 1.0 109.562 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 74.1 p -64.08 -34.38 77.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.231 -0.895 . . . . 1.0 109.782 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 700' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 696' ' ' VAL . 74.5 t -65.2 -45.17 94.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 61.3 mtt -63.45 -38.48 91.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.439 -0.8 . . . . 1.0 109.348 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.12 -41.68 99.69 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.232 -1.147 . . . . 1.0 110.232 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.66 94.61 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.636 0.255 . . . . 1.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 704' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 707' ' ' ILE . 97.5 mt -62.37 -43.91 98.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.59 0.71 . . . . 1.0 110.053 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.99 -43.34 99.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.601 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.06 -43.17 99.41 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.285 0.476 . . . . 1.0 112.285 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 707' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 704' ' ' ILE . 14.6 tt -65.33 -31.93 56.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.045 -0.662 . . . . 1.0 111.176 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.94 -45.75 71.35 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.624 -0.991 . . . . 1.0 110.624 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.68 -36.87 81.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 1.0 111.266 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -37.78 -62.05 0.69 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.982 -0.554 . . . . 1.0 112.311 -177.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 27.2 Cg_endo -62.57 -31.65 79.85 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.924 1.749 . . . . 1.0 112.502 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.8 -43.72 71.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.504 -0.479 . . . . 1.0 109.928 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.17 -45.05 86.48 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.935 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 714' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 715' ' ' TRP . 20.4 tt -70.26 -41.96 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 119.873 -0.731 . . . . 1.0 109.704 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 715' ' ' TRP . . . . . 0.446 ' N ' HG23 ' A' ' 714' ' ' ILE . 78.7 t90 -63.7 -47.28 81.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.887 -0.782 . . . . 1.0 108.887 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.95 85.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.17 -45.44 91.81 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.545 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.16 -44.2 89.3 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 121.298 0.571 . . . . 1.0 109.895 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 719' ' ' ILE . . . . . 0.56 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.2 mm -65.05 -44.41 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 98.9 m -63.91 -45.9 87.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.443 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 3.7 mm -65.89 -43.99 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 113.826 1.047 . . . . 1.0 113.826 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 722' ' ' HIS . . . . . 0.56 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 2.2 p-80 . . . . . 0 C--N 1.328 -0.353 0 C-N-CA 119.782 -0.767 . . . . 1.0 110.754 -178.097 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.6 t -63.72 -45.41 97.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.989 -0.55 . . . . 1.0 109.876 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.422 ' O ' ' OG ' ' A' ' 699' ' ' SER . 74.6 t -64.01 -43.52 97.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.329 -0.85 . . . . 1.0 109.852 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.92 -41.13 99.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.046 -0.525 . . . . 1.0 112.184 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.38 -42.27 88.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.238 0.542 . . . . 1.0 110.852 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.3 p -62.07 -39.63 93.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.68 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 16.2 m -69.82 -41.39 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 119.386 -0.926 . . . . 1.0 109.632 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.22 -39.0 88.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.92 -40.55 99.01 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.66 -36.87 82.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.511 0.196 . . . . 1.0 111.006 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 38.6 mm -60.93 -44.02 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 122.293 1.044 . . . . 1.0 109.547 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 46.4 tp -64.23 -44.21 92.59 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.674 -1.266 . . . . 1.0 112.404 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.06 -41.18 99.41 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 45.2 pt -65.38 -38.69 83.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.482 -0.487 . . . . 1.0 111.62 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.13 -40.98 92.82 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.414 -1.074 . . . . 1.0 110.414 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 97.0 mt -68.58 -35.27 77.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.42 -0.39 . . . . 1.0 111.505 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 710' ' ' ALA . . . . . 0.688 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -48.67 -60.91 3.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.03 -0.668 . . . . 1.0 112.075 -176.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 711' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 39.9 Cg_exo -53.88 -40.63 79.79 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.351 1.367 . . . . 1.0 112.35 178.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.34 -43.85 89.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.78 -43.94 91.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.236 178.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.82 -44.69 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -65.23 -47.77 75.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 716' ' ' ALA . . . . . 0.76 ' O ' HG23 ' A' ' 720' ' ' THR . . . -61.96 -39.43 92.12 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.096 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.412 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 60.8 tp -62.97 -46.47 87.56 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.93 -44.86 88.1 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.133 -0.627 . . . . 1.0 110.282 178.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.5 mm -66.62 -44.4 89.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.426 179.112 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 716' ' ' ALA . 57.4 p -65.71 -39.79 91.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.412 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.96 -43.29 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 120.015 -0.674 . . . . 1.0 110.986 178.331 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.624 -0.716 . . . . 1.0 110.294 -179.844 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 CA--C 1.517 -0.332 0 N-CA-C 108.356 -1.44 . . . . 15.1 108.356 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 686' ' ' GLU . . . . . 0.632 ' O ' ' C ' ' A' ' 687' ' ' SER . 0.0 OUTLIER -80.2 27.86 0.32 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 118.235 -0.888 . . . . 15.29 111.374 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.632 ' C ' ' O ' ' A' ' 686' ' ' GLU . 2.6 t -37.25 134.52 0.71 Allowed Pre-proline 0 C--N 1.378 1.811 0 N-CA-C 100.882 -3.747 . . . . 12.09 100.882 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 688' ' ' PRO . . . . . 0.607 ' C ' ' O ' ' A' ' 687' ' ' SER . 80.2 Cg_exo -40.62 118.7 0.64 Allowed 'Trans proline' 0 C--N 1.302 -1.889 0 CA-C-N 123.062 2.129 . . . . 10.02 110.06 -169.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 689' ' ' LYS . . . . . 0.566 ' NZ ' ' CB ' ' A' ' 689' ' ' LYS . 0.0 OUTLIER -74.17 -2.68 25.74 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 112.153 -2.294 . . . . 9.52 106.941 -176.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.508 ' O ' ' C ' ' A' ' 691' ' ' PRO . . . -115.86 62.57 0.36 Allowed Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 105.144 -3.182 . . . . 5.15 105.144 172.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.691 ' HG2' HD12 ' A' ' 694' ' ' LEU . 15.0 Cg_exo -51.38 126.17 18.58 Favored 'Trans proline' 0 CA--C 1.485 -1.952 1 N-CA-C 98.717 -5.147 . . . . 4.32 98.717 177.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.738 ' O ' HG23 ' A' ' 696' ' ' VAL . 67.4 m-20 -65.56 -22.22 66.68 Favored 'General case' 0 N--CA 1.406 -2.635 0 N-CA-C 106.107 -1.812 . . . . 2.13 106.107 -175.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 697' ' ' LEU . 50.2 mt -65.45 -55.21 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 114.95 -1.023 . . . . 1.25 111.662 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.691 HD12 ' HG2' ' A' ' 691' ' ' PRO . 21.0 mt -62.92 -43.83 97.74 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.728 -0.471 . . . . 0.94 109.728 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 91.4 t -67.3 -45.31 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 108.448 -0.945 . . . . 0.18 108.448 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.8 ' O ' HG23 ' A' ' 700' ' ' VAL . 71.6 t -64.51 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.342 -0.985 . . . . 0.6 108.342 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 693' ' ' ILE . 17.7 tp -60.69 -43.61 97.54 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.576 -0.284 . . . . 1.64 111.321 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 72.5 mt -66.46 -46.6 75.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.064 -0.717 . . . . 1.1 109.064 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 80.0 p -61.4 -36.78 81.24 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.415 -0.587 . . . . 0.17 109.415 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 696' ' ' VAL . 41.0 t -65.65 -46.92 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 107.977 -1.12 . . . . 0.82 107.977 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 6.3 mtp -59.94 -35.55 75.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.344 -0.984 . . . . 2.45 108.344 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.79 -44.07 81.63 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.57 -1.012 . . . . 0.14 110.57 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.72 96.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.14 110.232 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.67 -44.68 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.829 -0.748 . . . . 0.73 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.68 -44.49 96.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.89 -0.324 . . . . 1.68 110.374 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.99 -42.03 97.61 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.045 0.45 . . . . 1.82 110.259 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 89.2 mt -62.77 -41.5 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.804 -0.635 . . . . 1.37 111.021 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.29 -40.61 87.31 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.654 -0.978 . . . . 0.17 110.654 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 17.8 mt -77.68 -25.18 49.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 117.39 0.595 . . . . 1.36 110.693 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -48.44 -60.7 4.06 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.35 111.978 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 43.0 Cg_endo -66.73 -30.81 40.97 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.875 1.716 . . . . 0.4 112.354 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 712' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 716' ' ' ALA . 19.2 mt -68.04 -42.84 79.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 61.0 mt -65.4 -44.52 87.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.839 -0.43 . . . . 0.96 109.839 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.65 -46.33 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.376 -0.602 . . . . 1.09 109.376 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.815 ' CH2' HD11 ' A' ' 719' ' ' ILE . 8.7 t-105 -63.39 -47.35 82.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.442 -1.318 . . . . 3.42 107.442 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -56.24 -43.51 78.71 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.853 -0.612 . . . . 0.21 109.904 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.498 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 6.3 mt -64.48 -42.66 95.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.643 -0.253 . . . . 1.58 110.54 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 722' ' ' HIS . 80.6 mt -65.18 -45.6 84.21 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.212 -1.033 . . . . 0.88 108.212 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.815 HD11 ' CH2' ' A' ' 715' ' ' TRP . 12.7 mm -65.55 -46.96 88.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 N-CA-C 108.825 -0.806 . . . . 1.4 108.825 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 716' ' ' ALA . 31.8 m -60.35 -42.23 95.3 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.393 -1.336 . . . . 1.09 107.393 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.498 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 1.3 mm -65.67 -43.58 93.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.83 -0.748 . . . . 1.07 111.392 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 718' ' ' LEU . 46.6 m80 -76.1 -41.26 50.88 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 115.334 -0.848 . . . . 2.49 109.311 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.723 ' N ' ' O ' ' A' ' 719' ' ' ILE . 11.5 t0 -70.39 -52.65 20.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.979 -1.119 . . . . 2.6 107.979 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 724' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 720' ' ' THR . 10.8 ttp85 -68.88 148.07 50.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 102.296 -3.224 . . . . 7.61 102.296 173.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 726' ' ' GLU . 0.0 OUTLIER -167.63 -4.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.104 -1.438 . . . . 8.44 109.74 -175.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 726' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 725' ' ' LYS . 60.4 tt0 101.66 172.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.673 -1.232 . . . . 8.63 107.673 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 727' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 726' ' ' GLU . 2.8 m-85 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.09 -0.957 . . . . 11.47 109.51 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo . . . . . 0 N--CA 1.484 0.927 0 N-CA-C 109.829 -0.874 . . . . 1.0 109.829 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.89 -38.06 87.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.97 0.414 . . . . 1.0 110.333 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.543 ' H ' ' CD ' ' A' ' 688' ' ' PRO . 0.0 OUTLIER -164.78 -48.15 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.674 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 688' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' A' ' 687' ' ' SER . 21.8 Cg_exo -62.54 145.67 95.43 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.049 1.832 . . . . 1.0 111.498 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.08 144.9 50.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.672 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.524 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -97.25 -47.78 2.14 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.273 -0.731 . . . . 1.0 111.273 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 52.3 Cg_exo -54.15 -38.06 87.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.669 2.246 . . . . 1.0 112.346 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -81.34 106.09 13.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.617 0.722 . . . . 1.0 110.757 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.04 -43.17 92.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.732 -1.122 . . . . 1.0 110.965 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.13 -38.69 89.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.297 -0.865 . . . . 1.0 109.99 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.17 -44.77 97.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.162 0.506 . . . . 1.0 109.826 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.776 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.7 t -63.81 -43.79 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.375 -0.829 . . . . 1.0 109.583 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.1 -41.93 99.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.939 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.14 -42.96 96.58 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.294 0.569 . . . . 1.0 110.018 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 67.2 p -63.78 -34.9 78.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.33 -0.85 . . . . 1.0 109.94 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 696' ' ' VAL . 77.9 t -65.27 -44.85 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.27 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 60.9 mtt -63.22 -39.16 93.83 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.49 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.27 99.35 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.35 97.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.633 0.254 . . . . 1.0 111.075 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.37 -44.06 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.414 -0.515 . . . . 1.0 110.684 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.52 -42.7 99.21 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.538 -0.301 . . . . 1.0 111.315 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.57 -40.35 96.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.284 0.564 . . . . 1.0 111.162 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.02 -42.84 96.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.941 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.95 -40.12 89.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.01 -35.21 76.4 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 122.707 0.403 . . . . 1.0 111.536 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.683 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -49.61 -60.56 4.75 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 120.233 -0.587 . . . . 1.0 111.926 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 40.4 Cg_exo -53.49 -41.08 76.09 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.122 1.215 . . . . 1.0 112.434 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.23 -44.1 89.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.686 -0.487 . . . . 1.0 109.686 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 713' ' ' LEU . 87.0 mt -65.19 -43.79 90.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.093 0.473 . . . . 1.0 109.906 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.85 -44.8 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.909 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -65.14 -46.56 80.42 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.46 -38.41 87.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.541 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.99 -47.13 84.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.139 -0.319 . . . . 1.0 110.139 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.72 -44.34 90.5 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.13 -0.628 . . . . 1.0 110.111 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.5 mm -65.94 -44.46 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 716' ' ' ALA . 79.3 m -62.95 -44.91 94.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.44 -43.58 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.472 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -60.37 -39.41 87.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.593 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.24 141.77 39.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.996 0.427 . . . . 1.0 110.561 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -96.93 136.53 37.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.224 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -102.77 145.56 29.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.508 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.99 -38.97 89.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.496 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.915 -1.04 . . . . 1.0 110.515 -179.935 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.484 0.957 0 N-CA-C 109.528 -0.989 . . . . 1.0 109.528 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.94 -38.87 89.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.446 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 43.7 t -143.58 73.19 17.34 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -61.55 145.23 97.97 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.819 2.346 . . . . 1.0 112.034 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -67.74 133.91 50.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.517 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.441 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -172.14 -52.7 0.04 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.026 -0.83 . . . . 1.0 111.026 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 22.3 Cg_exo -61.62 145.14 97.86 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.565 2.177 . . . . 1.0 111.922 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -95.29 -6.03 42.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.306 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 47.1 mm -67.93 -43.61 85.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.835 0.826 . . . . 1.0 109.975 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.83 -39.32 93.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.698 -1.137 . . . . 1.0 110.317 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.62 -47.43 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.374 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 700' ' ' VAL . 29.7 m -66.62 -37.61 79.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.033 -0.667 . . . . 1.0 109.535 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 39.6 mt -63.07 -42.6 99.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.422 -0.511 . . . . 1.0 111.766 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.35 -42.76 96.07 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.366 0.603 . . . . 1.0 109.746 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 74.3 p -63.6 -34.33 77.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.21 -0.904 . . . . 1.0 109.943 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 696' ' ' VAL . 72.9 t -65.41 -45.77 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.188 0.518 . . . . 1.0 109.67 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.59 -38.57 91.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.674 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.79 99.61 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.01 85.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.762 0.315 . . . . 1.0 110.643 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.6 mt -62.77 -44.11 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.002 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.74 -42.03 99.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.091 -0.644 . . . . 1.0 110.779 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.76 -42.01 99.48 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.823 -0.351 . . . . 1.0 111.066 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.08 -41.58 93.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.597 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -71.11 -43.79 55.71 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 110.587 -1.005 . . . . 1.0 110.587 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.53 -37.42 84.97 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.873 0.469 . . . . 1.0 110.679 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.54 -62.58 0.92 Allowed Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.502 -0.772 . . . . 1.0 112.374 -177.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 20.2 Cg_endo -61.34 -34.51 87.11 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.802 1.668 . . . . 1.0 113.128 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 712' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.71 -43.18 89.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.94 -44.04 90.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.945 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.75 -44.88 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.701 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -65.24 -47.65 76.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.627 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.49 96.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.398 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 38.7 mt -63.6 -43.38 97.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.339 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 718' ' ' LEU . 85.0 mt -63.55 -44.33 94.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.298 -0.961 . . . . 1.0 109.292 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.74 -44.88 89.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.914 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 20.1 m -63.46 -45.8 89.15 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 79.3 mt -64.37 -43.1 97.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.538 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -59.96 -40.39 88.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.6 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -72.51 -29.27 63.46 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.596 0.712 . . . . 1.0 109.934 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -66.22 -44.94 82.39 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 118.917 -1.113 . . . . 1.0 110.188 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -69.25 136.35 51.83 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.591 -0.732 . . . . 1.0 110.503 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.32 -38.76 88.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.704 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.069 -0.967 . . . . 1.0 110.601 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 N--CA 1.484 0.954 0 N-CA-C 109.519 -0.993 . . . . 1.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -118.62 131.89 56.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.363 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 4.9 t -139.07 73.31 38.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.633 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.61 145.46 97.65 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.84 2.36 . . . . 1.0 112.065 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.02 144.78 50.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.464 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -115.25 -166.3 14.96 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.045 -0.822 . . . . 1.0 111.045 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -61.66 146.0 97.12 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.983 2.455 . . . . 1.0 112.051 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 696' ' ' VAL . 98.9 m-20 -67.92 144.07 55.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.464 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.29 -43.28 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.278 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 694' ' ' LEU . 90.9 mt -62.14 -40.12 94.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.351 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.73 -43.99 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.3 t -63.48 -42.96 98.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.957 -1.02 . . . . 1.0 109.235 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.4 tp -62.62 -42.74 99.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.379 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.14 -43.07 96.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.331 0.586 . . . . 1.0 109.655 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.6 p -63.48 -34.55 78.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.332 -0.849 . . . . 1.0 109.81 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 696' ' ' VAL . 79.4 t -65.67 -44.76 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.55 -39.0 93.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.243 -0.889 . . . . 1.0 109.42 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.27 -41.75 99.47 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.705 -0.958 . . . . 1.0 110.705 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.72 -38.5 91.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.702 0.287 . . . . 1.0 110.898 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.05 -43.46 99.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.342 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.64 -42.61 99.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.699 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.0 -41.77 98.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.88 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.14 -42.94 98.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.42 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.407 ' O ' HD13 ' A' ' 712' ' ' LEU . . . -65.91 -47.08 77.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.794 -0.922 . . . . 1.0 110.794 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.35 -36.8 79.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.868 0.467 . . . . 1.0 111.418 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.626 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -36.27 -61.39 0.6 Allowed Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.0 Cg_endo -62.79 -30.81 78.28 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.954 1.769 . . . . 1.0 113.322 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 712' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.13 -43.87 90.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.107 -0.637 . . . . 1.0 109.54 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 713' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 713' ' ' LEU . 11.2 mp -64.35 -42.93 95.99 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.216 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.79 -44.9 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.551 ' CZ2' HD13 ' A' ' 719' ' ' ILE . 66.9 t-105 -65.39 -46.48 79.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 720' ' ' THR . . . -57.89 -47.85 81.56 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.459 -0.791 . . . . 1.0 110.344 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.82 -44.25 93.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.563 -0.455 . . . . 1.0 110.789 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 82.8 mt -65.13 -45.03 86.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.431 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.551 HD13 ' CZ2' ' A' ' 715' ' ' TRP . 5.3 tp -71.4 -42.33 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.094 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 716' ' ' ALA . 67.8 p -66.7 -40.41 88.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.684 -0.807 . . . . 1.0 108.852 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.41 -40.3 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.676 0.751 . . . . 1.0 111.211 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 10.9 m80 -63.07 -35.89 81.74 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.935 -0.706 . . . . 1.0 109.67 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -75.22 -39.31 60.16 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.49 0.662 . . . . 1.0 110.552 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -66.96 134.75 52.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.142 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.61 144.13 49.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.74 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.06 -38.76 89.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.406 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 117.976 -1.012 . . . . 1.0 110.526 179.826 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo . . . . . 0 N--CA 1.484 0.937 0 N-CA-C 109.408 -1.035 . . . . 1.0 109.408 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -65.89 -38.63 89.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.485 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 1.4 m 65.06 59.41 1.31 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.714 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -72.38 154.76 55.97 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.963 2.442 . . . . 1.0 112.557 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.09 144.15 50.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.293 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.479 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . 56.12 52.36 49.83 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.011 -0.835 . . . . 1.0 111.011 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 36.5 Cg_endo -65.58 -21.35 59.66 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.954 2.436 . . . . 1.0 111.997 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 696' ' ' VAL . 79.9 m-20 -67.29 143.88 56.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.471 0.653 . . . . 1.0 110.618 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.98 -42.33 79.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.641 0.734 . . . . 1.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.2 mp -62.25 -39.16 91.97 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.077 -0.965 . . . . 1.0 108.713 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.12 -44.28 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.57 0.7 . . . . 1.0 109.229 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.2 t -63.71 -42.92 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.822 -1.081 . . . . 1.0 109.167 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.19 -42.94 99.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.387 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.96 -42.86 97.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.356 0.598 . . . . 1.0 109.755 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 73.4 p -63.61 -33.58 75.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.002 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.9 t -65.64 -45.22 92.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 99.0 mmm -63.57 -37.83 88.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.377 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.08 99.11 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.581 -1.008 . . . . 1.0 110.581 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.88 92.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.769 0.318 . . . . 1.0 110.72 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.56 -43.97 98.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.337 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.31 -42.79 99.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.776 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.2 -41.99 98.87 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.551 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.8 -42.84 97.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.92 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.21 -43.1 81.52 Favored Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.79 -37.31 81.86 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.939 0.496 . . . . 1.0 111.109 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.645 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -41.44 -61.57 1.36 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.592 -0.731 . . . . 1.0 112.623 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 27.6 Cg_endo -63.11 -32.95 74.63 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.766 1.644 . . . . 1.0 112.749 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 712' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 712' ' ' LEU . 90.6 mt -66.37 -43.78 84.97 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.14 -43.97 90.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.058 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 714' ' ' ILE . . . . . 0.48 ' O ' HD13 ' A' ' 718' ' ' LEU . 95.8 mt -64.98 -45.01 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.972 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -63.89 -46.5 84.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.48 -39.75 88.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.779 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.41 -46.33 86.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 714' ' ' ILE . 9.3 mp -64.68 -45.1 88.09 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 120.178 -0.609 . . . . 1.0 110.167 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 31.0 mm -66.28 -44.35 91.19 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 716' ' ' ALA . 78.8 m -62.83 -44.09 97.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.59 -43.59 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.789 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.507 ' O ' ' C ' ' A' ' 723' ' ' ASP . 7.5 m80 -64.1 -35.61 81.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.069 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 722' ' ' HIS . 99.5 m-20 -8.77 -72.1 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.999 0.812 . . . . 1.0 112.803 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 724' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 722' ' ' HIS . 85.6 mtp180 -79.23 144.61 34.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.647 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 727' ' ' PHE . 64.5 mttp -112.49 145.49 40.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.548 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 726' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 727' ' ' PHE . 97.3 mt-10 45.67 -89.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.613 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 727' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 725' ' ' LYS . 96.5 m-85 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.562 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 N--CA 1.483 0.903 0 N-CA-C 109.605 -0.96 . . . . 1.0 109.605 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.79 137.86 58.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.605 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 10.2 p -155.49 72.49 5.48 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.549 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -61.72 145.85 97.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.799 2.333 . . . . 1.0 111.942 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -106.13 146.32 30.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.263 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 139.43 -67.79 0.5 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.788 -0.925 . . . . 1.0 110.788 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.76 ' O ' HG23 ' A' ' 695' ' ' VAL . 31.8 Cg_endo -65.51 -22.2 59.1 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.378 2.052 . . . . 1.0 112.09 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -68.02 -41.06 82.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.506 ' O ' HD13 ' A' ' 697' ' ' LEU . 97.1 mt -67.48 -42.7 87.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.095 -0.957 . . . . 1.0 110.559 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 694' ' ' LEU . 90.8 mt -62.62 -36.56 83.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.016 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 691' ' ' PRO . 61.4 t -64.08 -43.73 97.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 O-C-N 123.699 0.624 . . . . 1.0 109.616 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.4 t -62.91 -43.47 98.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.614 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 693' ' ' ILE . 9.6 mp -63.23 -40.97 98.95 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.185 -0.606 . . . . 1.0 112.11 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.94 -43.24 96.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.441 0.639 . . . . 1.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 70.9 p -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.327 -0.852 . . . . 1.0 109.443 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.6 t -65.86 -45.72 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.523 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.7 ttp -62.05 -40.02 94.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.154 -0.93 . . . . 1.0 109.718 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.2 -40.67 99.28 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.71 -36.8 84.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.749 0.309 . . . . 1.0 110.479 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.64 -43.73 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.971 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.43 -41.41 98.7 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.906 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.24 -41.72 98.68 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.826 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 30.8 mm -63.43 -43.45 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.72 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.95 -46.81 64.03 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.392 -0.683 . . . . 1.0 111.392 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.39 -35.27 77.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.838 0.352 . . . . 1.0 111.123 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.647 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.47 -62.04 1.04 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 115.882 -0.599 . . . . 1.0 112.421 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.647 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 29.7 Cg_endo -63.53 -32.49 70.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.882 1.721 . . . . 1.0 112.575 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 712' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 712' ' ' LEU . 91.0 mt -65.57 -43.36 90.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.5 -43.7 93.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.794 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.71 -44.91 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.059 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.55 ' CD1' HD11 ' A' ' 719' ' ' ILE . 15.3 t-105 -65.02 -46.36 81.67 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.0 -41.91 97.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.287 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.7 mt -63.68 -43.79 95.64 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.723 -0.391 . . . . 1.0 109.991 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 718' ' ' LEU . 85.1 mt -64.38 -44.79 90.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.79 -0.764 . . . . 1.0 109.831 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.55 HD11 ' CD1' ' A' ' 715' ' ' TRP . 93.1 mt -66.27 -44.81 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 716' ' ' ALA . 99.9 m -63.66 -45.09 91.74 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.0 mm -64.23 -43.64 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.199 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -59.84 -39.57 85.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.731 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -167.91 163.98 13.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.42 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 724' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 726' ' ' GLU . 99.8 mtt180 -131.93 140.09 48.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.58 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 38.26 23.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.44 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 726' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 724' ' ' ARG . 97.0 mt-10 -140.81 148.74 41.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 1.0 110.715 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.611 179.848 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 N--CA 1.484 0.958 0 N-CA-C 109.569 -0.973 . . . . 1.0 109.569 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.89 -38.81 89.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.581 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 688' ' ' PRO . 0.4 OUTLIER -57.19 179.99 0.12 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.279 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 688' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 687' ' ' SER . 22.9 Cg_exo -61.7 145.28 97.56 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.138 1.892 . . . . 1.0 112.087 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.02 142.01 38.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 1.0 109.976 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.549 ' H ' ' CD ' ' A' ' 691' ' ' PRO . . . -108.69 -51.19 0.71 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.549 ' CD ' ' H ' ' A' ' 690' ' ' GLY . 21.7 Cg_exo -61.72 144.85 97.56 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.664 2.242 . . . . 1.0 111.794 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 696' ' ' VAL . 96.9 m-20 -90.02 -19.0 24.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.341 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.72 -43.69 89.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.336 0.588 . . . . 1.0 110.232 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 698' ' ' LEU . 95.1 mt -62.15 -37.57 85.73 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 65.7 t -64.92 -44.39 96.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.608 0.718 . . . . 1.0 109.204 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.753 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.1 t -63.4 -42.77 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.689 -1.141 . . . . 1.0 109.349 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.16 -44.24 97.06 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.147 0.425 . . . . 1.0 112.147 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 698' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 694' ' ' LEU . 4.5 mm? -64.38 -42.5 96.11 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -62.36 -35.38 78.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.779 . . . . 1.0 109.779 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 696' ' ' VAL . 66.3 t -66.66 -45.93 87.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.493 0.663 . . . . 1.0 109.331 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 63.4 mtt -62.83 -38.52 91.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.139 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.03 -41.2 99.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.83 84.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.665 0.269 . . . . 1.0 110.471 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.6 mt -62.84 -43.99 99.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.905 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.5 -42.1 99.27 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.056 -0.658 . . . . 1.0 110.969 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.65 -42.03 98.33 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.72 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.27 -40.79 90.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.964 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -73.27 -44.55 34.33 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.739 -0.944 . . . . 1.0 110.739 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.25 -36.83 80.05 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.629 0.372 . . . . 1.0 111.936 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.696 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -47.5 -59.79 5.05 Favored Pre-proline 0 N--CA 1.464 0.275 0 C-N-CA 120.057 -0.657 . . . . 1.0 111.405 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 35.5 Cg_exo -53.23 -40.3 77.94 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.43 1.42 . . . . 1.0 112.644 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.24 -44.67 87.45 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.563 -0.455 . . . . 1.0 109.936 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.77 -42.96 94.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.533 -0.467 . . . . 1.0 109.932 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.12 -44.74 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -65.68 -46.82 77.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.751 ' O ' HG23 ' A' ' 720' ' ' THR . . . -60.9 -41.11 95.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.29 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.479 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 35.4 mt -63.16 -44.34 95.78 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.104 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.73 -45.01 88.29 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 119.943 -0.703 . . . . 1.0 109.991 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.8 mm -66.86 -44.82 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.346 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 716' ' ' ALA . 66.5 p -67.45 -39.66 85.38 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 119.217 -0.993 . . . . 1.0 108.706 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.8 mm -64.65 -43.41 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 119.962 -0.695 . . . . 1.0 110.639 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -60.27 -39.38 86.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.333 -0.848 . . . . 1.0 110.647 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -74.01 -19.24 60.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.506 -0.316 . . . . 1.0 110.389 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 724' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' A' ' 721' ' ' ILE . 94.9 mtt-85 -102.71 136.83 41.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 1.0 110.59 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.18 -42.04 99.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.537 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 56.62 76.38 0.3 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.205 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.993 -1.003 . . . . 1.0 110.598 -179.796 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 N--CA 1.484 0.922 0 N-CA-C 109.575 -0.971 . . . . 1.0 109.575 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.66 126.21 54.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.616 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 70.1 m -139.95 72.75 34.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.533 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.51 145.19 98.12 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.911 2.407 . . . . 1.0 112.081 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.14 145.62 50.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.355 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.478 ' H ' ' HD2' ' A' ' 691' ' ' PRO . . . -151.13 -56.31 0.01 OUTLIER Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.889 -0.672 . . . . 1.0 111.451 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 690' ' ' GLY . 23.4 Cg_exo -61.34 144.06 98.24 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.309 2.006 . . . . 1.0 112.073 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 696' ' ' VAL . 95.8 m-20 -98.13 -4.45 35.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.412 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 694' ' ' LEU . 20.7 tt -69.9 -41.51 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.994 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.528 ' N ' HG23 ' A' ' 693' ' ' ILE . 90.9 mt -62.93 -40.27 97.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.437 -0.801 . . . . 1.0 109.204 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.0 -45.04 97.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.441 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.807 ' O ' HG23 ' A' ' 700' ' ' VAL . 75.9 t -63.86 -43.11 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.052 -0.977 . . . . 1.0 109.43 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.41 -43.02 99.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.562 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.34 -43.09 95.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.222 0.534 . . . . 1.0 109.56 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 75.7 p -63.96 -34.09 77.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.793 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 696' ' ' VAL . 73.6 t -65.77 -44.69 93.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.8 mtp -63.61 -38.97 93.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.297 -0.865 . . . . 1.0 109.619 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.78 -41.85 98.74 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.12 93.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.655 0.264 . . . . 1.0 110.844 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.26 -43.83 98.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.494 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 705' ' ' LEU . 93.7 mt -62.16 -42.18 99.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.654 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.94 -42.28 99.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.875 0.369 . . . . 1.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.427 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 96.0 mt -62.23 -40.85 89.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.55 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -72.83 -42.27 46.43 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.63 -37.34 84.64 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 122.921 0.488 . . . . 1.0 111.588 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -51.17 -59.91 6.74 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 120.285 -0.566 . . . . 1.0 112.172 -176.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 43.5 Cg_exo -53.02 -41.04 74.5 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.542 1.495 . . . . 1.0 112.18 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.27 -43.93 89.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.73 -43.45 93.36 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.834 -0.432 . . . . 1.0 109.834 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.42 -44.89 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.601 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 79.5 t90 -65.72 -47.01 76.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.748 ' O ' HG23 ' A' ' 720' ' ' THR . . . -61.75 -39.13 90.54 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.933 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 60.0 tp -63.03 -45.98 89.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.534 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 87.6 mt -65.13 -46.02 82.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.283 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.8 -44.46 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.284 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 716' ' ' ALA . 61.6 p -66.13 -36.13 82.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.307 -0.957 . . . . 1.0 108.605 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 2.3 mm -66.56 -39.48 84.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.976 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 725' ' ' LYS . 40.5 m80 -66.88 -34.64 78.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.36 -0.837 . . . . 1.0 111.225 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 722' ' ' HIS . 98.2 m-20 -8.89 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 124.336 1.023 . . . . 1.0 113.231 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -63.08 -43.33 98.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.039 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 722' ' ' HIS . 87.2 tttt -68.29 132.9 47.92 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.98 -41.94 90.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.336 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 727' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' A' ' 727' ' ' PHE . 52.0 p90 . . . . . 0 C--O 1.221 -0.395 0 CA-C-O 117.974 -1.012 . . . . 1.0 110.475 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.483 0.907 0 N-CA-C 109.609 -0.958 . . . . 1.0 109.609 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.0 -38.93 89.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.416 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.49 161.8 70.96 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.414 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.82 152.47 63.83 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.929 2.419 . . . . 1.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -141.26 151.19 43.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.793 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 167.02 -173.04 42.28 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.8 -38.68 85.5 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.782 2.321 . . . . 1.0 111.975 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 66.1 t0 67.6 -48.22 0.51 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.664 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.03 -43.85 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.018 0.437 . . . . 1.0 110.472 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 694' ' ' LEU . 94.4 mt -62.94 -38.74 92.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.723 -0.672 . . . . 1.0 109.447 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.54 -45.39 98.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.63 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.732 ' O ' HG23 ' A' ' 700' ' ' VAL . 74.7 t -63.85 -43.67 97.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.446 -0.797 . . . . 1.0 109.392 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.25 -42.05 99.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.267 0.469 . . . . 1.0 112.267 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.04 -42.76 96.96 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.256 0.55 . . . . 1.0 109.806 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.9 p -63.25 -34.08 76.88 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.002 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 696' ' ' VAL . 75.7 t -65.61 -45.21 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.643 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.27 -38.1 89.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.485 -0.779 . . . . 1.0 109.775 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.3 -42.24 99.3 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.561 -1.016 . . . . 1.0 110.561 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.93 96.15 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.673 0.237 . . . . 1.0 110.675 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.74 -42.93 98.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 121.867 0.841 . . . . 1.0 110.008 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.16 -41.56 98.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.985 -0.686 . . . . 1.0 110.876 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.98 -40.52 97.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.773 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.27 -43.16 98.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.578 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.76 -46.08 62.5 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.716 -0.954 . . . . 1.0 110.716 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.29 -35.75 78.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.163 0.506 . . . . 1.0 111.185 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.06 -61.95 1.01 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.429 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.7 Cg_endo -63.04 -32.33 75.76 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.811 1.674 . . . . 1.0 112.73 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 712' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 712' ' ' LEU . 90.7 mt -66.06 -43.57 87.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.04 -43.66 91.63 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.965 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.7 -44.82 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.96 -0.564 . . . . 1.0 109.748 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.437 ' CZ2' HD11 ' A' ' 719' ' ' ILE . 76.9 t-105 -65.5 -46.56 79.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -59.73 -42.06 92.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.111 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.444 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 37.7 mt -63.63 -44.09 94.92 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.238 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.74 -45.35 86.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.956 -0.698 . . . . 1.0 110.024 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.437 HD11 ' CZ2' ' A' ' 715' ' ' TRP . 30.7 mm -66.42 -44.61 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 716' ' ' ALA . 97.6 m -63.51 -44.9 92.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.536 -0.913 . . . . 1.0 108.536 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.444 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.5 -43.13 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.666 -0.697 . . . . 1.0 111.3 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -61.93 -36.33 81.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.755 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -86.64 112.45 21.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 1.0 110.91 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -124.41 133.68 53.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.042 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.53 133.41 50.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.607 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -115.54 126.91 54.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.377 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.553 -179.835 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 N--CA 1.483 0.896 0 N-CA-C 109.612 -0.957 . . . . 1.0 109.612 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -96.79 -7.99 32.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.816 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.562 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 0.0 OUTLIER -62.4 -43.55 85.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.123 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 688' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 687' ' ' SER . 22.7 Cg_exo -61.38 144.72 98.49 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.555 2.17 . . . . 1.0 112.027 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.39 -41.89 98.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.768 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -151.95 84.89 0.15 Allowed Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.08 153.11 46.46 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.073 1.849 . . . . 1.0 112.501 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 696' ' ' VAL . 95.7 m-20 -97.33 -4.48 38.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.559 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.4 mt -65.4 -43.65 94.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-O 121.296 0.57 . . . . 1.0 110.164 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.87 -40.0 96.16 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.315 -0.857 . . . . 1.0 109.333 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.05 -45.15 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.382 0.611 . . . . 1.0 109.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 700' ' ' VAL . 76.4 t -64.11 -42.99 97.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.995 -1.002 . . . . 1.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 51.7 tp -62.61 -43.03 99.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.71 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.99 -43.02 96.94 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.259 0.552 . . . . 1.0 109.748 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.6 p -63.23 -34.32 77.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.856 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.4 t -65.44 -45.3 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.638 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.9 mmm -63.93 -37.98 89.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.441 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.49 -42.38 98.98 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.546 -1.022 . . . . 1.0 110.546 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.3 90.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.713 0.292 . . . . 1.0 110.866 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.94 -43.55 99.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.472 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.33 -42.19 99.18 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.784 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.0 mt -62.89 -41.51 99.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.354 . . . . 1.0 110.705 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.3 -43.25 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.291 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.86 -43.57 73.44 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.49 -37.14 82.41 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 122.879 0.472 . . . . 1.0 110.954 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -41.45 -61.96 1.23 Allowed Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.782 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.4 Cg_endo -63.27 -33.09 72.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.782 1.654 . . . . 1.0 112.672 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.19 -43.95 85.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.45 -44.21 87.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.155 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.18 -44.68 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.282 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.577 ' NE1' HD11 ' A' ' 719' ' ' ILE . 58.3 t-105 -66.08 -46.54 77.34 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.54 -37.98 85.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.848 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 721' ' ' ILE . 58.6 tp -63.54 -44.15 95.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.557 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 84.4 mt -64.63 -43.62 93.13 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.577 HD11 ' NE1' ' A' ' 715' ' ' TRP . 97.9 mt -65.25 -41.74 92.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 CA-C-O 123.64 1.686 . . . . 1.0 107.962 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 716' ' ' ALA . 99.0 m -68.29 -41.23 81.28 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 117.978 -1.489 . . . . 1.0 108.629 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.2 mm -64.71 -44.13 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 119.802 -0.759 . . . . 1.0 111.339 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 43.1 m80 -63.17 -40.62 98.08 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.274 -0.876 . . . . 1.0 110.442 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -67.92 -41.26 82.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.781 0.324 . . . . 1.0 110.256 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -62.76 -43.03 99.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.423 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -71.26 136.61 48.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.238 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.63 -39.22 93.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.911 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 727' ' ' PHE . . . . . 0.54 ' O ' ' CD2' ' A' ' 727' ' ' PHE . 81.8 t80 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 N--CA 1.483 0.897 0 N-CA-C 109.584 -0.968 . . . . 1.0 109.584 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -114.19 125.71 54.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.301 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 9.5 p -177.23 73.05 0.23 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.59 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.62 145.6 97.5 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.932 2.421 . . . . 1.0 111.97 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -110.86 146.07 37.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.389 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 145.26 -160.53 28.08 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.16 145.42 98.75 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.538 2.158 . . . . 1.0 111.671 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -98.75 -3.18 36.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.573 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.82 -43.76 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.426 0.631 . . . . 1.0 109.886 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 698' ' ' LEU . 11.0 mp -63.04 -39.91 96.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.503 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.73 -45.47 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.798 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.3 t -64.04 -43.38 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.165 -0.925 . . . . 1.0 109.156 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.65 -43.71 98.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.841 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 698' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 694' ' ' LEU . 9.9 mp -64.44 -42.56 95.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.136 0.493 . . . . 1.0 109.7 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 78.0 p -63.21 -34.8 78.42 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.883 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 696' ' ' VAL . 74.2 t -65.63 -45.43 92.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.2 ttp -62.05 -39.56 92.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.587 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.96 -42.43 98.29 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.898 -0.881 . . . . 1.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.92 95.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.586 0.231 . . . . 1.0 110.716 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.37 -44.04 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.399 -0.521 . . . . 1.0 110.36 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.25 -43.09 99.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.714 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.8 -41.19 99.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.153 0.502 . . . . 1.0 111.855 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.7 -39.98 87.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.351 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.41 -42.88 63.7 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.612 -0.995 . . . . 1.0 110.612 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 709' ' ' LEU . . . . . 0.411 HD23 HD12 ' A' ' 712' ' ' LEU . 96.7 mt -67.47 -37.88 83.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.278 0.561 . . . . 1.0 110.631 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.622 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -36.55 -62.31 0.54 Allowed Pre-proline 0 C--N 1.333 -0.118 0 CA-C-N 115.618 -0.719 . . . . 1.0 112.096 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.622 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.0 Cg_endo -62.03 -31.19 83.78 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.654 1.569 . . . . 1.0 113.256 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 712' ' ' LEU . . . . . 0.411 HD12 HD23 ' A' ' 709' ' ' LEU . 90.1 mt -65.72 -44.11 87.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.48 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 713' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 713' ' ' LEU . 11.2 mp -64.29 -42.84 96.21 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.293 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.95 -44.9 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -65.91 -45.91 80.23 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.273 -0.639 . . . . 1.0 109.273 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 720' ' ' THR . . . -57.96 -47.65 82.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.372 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.462 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 83.1 mt -64.26 -43.73 93.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.75 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.06 -44.89 87.52 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.139 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 5.1 tp -71.4 -41.88 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 108.925 -0.769 . . . . 1.0 108.925 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 716' ' ' ALA . 96.9 m -63.6 -44.86 92.78 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.42 -43.33 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.021 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -60.73 -38.34 84.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -77.34 143.33 38.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.466 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -138.85 152.24 47.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.607 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -127.28 144.63 51.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.565 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -116.86 127.41 54.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.519 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.03 -0.986 . . . . 1.0 110.562 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 N--CA 1.483 0.907 0 N-CA-C 109.569 -0.973 . . . . 1.0 109.569 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -114.12 125.94 54.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.398 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 2.7 m 176.4 73.93 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.538 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.49 145.27 98.09 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.842 2.361 . . . . 1.0 111.962 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -127.05 145.01 50.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.618 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 167.43 71.54 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.939 -0.865 . . . . 1.0 110.939 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.73 145.36 97.41 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.744 2.296 . . . . 1.0 111.943 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 696' ' ' VAL . 95.9 m-20 -95.58 -7.58 37.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.131 0.491 . . . . 1.0 110.039 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 32.3 mm -65.66 -43.47 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.665 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 698' ' ' LEU . 89.9 mt -62.63 -40.23 96.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.463 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.9 t -63.23 -45.2 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.322 0.582 . . . . 1.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.4 t -63.9 -43.17 97.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.48 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 40.4 mt -62.84 -42.48 99.76 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.497 -0.481 . . . . 1.0 112.057 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 698' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 694' ' ' LEU . 9.8 mp -64.26 -42.61 96.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.25 0.548 . . . . 1.0 109.805 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -63.28 -34.61 78.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.893 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 696' ' ' VAL . 71.6 t -65.44 -45.65 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.695 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 99.0 mmm -64.94 -37.51 87.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.644 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.38 -43.14 99.49 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.86 77.69 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.092 -0.643 . . . . 1.0 110.823 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.96 -43.11 98.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.062 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.83 -42.08 99.58 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.088 -0.645 . . . . 1.0 111.892 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.79 -40.27 96.25 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.648 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.425 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 36.8 mm -64.55 -34.14 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.858 0.361 . . . . 1.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -77.5 -43.94 14.22 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.021 -1.085 . . . . 1.0 111.024 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.26 -36.56 81.84 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.76 0.424 . . . . 1.0 111.969 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.716 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -50.72 -60.04 6.23 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.079 -0.649 . . . . 1.0 111.768 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 42.8 Cg_exo -53.07 -41.29 72.83 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.296 1.331 . . . . 1.0 112.113 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.31 -44.12 88.89 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.59 -43.46 93.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.607 -0.437 . . . . 1.0 110.007 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.58 -44.79 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.7 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.565 ' CE2' HD11 ' A' ' 719' ' ' ILE . 12.7 t90 -66.33 -46.12 77.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.862 ' O ' HG23 ' A' ' 720' ' ' THR . . . -61.82 -38.59 88.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.661 -0.7 . . . . 1.0 109.655 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.09 -45.56 91.54 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.533 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 86.7 mt -63.59 -43.36 97.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.23 -0.588 . . . . 1.0 109.499 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.565 HD11 ' CE2' ' A' ' 715' ' ' TRP . 92.2 mt -64.63 -44.26 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.862 HG23 ' O ' ' A' ' 716' ' ' ALA . 74.3 p -64.12 -41.21 97.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.042 -1.063 . . . . 1.0 108.404 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 81.7 mt -64.46 -43.4 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 119.57 -0.852 . . . . 1.0 111.706 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 52.0 m80 -65.18 -37.73 88.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.547 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -85.23 114.54 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 1.0 110.784 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -73.48 146.05 45.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.555 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.93 -41.92 99.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 726' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 727' ' ' PHE . 83.9 tt0 -109.75 117.26 33.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.435 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 727' ' ' PHE . . . . . 0.443 ' C ' ' O ' ' A' ' 726' ' ' GLU . 88.0 m-85 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.961 -1.019 . . . . 1.0 111.567 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.484 0.957 0 N-CA-C 109.659 -0.939 . . . . 1.0 109.659 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -65.98 -38.51 88.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.409 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 62.1 m -131.89 78.05 70.76 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.53 145.0 98.21 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.593 2.195 . . . . 1.0 112.004 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 689' ' ' LYS . . . . . 0.41 ' O ' ' CD1' ' A' ' 694' ' ' LEU . 88.7 tttt -62.21 -44.21 97.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.537 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 43.98 69.5 0.68 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 695' ' ' VAL . 50.4 Cg_exo -54.71 -38.02 91.51 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.966 2.444 . . . . 1.0 112.294 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 696' ' ' VAL . 54.8 m-20 -65.89 -42.41 90.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.367 0.603 . . . . 1.0 110.046 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 94.8 mt -65.55 -43.27 94.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.353 -0.839 . . . . 1.0 110.031 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 689' ' ' LYS . 88.8 mt -62.65 -39.96 95.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.996 -1.002 . . . . 1.0 109.53 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 691' ' ' PRO . 68.8 t -63.75 -45.1 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.298 -0.63 . . . . 1.0 109.298 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.0 t -64.05 -43.15 97.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.961 -1.018 . . . . 1.0 109.282 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.49 -42.99 99.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.598 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.32 -43.17 95.52 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.183 0.516 . . . . 1.0 109.671 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -63.28 -34.95 78.79 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.825 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 696' ' ' VAL . 74.7 t -65.81 -45.39 91.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.0 ttp -61.92 -39.42 91.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.136 -0.938 . . . . 1.0 109.571 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.53 -40.78 99.56 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.41 87.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.497 0.189 . . . . 1.0 111.016 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 31.6 mm -62.95 -44.12 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.434 -0.507 . . . . 1.0 110.771 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.71 -41.98 99.42 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.932 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.29 -42.53 99.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.811 0.339 . . . . 1.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.43 -43.25 98.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.197 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 712' ' ' LEU . . . -68.52 -43.9 75.02 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.42 -36.88 82.14 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.869 0.468 . . . . 1.0 111.115 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.64 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.12 -62.19 0.96 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.83 -0.623 . . . . 1.0 112.435 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 22.4 Cg_endo -62.02 -33.65 82.5 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.657 1.571 . . . . 1.0 113.036 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 712' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.66 -42.94 90.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 177.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.45 -43.69 93.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.883 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.78 -44.9 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.888 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -65.96 -45.96 79.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -55.46 -47.65 75.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.275 -0.875 . . . . 1.0 109.857 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 40.3 mt -63.69 -43.3 97.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.539 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.44 -44.89 89.72 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 120.171 -0.611 . . . . 1.0 111.243 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 719' ' ' ILE . 14.1 pt -73.17 -41.85 58.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 94.8 m -64.14 -43.55 94.88 Favored 'General case' 0 C--O 1.265 1.876 0 CA-C-O 122.346 1.07 . . . . 1.0 108.616 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.0 -44.43 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 117.802 -1.559 . . . . 1.0 111.702 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -59.38 -39.64 84.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.083 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -66.75 -39.09 87.77 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.78 0.324 . . . . 1.0 110.255 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -62.65 -42.9 99.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.395 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -62.41 -44.35 96.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.454 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 56.23 76.23 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.269 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 727' ' ' PHE . . . . . 0.491 ' CD2' ' OXT' ' A' ' 727' ' ' PHE . 55.2 p90 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.997 -1.002 . . . . 1.0 110.517 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 N--CA 1.484 0.956 0 N-CA-C 109.521 -0.992 . . . . 1.0 109.521 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.04 -38.92 89.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.579 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 74.9 m 44.11 59.47 12.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.785 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.2 153.74 56.75 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.937 2.425 . . . . 1.0 112.41 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -110.78 130.16 55.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.338 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 103.59 75.53 1.06 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.827 -0.909 . . . . 1.0 110.827 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.76 145.49 97.26 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.858 2.372 . . . . 1.0 111.606 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -94.84 -8.66 36.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.299 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.63 -43.19 93.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.633 0.73 . . . . 1.0 110.071 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.04 -37.17 86.73 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.788 -1.096 . . . . 1.0 109.737 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.89 -43.29 93.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.806 0.812 . . . . 1.0 109.571 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.795 ' O ' HG23 ' A' ' 700' ' ' VAL . 71.1 t -66.05 -39.74 85.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.48 -1.236 . . . . 1.0 109.693 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.98 -43.05 96.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.833 -0.621 . . . . 1.0 111.684 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -65.36 -42.23 92.98 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.319 -0.622 . . . . 1.0 109.319 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 59.3 p -62.98 -35.05 78.91 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.678 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 696' ' ' VAL . 75.5 t -66.44 -44.53 90.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.333 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 5.7 ttp -61.89 -39.26 91.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.29 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.92 -41.67 98.62 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.13 96.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.775 0.321 . . . . 1.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.0 -43.72 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.26 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.41 -42.32 99.35 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.659 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.58 -42.38 99.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 1.0 110.446 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.23 -43.35 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.62 -44.88 69.31 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.414 -1.074 . . . . 1.0 110.414 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.05 -38.04 82.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.138 0.494 . . . . 1.0 110.99 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -37.13 -61.77 0.65 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.726 -0.67 . . . . 1.0 112.315 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.0 Cg_endo -62.79 -31.25 78.35 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.764 1.643 . . . . 1.0 113.192 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 712' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 712' ' ' LEU . 91.2 mt -65.5 -44.45 86.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.3 -0.56 . . . . 1.0 109.525 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 713' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 713' ' ' LEU . 11.2 mp -64.45 -42.84 95.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.099 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.26 -45.09 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 120.297 -0.561 . . . . 1.0 109.872 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.568 ' CD2' HD11 ' A' ' 719' ' ' ILE . 1.5 t90 -65.98 -46.53 77.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.15 -43.4 95.76 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.352 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 721' ' ' ILE . 38.0 mt -63.39 -43.95 96.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.297 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.58 -44.57 90.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.749 -0.78 . . . . 1.0 109.679 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.568 HD11 ' CD2' ' A' ' 715' ' ' TRP . 93.3 mt -66.32 -45.01 90.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.756 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 716' ' ' ALA . 97.3 m -63.84 -44.74 92.28 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 724' ' ' ARG . 3.0 mm -64.18 -43.59 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.984 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -60.28 -40.09 89.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.545 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.95 -42.99 69.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.789 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 724' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 721' ' ' ILE . 99.9 mtt180 -130.36 140.6 50.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.842 0.353 . . . . 1.0 110.991 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.32 -42.08 98.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.634 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -135.63 148.25 48.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.702 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.987 -1.006 . . . . 1.0 110.613 -179.921 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.483 0.885 0 N-CA-C 109.576 -0.971 . . . . 1.0 109.576 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -65.98 -38.9 89.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.027 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 70.1 m -144.01 74.74 16.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.48 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.57 145.05 98.07 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.748 2.299 . . . . 1.0 112.004 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -68.75 133.68 48.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.683 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -144.83 -172.73 15.53 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -61.65 144.16 97.23 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.508 2.139 . . . . 1.0 111.888 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 696' ' ' VAL . 95.8 m-20 -97.73 -5.23 35.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.413 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.51 -43.74 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.408 0.623 . . . . 1.0 110.26 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.0 mp -62.81 -40.06 96.19 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.274 -0.875 . . . . 1.0 109.563 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.86 -45.42 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-O 121.42 0.629 . . . . 1.0 109.734 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 699' ' ' SER . 79.3 t -64.29 -43.08 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.001 -1.0 . . . . 1.0 109.382 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 51.9 tp -61.93 -42.47 99.13 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.87 -0.605 . . . . 1.0 112.031 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.19 -42.15 89.22 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.178 0.513 . . . . 1.0 110.926 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 68.8 p -61.73 -39.39 91.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.445 -0.798 . . . . 1.0 111.633 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.27 -40.31 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 119.67 -0.812 . . . . 1.0 109.498 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 56.0 ttp -61.23 -39.5 90.52 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.2 -40.81 98.33 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 110.595 -1.002 . . . . 1.0 110.595 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.52 91.37 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.689 -0.404 . . . . 1.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.96 -44.52 99.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 120.452 -0.499 . . . . 1.0 110.272 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.21 -43.16 99.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.628 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.58 -40.29 96.43 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.75 0.31 . . . . 1.0 111.142 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.455 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 85.2 mt -62.28 -41.54 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.84 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.31 -44.71 64.17 Favored Glycine 0 N--CA 1.471 0.996 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 8.9 mp -69.07 -35.47 76.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.501 -0.35 . . . . 1.0 111.936 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.678 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -50.5 -59.83 6.52 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 119.445 -0.902 . . . . 1.0 111.644 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 38.7 Cg_exo -53.16 -41.04 74.99 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.538 1.492 . . . . 1.0 112.308 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.52 -44.07 88.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.499 -0.556 . . . . 1.0 109.499 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.6 -43.82 92.6 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.475 -0.49 . . . . 1.0 109.876 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 714' ' ' ILE . . . . . 0.424 ' O ' HD13 ' A' ' 718' ' ' LEU . 95.5 mt -64.53 -44.84 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.483 ' CZ2' HD11 ' A' ' 719' ' ' ILE . 68.9 t-105 -63.76 -45.84 87.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.979 -0.748 . . . . 1.0 108.979 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.52 86.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.999 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.9 mt -63.16 -43.7 97.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.426 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 714' ' ' ILE . 8.8 mp -63.86 -43.93 94.62 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.413 -0.915 . . . . 1.0 109.021 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.483 HD11 ' CZ2' ' A' ' 715' ' ' TRP . 30.1 mm -65.11 -45.24 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.7 m -64.92 -46.61 80.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.953 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 717' ' ' LEU . 82.7 mt -65.52 -44.19 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.488 ' O ' ' C ' ' A' ' 723' ' ' ASP . 1.7 p-80 -67.69 -30.03 69.44 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 119.799 -0.76 . . . . 1.0 110.512 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.488 ' C ' ' O ' ' A' ' 722' ' ' HIS . 51.6 p-10 -7.05 126.27 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.154 0.908 . . . . 1.0 113.392 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -62.51 -42.87 99.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.348 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.5 146.61 48.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.637 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -109.21 124.11 50.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.521 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.554 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo . . . . . 0 N--CA 1.484 0.945 0 N-CA-C 109.56 -0.977 . . . . 1.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -64.97 138.35 58.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.98 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 32.1 m 54.48 73.01 0.96 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.59 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -61.69 145.25 97.6 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.747 2.298 . . . . 1.0 112.072 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.56 144.54 50.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.572 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -177.61 -70.14 0.06 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.797 ' O ' HG23 ' A' ' 695' ' ' VAL . 29.7 Cg_endo -64.77 -23.06 63.25 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.756 2.304 . . . . 1.0 112.144 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 693' ' ' ILE . 38.2 p-10 -71.83 -40.98 68.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.8 -0.637 . . . . 1.0 109.836 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.548 ' N ' ' OD1' ' A' ' 692' ' ' ASP . 97.9 mt -65.44 -43.66 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.039 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 694' ' ' LEU . 94.0 mt -62.33 -37.05 84.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.307 -0.861 . . . . 1.0 109.129 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 691' ' ' PRO . 78.5 t -65.81 -45.09 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.772 0.796 . . . . 1.0 109.334 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.764 ' O ' HG23 ' A' ' 700' ' ' VAL . 76.2 t -63.32 -43.09 98.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.207 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.26 -43.04 99.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.642 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.04 -43.19 96.29 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.143 0.497 . . . . 1.0 109.724 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 72.8 p -63.4 -34.61 78.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.466 -0.788 . . . . 1.0 109.883 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 696' ' ' VAL . 73.1 t -65.67 -45.27 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 53.4 ttp -61.71 -39.91 93.17 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.345 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.42 -42.42 99.06 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.28 92.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.834 0.826 . . . . 1.0 110.341 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.12 -43.76 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 119.763 -0.775 . . . . 1.0 109.943 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.05 -43.81 98.03 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.94 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.54 -41.2 98.73 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.631 0.253 . . . . 1.0 110.598 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.43 -43.0 98.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.31 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.39 -40.84 94.63 Favored Glycine 0 N--CA 1.468 0.783 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.06 -35.15 76.23 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.715 0.406 . . . . 1.0 111.757 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -48.62 -60.54 4.39 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.201 -0.6 . . . . 1.0 111.862 -177.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 39.3 Cg_exo -53.49 -41.44 73.3 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.235 1.29 . . . . 1.0 112.529 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 712' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -64.68 -43.3 94.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.631 -0.428 . . . . 1.0 109.891 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.43 -43.9 92.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.403 -0.519 . . . . 1.0 110.249 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.69 -44.77 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.41 ' O ' HD13 ' A' ' 719' ' ' ILE . 85.6 t90 -64.35 -48.65 74.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.438 -0.579 . . . . 1.0 109.438 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -58.76 -41.74 87.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.987 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 37.2 mt -63.69 -44.17 94.47 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.731 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 718' ' ' LEU . 88.7 mt -64.47 -45.43 87.39 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.796 -0.762 . . . . 1.0 110.034 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.535 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 1.7 mp -66.78 -45.3 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.11 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 716' ' ' ALA . 98.8 m -64.87 -45.95 83.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.11 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.61 -43.97 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.156 0.799 . . . . 1.0 113.156 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 1.9 p-80 -65.64 -35.52 81.02 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.306 -0.958 . . . . 1.0 110.266 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 722' ' ' HIS . 64.6 t0 -66.83 -40.01 87.84 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.058 -0.349 . . . . 1.0 110.058 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -67.45 134.43 51.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.288 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 727' ' ' PHE . 98.8 mttt -63.04 -41.96 99.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.593 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 45.38 -88.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.671 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 727' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 725' ' ' LYS . 89.0 t80 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.047 -0.978 . . . . 1.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.482 0.829 0 N-CA-C 109.463 -1.014 . . . . 1.0 109.463 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -114.41 125.96 54.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.6 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 10.6 t -166.82 73.52 1.09 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.697 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.9 145.14 97.1 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.852 2.368 . . . . 1.0 111.964 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.35 -44.11 97.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.591 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.475 ' O ' HG22 ' A' ' 693' ' ' ILE . . . 97.97 55.87 1.11 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.648 ' O ' HG23 ' A' ' 695' ' ' VAL . 41.4 Cg_endo -69.37 -11.8 32.17 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.77 2.313 . . . . 1.0 112.314 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -65.7 -40.54 92.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.17 0.509 . . . . 1.0 110.315 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 690' ' ' GLY . 10.9 tp -70.18 -39.25 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.268 0.556 . . . . 1.0 109.968 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.34 -39.27 92.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.269 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 691' ' ' PRO . 66.7 t -63.73 -44.82 98.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.755 ' O ' HG23 ' A' ' 700' ' ' VAL . 75.6 t -64.06 -43.56 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.643 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.37 -41.89 98.83 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.276 0.472 . . . . 1.0 112.276 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.88 -42.87 97.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.325 0.583 . . . . 1.0 109.728 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.2 p -64.04 -34.05 77.15 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.253 -0.885 . . . . 1.0 109.801 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 696' ' ' VAL . 72.5 t -65.54 -45.55 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.659 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.9 mmm -64.52 -38.48 91.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.629 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.59 -41.2 99.53 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.456 -1.058 . . . . 1.0 110.456 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.78 84.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.806 0.336 . . . . 1.0 110.555 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.7 mt -62.8 -43.92 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.454 -0.499 . . . . 1.0 110.954 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.51 -42.02 99.22 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.185 -0.606 . . . . 1.0 110.743 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.25 -42.44 99.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 1.0 110.551 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.35 -43.27 98.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.229 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.83 -43.81 72.53 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.718 -0.953 . . . . 1.0 110.718 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.41 -37.38 82.97 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 122.79 0.436 . . . . 1.0 111.067 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.645 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.28 -62.2 0.98 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.602 -0.726 . . . . 1.0 112.529 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.2 Cg_endo -63.24 -32.85 73.22 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.672 1.581 . . . . 1.0 112.573 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 712' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 712' ' ' LEU . 89.4 mt -66.01 -43.52 87.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.1 -43.89 90.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.087 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.7 mt -64.03 -44.58 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.751 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.514 ' CZ2' HD11 ' A' ' 719' ' ' ILE . 76.0 t-105 -65.26 -46.46 80.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -58.16 -43.89 87.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.125 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 721' ' ' ILE . 80.2 mt -63.85 -42.89 97.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.633 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.1 -44.37 89.04 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.693 -0.803 . . . . 1.0 109.733 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.548 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.5 mm -66.37 -45.39 89.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.881 -0.785 . . . . 1.0 108.881 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.428 ' O ' ' OD2' ' A' ' 723' ' ' ASP . 38.3 m -64.69 -44.64 89.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.14 -0.936 . . . . 1.0 110.912 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 717' ' ' LEU . 81.0 mt -67.26 -41.73 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 112.991 0.738 . . . . 1.0 112.991 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.548 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 2.6 p-80 -69.95 -26.67 64.23 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.191 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 722' ' ' HIS . 98.5 m-20 -9.76 -73.99 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.908 0.755 . . . . 1.0 113.02 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -126.45 132.78 51.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.188 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.03 142.37 41.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.376 -0.374 . . . . 1.0 110.505 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -89.96 139.36 30.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.535 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.061 -0.971 . . . . 1.0 110.661 179.91 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 N--CA 1.484 0.928 0 N-CA-C 109.538 -0.985 . . . . 1.0 109.538 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.01 137.96 58.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.61 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.435 ' CB ' ' CD ' ' A' ' 688' ' ' PRO . 0.1 OUTLIER -141.33 179.47 1.22 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.263 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 688' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 687' ' ' SER . 22.6 Cg_exo -61.75 144.94 97.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.137 1.892 . . . . 1.0 112.04 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.35 134.51 36.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.27 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -170.43 -167.16 30.45 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.84 146.98 96.19 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.105 2.536 . . . . 1.0 112.195 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.555 ' O ' HG23 ' A' ' 696' ' ' VAL . 83.7 m-20 -66.66 142.69 57.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.134 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.27 -43.36 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.386 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 694' ' ' LEU . 90.9 mt -62.1 -40.26 95.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.188 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.0 -43.92 96.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.812 ' O ' HG23 ' A' ' 700' ' ' VAL . 76.4 t -63.62 -42.99 97.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.189 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.33 -42.91 99.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.351 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.96 -43.28 96.25 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.294 0.569 . . . . 1.0 109.572 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 76.4 p -63.72 -34.44 77.88 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.352 -0.84 . . . . 1.0 109.893 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.3 t -65.47 -45.06 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.6 ttp -61.76 -39.69 92.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.252 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.74 99.35 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.427 -1.069 . . . . 1.0 110.427 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.74 -36.23 82.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.713 0.292 . . . . 1.0 110.418 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.85 -44.1 99.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.551 -0.459 . . . . 1.0 110.757 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.4 -42.07 98.77 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.653 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 51.7 tp -62.48 -43.99 97.47 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.403 0.52 . . . . 1.0 112.403 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 21.2 tt -67.28 -38.41 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.211 -0.596 . . . . 1.0 111.749 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 712' ' ' LEU . . . -68.2 -44.97 73.69 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.35 -35.28 77.51 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.954 0.502 . . . . 1.0 111.07 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.642 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -41.03 -61.87 1.18 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.925 -0.58 . . . . 1.0 112.559 -177.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 23.1 Cg_endo -62.15 -33.07 82.89 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.756 1.637 . . . . 1.0 112.918 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 712' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.36 -43.17 91.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 177.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.76 -44.13 91.07 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.085 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.5 mm -64.85 -44.72 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 80.8 t90 -65.74 -47.03 76.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.25 95.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.255 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.7 mt -63.07 -43.11 99.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.714 -0.395 . . . . 1.0 110.236 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.432 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 85.3 mt -64.17 -44.91 90.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.81 -0.756 . . . . 1.0 109.515 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.37 -45.25 89.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.774 -0.648 . . . . 1.0 109.642 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.7 m -64.29 -44.17 92.52 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.4 mm -64.59 -42.23 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.943 0.878 . . . . 1.0 110.819 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.557 ' O ' ' CB ' ' A' ' 723' ' ' ASP . 11.7 m80 -61.47 -29.72 70.14 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.995 -1.002 . . . . 1.0 110.487 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 722' ' ' HIS . 48.1 t0 108.46 46.63 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.454 1.121 . . . . 1.0 109.296 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 724' ' ' ARG . . . . . 0.51 ' O ' ' CE1' ' A' ' 727' ' ' PHE . 99.8 mtt180 41.81 81.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.287 -0.965 . . . . 1.0 111.159 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -62.16 -43.86 97.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.318 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.38 -37.41 83.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.856 0.36 . . . . 1.0 111.079 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 727' ' ' PHE . . . . . 0.51 ' CE1' ' O ' ' A' ' 724' ' ' ARG . 73.3 m-85 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.433 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 685' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 687' ' ' SER . 12.3 Cg_exo . . . . . 0 N--CA 1.483 0.864 0 N-CA-C 109.608 -0.959 . . . . 1.0 109.608 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 46.82 -89.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.264 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 685' ' ' PRO . 0.0 OUTLIER -73.97 161.86 76.6 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.484 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.51 152.96 60.5 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.016 2.477 . . . . 1.0 112.392 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -63.09 -42.08 99.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.589 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.44 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . 86.0 53.99 2.86 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.517 ' O ' HG23 ' A' ' 695' ' ' VAL . 33.8 Cg_endo -65.7 -19.81 59.52 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.765 2.31 . . . . 1.0 111.362 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -67.41 -39.8 85.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.52 -42.29 89.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 122.173 0.987 . . . . 1.0 109.548 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.0 mp -63.64 -38.0 89.45 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 122.09 0.948 . . . . 1.0 109.579 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 691' ' ' PRO . 62.1 t -64.3 -44.49 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.31 -0.859 . . . . 1.0 109.229 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.791 ' O ' HG23 ' A' ' 700' ' ' VAL . 73.5 t -63.13 -43.52 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.115 -0.948 . . . . 1.0 109.609 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.31 -42.08 98.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.993 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.05 -43.16 96.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.282 0.563 . . . . 1.0 109.581 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 78.0 p -63.65 -34.82 78.68 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.661 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 696' ' ' VAL . 73.3 t -65.39 -45.35 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.2 ttp -61.86 -39.73 92.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.334 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.69 -42.37 98.69 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.745 -0.942 . . . . 1.0 110.745 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.91 96.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.636 0.255 . . . . 1.0 111.376 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.49 -41.56 92.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 82.0 mt -61.67 -42.05 98.38 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.979 -0.688 . . . . 1.0 110.446 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.82 -41.6 99.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.752 0.311 . . . . 1.0 111.199 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.404 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 31.1 mm -63.46 -43.2 98.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.371 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.55 -42.27 81.53 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 110.956 -0.857 . . . . 1.0 110.956 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.5 mt -68.3 -35.86 78.47 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.974 0.51 . . . . 1.0 111.74 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.699 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -49.59 -60.37 5.08 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.091 -0.644 . . . . 1.0 111.921 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 38.5 Cg_exo -53.76 -40.93 78.13 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.443 1.429 . . . . 1.0 112.399 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.19 -44.16 89.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.0 -43.61 91.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.563 -0.455 . . . . 1.0 109.928 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.7 -44.76 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.837 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -66.51 -46.86 74.84 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.41 -40.07 89.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.843 -0.617 . . . . 1.0 109.703 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 59.2 tp -63.64 -46.21 86.7 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.66 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 718' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 718' ' ' LEU . 86.5 mt -64.19 -44.36 92.23 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.248 -0.581 . . . . 1.0 109.935 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.3 mm -65.82 -43.95 93.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 716' ' ' ALA . 95.4 m -62.58 -45.24 93.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.35 -43.32 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 119.742 -0.783 . . . . 1.0 111.754 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.545 ' O ' ' CB ' ' A' ' 723' ' ' ASP . 7.0 m80 -60.15 -38.86 84.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.542 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 722' ' ' HIS . 67.0 t0 117.54 117.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.72 1.263 . . . . 1.0 109.989 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -68.19 134.15 50.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -108.28 145.77 33.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 1.0 109.905 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.12 138.03 58.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.525 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 55.2 p90 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.412 -179.941 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.484 0.919 0 N-CA-C 109.606 -0.959 . . . . 1.0 109.606 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.87 148.05 50.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.289 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 6.3 m -126.07 81.7 66.14 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.634 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -61.32 144.91 98.76 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.36 2.04 . . . . 1.0 111.96 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 18.1 tttm 48.06 27.56 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.807 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -170.0 71.2 0.13 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.999 -0.84 . . . . 1.0 110.999 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.38 144.51 98.37 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.68 2.254 . . . . 1.0 112.042 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 692' ' ' ASP . . . . . 0.444 ' O ' HG23 ' A' ' 696' ' ' VAL . 96.4 m-20 -96.74 -6.62 35.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.307 179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.11 -43.62 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.163 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 694' ' ' LEU . 92.1 mt -62.94 -39.48 94.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.244 -0.889 . . . . 1.0 109.219 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 69.5 t -64.45 -45.2 96.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.503 0.668 . . . . 1.0 109.489 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.803 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.3 t -64.32 -43.06 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.955 -1.02 . . . . 1.0 109.336 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.2 -43.16 99.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.802 -0.635 . . . . 1.0 111.594 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.13 -43.0 96.62 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.423 0.63 . . . . 1.0 109.562 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 74.1 p -64.08 -34.38 77.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.231 -0.895 . . . . 1.0 109.782 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 696' ' ' VAL . 74.5 t -65.2 -45.17 94.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 61.3 mtt -63.45 -38.48 91.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.439 -0.8 . . . . 1.0 109.348 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.12 -41.68 99.69 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.232 -1.147 . . . . 1.0 110.232 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.66 94.61 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.636 0.255 . . . . 1.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 707' ' ' ILE . 97.5 mt -62.37 -43.91 98.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.59 0.71 . . . . 1.0 110.053 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.99 -43.34 99.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.601 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.06 -43.17 99.41 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.285 0.476 . . . . 1.0 112.285 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 707' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 704' ' ' ILE . 14.6 tt -65.33 -31.93 56.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.045 -0.662 . . . . 1.0 111.176 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.94 -45.75 71.35 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.624 -0.991 . . . . 1.0 110.624 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.68 -36.87 81.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 1.0 111.266 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -37.78 -62.05 0.69 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.982 -0.554 . . . . 1.0 112.311 -177.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 27.2 Cg_endo -62.57 -31.65 79.85 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.924 1.749 . . . . 1.0 112.502 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.8 -43.72 71.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.504 -0.479 . . . . 1.0 109.928 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.17 -45.05 86.48 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.935 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 715' ' ' TRP . 20.4 tt -70.26 -41.96 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 119.873 -0.731 . . . . 1.0 109.704 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 715' ' ' TRP . . . . . 0.446 ' N ' HG23 ' A' ' 714' ' ' ILE . 78.7 t90 -63.7 -47.28 81.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.887 -0.782 . . . . 1.0 108.887 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.95 85.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.17 -45.44 91.81 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.545 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.16 -44.2 89.3 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 121.298 0.571 . . . . 1.0 109.895 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 719' ' ' ILE . . . . . 0.56 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.2 mm -65.05 -44.41 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 98.9 m -63.91 -45.9 87.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.443 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 3.7 mm -65.89 -43.99 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 113.826 1.047 . . . . 1.0 113.826 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 722' ' ' HIS . . . . . 0.56 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 2.2 p-80 -64.68 -30.41 71.42 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.782 -0.767 . . . . 1.0 110.754 -178.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -87.92 110.5 20.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.918 0.39 . . . . 1.0 110.625 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -103.28 137.85 40.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.507 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.71 144.27 50.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.574 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -116.27 127.28 54.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.342 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.963 -1.018 . . . . 1.0 110.542 179.98 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 N--CA 1.484 0.95 0 N-CA-C 109.641 -0.946 . . . . 1.0 109.641 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.88 138.28 58.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.352 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 687' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 0.1 OUTLIER -99.7 -43.21 0.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.903 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 688' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 687' ' ' SER . 22.5 Cg_exo -61.56 145.16 98.0 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.521 2.148 . . . . 1.0 111.957 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.25 -41.93 99.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.548 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 690' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 693' ' ' ILE . . . 160.88 177.6 34.13 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 691' ' ' PRO . . . . . 0.66 ' O ' HG23 ' A' ' 695' ' ' VAL . 53.4 Cg_endo -72.55 -11.61 26.4 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 123.318 2.679 . . . . 1.0 112.746 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.06 -42.17 94.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.49 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 690' ' ' GLY . 20.1 tt -70.33 -39.38 76.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.207 0.527 . . . . 1.0 110.183 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 694' ' ' LEU . . . . . 0.416 ' N ' HG23 ' A' ' 693' ' ' ILE . 91.5 mt -62.19 -39.59 93.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.211 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 691' ' ' PRO . 68.6 t -63.72 -45.41 97.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.989 -0.55 . . . . 1.0 109.876 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.422 ' O ' ' OG ' ' A' ' 699' ' ' SER . 74.6 t -64.01 -43.52 97.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.329 -0.85 . . . . 1.0 109.852 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.92 -41.13 99.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.046 -0.525 . . . . 1.0 112.184 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.38 -42.27 88.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.238 0.542 . . . . 1.0 110.852 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.3 p -62.07 -39.63 93.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.68 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 16.2 m -69.82 -41.39 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 119.386 -0.926 . . . . 1.0 109.632 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.22 -39.0 88.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.92 -40.55 99.01 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.66 -36.87 82.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.511 0.196 . . . . 1.0 111.006 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 38.6 mm -60.93 -44.02 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 122.293 1.044 . . . . 1.0 109.547 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 46.4 tp -64.23 -44.21 92.59 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.674 -1.266 . . . . 1.0 112.404 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.06 -41.18 99.41 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 45.2 pt -65.38 -38.69 83.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.482 -0.487 . . . . 1.0 111.62 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.13 -40.98 92.82 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.414 -1.074 . . . . 1.0 110.414 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 97.0 mt -68.58 -35.27 77.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.42 -0.39 . . . . 1.0 111.505 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 710' ' ' ALA . . . . . 0.688 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -48.67 -60.91 3.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.03 -0.668 . . . . 1.0 112.075 -176.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 711' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 39.9 Cg_exo -53.88 -40.63 79.79 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.351 1.367 . . . . 1.0 112.35 178.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.34 -43.85 89.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.78 -43.94 91.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.236 178.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.82 -44.69 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -65.23 -47.77 75.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 716' ' ' ALA . . . . . 0.76 ' O ' HG23 ' A' ' 720' ' ' THR . . . -61.96 -39.43 92.12 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.096 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.412 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 60.8 tp -62.97 -46.47 87.56 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.93 -44.86 88.1 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.133 -0.627 . . . . 1.0 110.282 178.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.5 mm -66.62 -44.4 89.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.426 179.112 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 716' ' ' ALA . 57.4 p -65.71 -39.79 91.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.412 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.96 -43.29 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 120.015 -0.674 . . . . 1.0 110.986 178.331 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -59.82 -41.11 90.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.624 -0.716 . . . . 1.0 110.294 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 723' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 725' ' ' LYS . 64.7 t0 -67.38 -40.81 85.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.095 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 61.76 -42.41 0.14 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.27 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 723' ' ' ASP . 27.2 tttt 46.97 32.68 1.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.681 0.277 . . . . 1.0 110.472 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 726' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 725' ' ' LYS . 97.4 mt-10 55.53 158.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.858 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.026 -0.988 . . . . 1.0 110.552 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 CA--C 1.514 -0.406 0 N-CA-C 109.728 -0.471 . . . . 0.93999999999999995 109.728 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 91.4 t -67.3 -45.31 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 108.448 -0.945 . . . . 0.17999999999999999 108.448 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.8 ' O ' HG23 ' A' ' 700' ' ' VAL . 71.6 t -64.51 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.342 -0.985 . . . . 0.59999999999999998 108.342 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 17.7 tp -60.69 -43.61 97.54 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.576 -0.284 . . . . 1.6399999999999999 111.321 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 72.5 mt -66.46 -46.6 75.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.064 -0.717 . . . . 1.1000000000000001 109.064 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 80.0 p -61.4 -36.78 81.24 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.415 -0.587 . . . . 0.17000000000000001 109.415 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 696' ' ' VAL . 41.0 t -65.65 -46.92 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 107.977 -1.12 . . . . 0.81999999999999995 107.977 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 6.3 mtp -59.94 -35.55 75.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.344 -0.984 . . . . 2.4500000000000002 108.344 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.79 -44.07 81.63 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.57 -1.012 . . . . 0.14000000000000001 110.57 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.72 96.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.14000000000000001 110.232 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.67 -44.68 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.829 -0.748 . . . . 0.72999999999999998 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.68 -44.49 96.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.89 -0.324 . . . . 1.6799999999999999 110.374 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.99 -42.03 97.61 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.045 0.45 . . . . 1.8200000000000001 110.259 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 89.2 mt -62.77 -41.5 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.804 -0.635 . . . . 1.3700000000000001 111.021 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.29 -40.61 87.31 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.654 -0.978 . . . . 0.17000000000000001 110.654 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 17.8 mt -77.68 -25.18 49.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 117.39 0.595 . . . . 1.3600000000000001 110.693 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -48.44 -60.7 4.06 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.34999999999999998 111.978 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 43.0 Cg_endo -66.73 -30.81 40.97 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.875 1.716 . . . . 0.40000000000000002 112.354 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 716' ' ' ALA . 19.2 mt -68.04 -42.84 79.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 61.0 mt -65.4 -44.52 87.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.839 -0.43 . . . . 0.95999999999999996 109.839 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.65 -46.33 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.376 -0.602 . . . . 1.0900000000000001 109.376 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.815 ' CH2' HD11 ' A' ' 719' ' ' ILE . 8.7 t-105 -63.39 -47.35 82.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.442 -1.318 . . . . 3.4199999999999999 107.442 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -56.24 -43.51 78.71 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.853 -0.612 . . . . 0.20999999999999999 109.904 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.498 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 6.3 mt -64.48 -42.66 95.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.643 -0.253 . . . . 1.5800000000000001 110.54 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 722' ' ' HIS . 80.6 mt -65.18 -45.6 84.21 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.212 -1.033 . . . . 0.88 108.212 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.815 HD11 ' CH2' ' A' ' 715' ' ' TRP . 12.7 mm -65.55 -46.96 88.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 N-CA-C 108.825 -0.806 . . . . 1.3999999999999999 108.825 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 716' ' ' ALA . 31.8 m -60.35 -42.23 95.3 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.393 -1.336 . . . . 1.0900000000000001 107.393 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.498 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 1.3 mm -65.67 -43.58 93.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.83 -0.748 . . . . 1.0700000000000001 111.392 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 718' ' ' LEU . 46.6 m80 . . . . . 0 C--N 1.343 0.318 0 CA-C-N 115.334 -0.848 . . . . 2.4900000000000002 109.311 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.17 -44.77 97.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.162 0.506 . . . . 1.0 109.826 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.776 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.7 t -63.81 -43.79 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.375 -0.829 . . . . 1.0 109.583 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.1 -41.93 99.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.939 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.14 -42.96 96.58 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.294 0.569 . . . . 1.0 110.018 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 67.2 p -63.78 -34.9 78.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.33 -0.85 . . . . 1.0 109.94 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 696' ' ' VAL . 77.9 t -65.27 -44.85 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.27 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 60.9 mtt -63.22 -39.16 93.83 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.49 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.27 99.35 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.35 97.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.633 0.254 . . . . 1.0 111.075 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.37 -44.06 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.414 -0.515 . . . . 1.0 110.684 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.52 -42.7 99.21 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.538 -0.301 . . . . 1.0 111.315 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.57 -40.35 96.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.284 0.564 . . . . 1.0 111.162 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.02 -42.84 96.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.941 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.95 -40.12 89.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.01 -35.21 76.4 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 122.707 0.403 . . . . 1.0 111.536 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.683 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -49.61 -60.56 4.75 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 120.233 -0.587 . . . . 1.0 111.926 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 40.4 Cg_exo -53.49 -41.08 76.09 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.122 1.215 . . . . 1.0 112.434 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.23 -44.1 89.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.686 -0.487 . . . . 1.0 109.686 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 713' ' ' LEU . 87.0 mt -65.19 -43.79 90.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.093 0.473 . . . . 1.0 109.906 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.85 -44.8 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.909 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -65.14 -46.56 80.42 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.46 -38.41 87.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.541 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.99 -47.13 84.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.139 -0.319 . . . . 1.0 110.139 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.72 -44.34 90.5 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.13 -0.628 . . . . 1.0 110.111 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.5 mm -65.94 -44.46 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 716' ' ' ALA . 79.3 m -62.95 -44.91 94.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.44 -43.58 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.472 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.593 -179.627 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 120.726 0.298 . . . . 1.0 110.317 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.62 -47.43 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.374 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 700' ' ' VAL . 29.7 m -66.62 -37.61 79.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.033 -0.667 . . . . 1.0 109.535 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 39.6 mt -63.07 -42.6 99.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.422 -0.511 . . . . 1.0 111.766 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.35 -42.76 96.07 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.366 0.603 . . . . 1.0 109.746 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 74.3 p -63.6 -34.33 77.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.21 -0.904 . . . . 1.0 109.943 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 696' ' ' VAL . 72.9 t -65.41 -45.77 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.188 0.518 . . . . 1.0 109.67 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.59 -38.57 91.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.674 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.79 99.61 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.01 85.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.762 0.315 . . . . 1.0 110.643 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.6 mt -62.77 -44.11 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.002 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.74 -42.03 99.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.091 -0.644 . . . . 1.0 110.779 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.76 -42.01 99.48 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.823 -0.351 . . . . 1.0 111.066 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.08 -41.58 93.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.597 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -71.11 -43.79 55.71 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 110.587 -1.005 . . . . 1.0 110.587 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.53 -37.42 84.97 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.873 0.469 . . . . 1.0 110.679 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.54 -62.58 0.92 Allowed Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.502 -0.772 . . . . 1.0 112.374 -177.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 20.2 Cg_endo -61.34 -34.51 87.11 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.802 1.668 . . . . 1.0 113.128 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.71 -43.18 89.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.94 -44.04 90.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.945 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.75 -44.88 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.701 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -65.24 -47.65 76.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.627 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.49 96.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.398 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 38.7 mt -63.6 -43.38 97.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.339 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 718' ' ' LEU . 85.0 mt -63.55 -44.33 94.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.298 -0.961 . . . . 1.0 109.292 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.74 -44.88 89.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.914 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 20.1 m -63.46 -45.8 89.15 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 79.3 mt -64.37 -43.1 97.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.538 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 9.6 m80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.6 -179.86 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 694' ' ' LEU . 90.9 mt . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.73 -43.99 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.3 t -63.48 -42.96 98.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.957 -1.02 . . . . 1.0 109.235 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.4 tp -62.62 -42.74 99.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.379 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.14 -43.07 96.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.331 0.586 . . . . 1.0 109.655 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.6 p -63.48 -34.55 78.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.332 -0.849 . . . . 1.0 109.81 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 696' ' ' VAL . 79.4 t -65.67 -44.76 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.55 -39.0 93.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.243 -0.889 . . . . 1.0 109.42 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.27 -41.75 99.47 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.705 -0.958 . . . . 1.0 110.705 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.72 -38.5 91.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.702 0.287 . . . . 1.0 110.898 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.05 -43.46 99.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.342 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.64 -42.61 99.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.699 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.0 -41.77 98.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.88 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.14 -42.94 98.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.42 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . 0.407 ' O ' HD13 ' A' ' 712' ' ' LEU . . . -65.91 -47.08 77.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.794 -0.922 . . . . 1.0 110.794 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.35 -36.8 79.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.868 0.467 . . . . 1.0 111.418 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.626 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -36.27 -61.39 0.6 Allowed Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.0 Cg_endo -62.79 -30.81 78.28 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.954 1.769 . . . . 1.0 113.322 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.13 -43.87 90.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.107 -0.637 . . . . 1.0 109.54 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 713' ' ' LEU . 11.2 mp -64.35 -42.93 95.99 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.216 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.79 -44.9 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.551 ' CZ2' HD13 ' A' ' 719' ' ' ILE . 66.9 t-105 -65.39 -46.48 79.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 720' ' ' THR . . . -57.89 -47.85 81.56 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.459 -0.791 . . . . 1.0 110.344 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.82 -44.25 93.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.563 -0.455 . . . . 1.0 110.789 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 82.8 mt -65.13 -45.03 86.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.431 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.551 HD13 ' CZ2' ' A' ' 715' ' ' TRP . 5.3 tp -71.4 -42.33 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.094 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 716' ' ' ALA . 67.8 p -66.7 -40.41 88.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.684 -0.807 . . . . 1.0 108.852 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.41 -40.3 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.676 0.751 . . . . 1.0 111.211 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 10.9 m80 . . . . . 0 C--N 1.321 -0.637 0 C-N-CA 119.935 -0.706 . . . . 1.0 109.67 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.2 mp . . . . . 0 CA--C 1.515 -0.398 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.12 -44.28 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.57 0.7 . . . . 1.0 109.229 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.2 t -63.71 -42.92 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.822 -1.081 . . . . 1.0 109.167 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.19 -42.94 99.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.387 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.96 -42.86 97.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.356 0.598 . . . . 1.0 109.755 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 73.4 p -63.61 -33.58 75.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.002 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.9 t -65.64 -45.22 92.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 99.0 mmm -63.57 -37.83 88.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.377 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.08 99.11 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.581 -1.008 . . . . 1.0 110.581 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.88 92.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.769 0.318 . . . . 1.0 110.72 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.56 -43.97 98.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.337 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.31 -42.79 99.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.776 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.2 -41.99 98.87 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.551 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.8 -42.84 97.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.92 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.21 -43.1 81.52 Favored Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.79 -37.31 81.86 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.939 0.496 . . . . 1.0 111.109 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.645 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -41.44 -61.57 1.36 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.592 -0.731 . . . . 1.0 112.623 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 27.6 Cg_endo -63.11 -32.95 74.63 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.766 1.644 . . . . 1.0 112.749 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 712' ' ' LEU . 90.6 mt -66.37 -43.78 84.97 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.14 -43.97 90.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.058 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . 0.48 ' O ' HD13 ' A' ' 718' ' ' LEU . 95.8 mt -64.98 -45.01 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.972 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -63.89 -46.5 84.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.48 -39.75 88.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.779 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.41 -46.33 86.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 714' ' ' ILE . 9.3 mp -64.68 -45.1 88.09 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 120.178 -0.609 . . . . 1.0 110.167 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 31.0 mm -66.28 -44.35 91.19 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 716' ' ' ALA . 78.8 m -62.83 -44.09 97.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.59 -43.59 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.789 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.5 m80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.069 -179.275 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 694' ' ' LEU . 90.8 mt . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.08 -43.73 97.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 O-C-N 123.699 0.624 . . . . 1.0 109.616 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.4 t -62.91 -43.47 98.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.614 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.23 -40.97 98.95 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.185 -0.606 . . . . 1.0 112.11 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.94 -43.24 96.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.441 0.639 . . . . 1.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 70.9 p -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.327 -0.852 . . . . 1.0 109.443 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.6 t -65.86 -45.72 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.523 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.7 ttp -62.05 -40.02 94.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.154 -0.93 . . . . 1.0 109.718 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.2 -40.67 99.28 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.71 -36.8 84.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.749 0.309 . . . . 1.0 110.479 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.64 -43.73 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.971 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.43 -41.41 98.7 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.906 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.24 -41.72 98.68 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.826 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 30.8 mm -63.43 -43.45 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.72 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.95 -46.81 64.03 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.392 -0.683 . . . . 1.0 111.392 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.39 -35.27 77.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.838 0.352 . . . . 1.0 111.123 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.647 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.47 -62.04 1.04 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 115.882 -0.599 . . . . 1.0 112.421 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.647 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 29.7 Cg_endo -63.53 -32.49 70.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.882 1.721 . . . . 1.0 112.575 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 712' ' ' LEU . 91.0 mt -65.57 -43.36 90.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.5 -43.7 93.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.794 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.71 -44.91 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.059 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.55 ' CD1' HD11 ' A' ' 719' ' ' ILE . 15.3 t-105 -65.02 -46.36 81.67 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.0 -41.91 97.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.287 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.7 mt -63.68 -43.79 95.64 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.723 -0.391 . . . . 1.0 109.991 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 718' ' ' LEU . 85.1 mt -64.38 -44.79 90.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.79 -0.764 . . . . 1.0 109.831 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.55 HD11 ' CD1' ' A' ' 715' ' ' TRP . 93.1 mt -66.27 -44.81 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 716' ' ' ALA . 99.9 m -63.66 -45.09 91.74 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.0 mm -64.23 -43.64 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.199 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.6 m80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.731 -179.695 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 698' ' ' LEU . 95.1 mt . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 65.7 t -64.92 -44.39 96.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.608 0.718 . . . . 1.0 109.204 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.753 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.1 t -63.4 -42.77 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.689 -1.141 . . . . 1.0 109.349 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.16 -44.24 97.06 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.147 0.425 . . . . 1.0 112.147 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 694' ' ' LEU . 4.5 mm? -64.38 -42.5 96.11 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -62.36 -35.38 78.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.779 . . . . 1.0 109.779 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 696' ' ' VAL . 66.3 t -66.66 -45.93 87.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.493 0.663 . . . . 1.0 109.331 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 63.4 mtt -62.83 -38.52 91.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.139 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.03 -41.2 99.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.83 84.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.665 0.269 . . . . 1.0 110.471 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.6 mt -62.84 -43.99 99.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.905 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.5 -42.1 99.27 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.056 -0.658 . . . . 1.0 110.969 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.65 -42.03 98.33 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.72 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.27 -40.79 90.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.964 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -73.27 -44.55 34.33 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.739 -0.944 . . . . 1.0 110.739 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.25 -36.83 80.05 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.629 0.372 . . . . 1.0 111.936 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.696 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -47.5 -59.79 5.05 Favored Pre-proline 0 N--CA 1.464 0.275 0 C-N-CA 120.057 -0.657 . . . . 1.0 111.405 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 35.5 Cg_exo -53.23 -40.3 77.94 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.43 1.42 . . . . 1.0 112.644 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.24 -44.67 87.45 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.563 -0.455 . . . . 1.0 109.936 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.77 -42.96 94.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.533 -0.467 . . . . 1.0 109.932 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.12 -44.74 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -65.68 -46.82 77.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.751 ' O ' HG23 ' A' ' 720' ' ' THR . . . -60.9 -41.11 95.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.29 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.479 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 35.4 mt -63.16 -44.34 95.78 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.104 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.73 -45.01 88.29 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 119.943 -0.703 . . . . 1.0 109.991 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.8 mm -66.86 -44.82 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.346 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 716' ' ' ALA . 66.5 p -67.45 -39.66 85.38 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 119.217 -0.993 . . . . 1.0 108.706 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.8 mm -64.65 -43.41 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 119.962 -0.695 . . . . 1.0 110.639 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.2 m80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.333 -0.848 . . . . 1.0 110.647 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.0 -45.04 97.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.441 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.807 ' O ' HG23 ' A' ' 700' ' ' VAL . 75.9 t -63.86 -43.11 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.052 -0.977 . . . . 1.0 109.43 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.41 -43.02 99.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.562 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.34 -43.09 95.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.222 0.534 . . . . 1.0 109.56 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 75.7 p -63.96 -34.09 77.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.793 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 696' ' ' VAL . 73.6 t -65.77 -44.69 93.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.8 mtp -63.61 -38.97 93.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.297 -0.865 . . . . 1.0 109.619 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.78 -41.85 98.74 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.12 93.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.655 0.264 . . . . 1.0 110.844 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.26 -43.83 98.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.494 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 705' ' ' LEU . 93.7 mt -62.16 -42.18 99.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.654 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.94 -42.28 99.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.875 0.369 . . . . 1.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.427 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 96.0 mt -62.23 -40.85 89.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.55 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -72.83 -42.27 46.43 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.63 -37.34 84.64 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 122.921 0.488 . . . . 1.0 111.588 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -51.17 -59.91 6.74 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 120.285 -0.566 . . . . 1.0 112.172 -176.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 43.5 Cg_exo -53.02 -41.04 74.5 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.542 1.495 . . . . 1.0 112.18 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.27 -43.93 89.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.73 -43.45 93.36 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.834 -0.432 . . . . 1.0 109.834 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.42 -44.89 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.601 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 79.5 t90 -65.72 -47.01 76.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.748 ' O ' HG23 ' A' ' 720' ' ' THR . . . -61.75 -39.13 90.54 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.933 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 60.0 tp -63.03 -45.98 89.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . 0.534 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 87.6 mt -65.13 -46.02 82.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.283 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.8 -44.46 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.284 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 716' ' ' ALA . 61.6 p -66.13 -36.13 82.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.307 -0.957 . . . . 1.0 108.605 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 2.3 mm -66.56 -39.48 84.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.976 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . 0.534 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 40.5 m80 . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 115.36 -0.837 . . . . 1.0 111.225 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 694' ' ' LEU . 94.4 mt . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.54 -45.39 98.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.63 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.732 ' O ' HG23 ' A' ' 700' ' ' VAL . 74.7 t -63.85 -43.67 97.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.446 -0.797 . . . . 1.0 109.392 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.25 -42.05 99.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.267 0.469 . . . . 1.0 112.267 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.04 -42.76 96.96 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.256 0.55 . . . . 1.0 109.806 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.9 p -63.25 -34.08 76.88 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.002 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 696' ' ' VAL . 75.7 t -65.61 -45.21 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.643 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.27 -38.1 89.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.485 -0.779 . . . . 1.0 109.775 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.3 -42.24 99.3 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.561 -1.016 . . . . 1.0 110.561 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.93 96.15 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.673 0.237 . . . . 1.0 110.675 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.74 -42.93 98.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 121.867 0.841 . . . . 1.0 110.008 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.16 -41.56 98.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.985 -0.686 . . . . 1.0 110.876 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.98 -40.52 97.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.773 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.27 -43.16 98.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.578 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.76 -46.08 62.5 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.716 -0.954 . . . . 1.0 110.716 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.29 -35.75 78.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.163 0.506 . . . . 1.0 111.185 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.06 -61.95 1.01 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.429 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.7 Cg_endo -63.04 -32.33 75.76 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.811 1.674 . . . . 1.0 112.73 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 712' ' ' LEU . 90.7 mt -66.06 -43.57 87.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.04 -43.66 91.63 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.965 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.7 -44.82 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.96 -0.564 . . . . 1.0 109.748 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.437 ' CZ2' HD11 ' A' ' 719' ' ' ILE . 76.9 t-105 -65.5 -46.56 79.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -59.73 -42.06 92.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.111 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.444 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 37.7 mt -63.63 -44.09 94.92 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.238 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.74 -45.35 86.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.956 -0.698 . . . . 1.0 110.024 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.437 HD11 ' CZ2' ' A' ' 715' ' ' TRP . 30.7 mm -66.42 -44.61 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 716' ' ' ALA . 97.6 m -63.51 -44.9 92.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.536 -0.913 . . . . 1.0 108.536 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.444 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.5 -43.13 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.666 -0.697 . . . . 1.0 111.3 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 8.2 m80 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.755 -179.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.448 -0.572 0 N-CA-C 109.333 -0.618 . . . . 1.0 109.333 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.05 -45.15 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.382 0.611 . . . . 1.0 109.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 700' ' ' VAL . 76.4 t -64.11 -42.99 97.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.995 -1.002 . . . . 1.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 51.7 tp -62.61 -43.03 99.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.71 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.99 -43.02 96.94 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.259 0.552 . . . . 1.0 109.748 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.6 p -63.23 -34.32 77.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.856 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.4 t -65.44 -45.3 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.638 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.9 mmm -63.93 -37.98 89.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.441 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.49 -42.38 98.98 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.546 -1.022 . . . . 1.0 110.546 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.3 90.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.713 0.292 . . . . 1.0 110.866 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.94 -43.55 99.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.472 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.33 -42.19 99.18 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.784 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.0 mt -62.89 -41.51 99.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.354 . . . . 1.0 110.705 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.3 -43.25 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.291 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.86 -43.57 73.44 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.49 -37.14 82.41 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 122.879 0.472 . . . . 1.0 110.954 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -41.45 -61.96 1.23 Allowed Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.782 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.4 Cg_endo -63.27 -33.09 72.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.782 1.654 . . . . 1.0 112.672 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.19 -43.95 85.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.45 -44.21 87.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.155 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.18 -44.68 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.282 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.577 ' NE1' HD11 ' A' ' 719' ' ' ILE . 58.3 t-105 -66.08 -46.54 77.34 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.54 -37.98 85.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.848 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 721' ' ' ILE . 58.6 tp -63.54 -44.15 95.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . 0.557 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 84.4 mt -64.63 -43.62 93.13 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.577 HD11 ' NE1' ' A' ' 715' ' ' TRP . 97.9 mt -65.25 -41.74 92.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 CA-C-O 123.64 1.686 . . . . 1.0 107.962 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 716' ' ' ALA . 99.0 m -68.29 -41.23 81.28 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 117.978 -1.489 . . . . 1.0 108.629 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.2 mm -64.71 -44.13 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 119.802 -0.759 . . . . 1.0 111.339 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 43.1 m80 . . . . . 0 N--CA 1.466 0.335 0 CA-C-N 115.274 -0.876 . . . . 1.0 110.442 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 698' ' ' LEU . 11.0 mp . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.73 -45.47 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.798 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.3 t -64.04 -43.38 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.165 -0.925 . . . . 1.0 109.156 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.65 -43.71 98.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.841 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 694' ' ' LEU . 9.9 mp -64.44 -42.56 95.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.136 0.493 . . . . 1.0 109.7 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 78.0 p -63.21 -34.8 78.42 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.883 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 696' ' ' VAL . 74.2 t -65.63 -45.43 92.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.2 ttp -62.05 -39.56 92.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.587 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.96 -42.43 98.29 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.898 -0.881 . . . . 1.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.92 95.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.586 0.231 . . . . 1.0 110.716 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.37 -44.04 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.399 -0.521 . . . . 1.0 110.36 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.25 -43.09 99.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.714 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.8 -41.19 99.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.153 0.502 . . . . 1.0 111.855 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.7 -39.98 87.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.351 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.41 -42.88 63.7 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.612 -0.995 . . . . 1.0 110.612 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . 0.411 HD23 HD12 ' A' ' 712' ' ' LEU . 96.7 mt -67.47 -37.88 83.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.278 0.561 . . . . 1.0 110.631 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.622 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -36.55 -62.31 0.54 Allowed Pre-proline 0 C--N 1.333 -0.118 0 CA-C-N 115.618 -0.719 . . . . 1.0 112.096 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.622 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.0 Cg_endo -62.03 -31.19 83.78 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.654 1.569 . . . . 1.0 113.256 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . 0.411 HD12 HD23 ' A' ' 709' ' ' LEU . 90.1 mt -65.72 -44.11 87.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.48 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 713' ' ' LEU . 11.2 mp -64.29 -42.84 96.21 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.293 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.95 -44.9 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -65.91 -45.91 80.23 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.273 -0.639 . . . . 1.0 109.273 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 720' ' ' THR . . . -57.96 -47.65 82.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.372 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.462 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 83.1 mt -64.26 -43.73 93.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.75 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.06 -44.89 87.52 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.139 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 5.1 tp -71.4 -41.88 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 108.925 -0.769 . . . . 1.0 108.925 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 716' ' ' ALA . 96.9 m -63.6 -44.86 92.78 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.42 -43.33 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.021 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.294 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 698' ' ' LEU . 89.9 mt . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.9 t -63.23 -45.2 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.322 0.582 . . . . 1.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.4 t -63.9 -43.17 97.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.48 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 40.4 mt -62.84 -42.48 99.76 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.497 -0.481 . . . . 1.0 112.057 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 694' ' ' LEU . 9.8 mp -64.26 -42.61 96.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.25 0.548 . . . . 1.0 109.805 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -63.28 -34.61 78.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.893 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 696' ' ' VAL . 71.6 t -65.44 -45.65 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.695 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 99.0 mmm -64.94 -37.51 87.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.644 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.38 -43.14 99.49 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.86 77.69 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.092 -0.643 . . . . 1.0 110.823 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.96 -43.11 98.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.062 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.83 -42.08 99.58 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.088 -0.645 . . . . 1.0 111.892 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.79 -40.27 96.25 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.648 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.425 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 36.8 mm -64.55 -34.14 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.858 0.361 . . . . 1.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -77.5 -43.94 14.22 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.021 -1.085 . . . . 1.0 111.024 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.26 -36.56 81.84 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.76 0.424 . . . . 1.0 111.969 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.716 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -50.72 -60.04 6.23 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.079 -0.649 . . . . 1.0 111.768 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 42.8 Cg_exo -53.07 -41.29 72.83 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.296 1.331 . . . . 1.0 112.113 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.31 -44.12 88.89 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.59 -43.46 93.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.607 -0.437 . . . . 1.0 110.007 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.58 -44.79 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.7 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.565 ' CE2' HD11 ' A' ' 719' ' ' ILE . 12.7 t90 -66.33 -46.12 77.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.862 ' O ' HG23 ' A' ' 720' ' ' THR . . . -61.82 -38.59 88.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.661 -0.7 . . . . 1.0 109.655 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.09 -45.56 91.54 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . 0.533 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 86.7 mt -63.59 -43.36 97.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.23 -0.588 . . . . 1.0 109.499 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.565 HD11 ' CE2' ' A' ' 715' ' ' TRP . 92.2 mt -64.63 -44.26 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.862 HG23 ' O ' ' A' ' 716' ' ' ALA . 74.3 p -64.12 -41.21 97.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.042 -1.063 . . . . 1.0 108.404 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 81.7 mt -64.46 -43.4 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 119.57 -0.852 . . . . 1.0 111.706 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 52.0 m80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.547 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.75 -45.1 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.298 -0.63 . . . . 1.0 109.298 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.0 t -64.05 -43.15 97.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.961 -1.018 . . . . 1.0 109.282 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.49 -42.99 99.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.598 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.32 -43.17 95.52 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.183 0.516 . . . . 1.0 109.671 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -63.28 -34.95 78.79 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.825 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 696' ' ' VAL . 74.7 t -65.81 -45.39 91.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.0 ttp -61.92 -39.42 91.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.136 -0.938 . . . . 1.0 109.571 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.53 -40.78 99.56 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.41 87.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.497 0.189 . . . . 1.0 111.016 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 31.6 mm -62.95 -44.12 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.434 -0.507 . . . . 1.0 110.771 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.71 -41.98 99.42 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.932 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.29 -42.53 99.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.811 0.339 . . . . 1.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.43 -43.25 98.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.197 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 712' ' ' LEU . . . -68.52 -43.9 75.02 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.42 -36.88 82.14 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.869 0.468 . . . . 1.0 111.115 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.64 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.12 -62.19 0.96 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.83 -0.623 . . . . 1.0 112.435 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 22.4 Cg_endo -62.02 -33.65 82.5 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.657 1.571 . . . . 1.0 113.036 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.66 -42.94 90.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 177.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.45 -43.69 93.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.883 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.78 -44.9 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.888 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -65.96 -45.96 79.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -55.46 -47.65 75.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.275 -0.875 . . . . 1.0 109.857 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 40.3 mt -63.69 -43.3 97.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.539 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.44 -44.89 89.72 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 120.171 -0.611 . . . . 1.0 111.243 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 719' ' ' ILE . 14.1 pt -73.17 -41.85 58.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 94.8 m -64.14 -43.55 94.88 Favored 'General case' 0 C--O 1.265 1.876 0 CA-C-O 122.346 1.07 . . . . 1.0 108.616 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.0 -44.43 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 117.802 -1.559 . . . . 1.0 111.702 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 10.3 m80 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.083 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.89 -43.29 93.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.806 0.812 . . . . 1.0 109.571 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.795 ' O ' HG23 ' A' ' 700' ' ' VAL . 71.1 t -66.05 -39.74 85.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.48 -1.236 . . . . 1.0 109.693 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.98 -43.05 96.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.833 -0.621 . . . . 1.0 111.684 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -65.36 -42.23 92.98 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.319 -0.622 . . . . 1.0 109.319 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 59.3 p -62.98 -35.05 78.91 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.678 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 696' ' ' VAL . 75.5 t -66.44 -44.53 90.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.333 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 5.7 ttp -61.89 -39.26 91.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.29 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.92 -41.67 98.62 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.13 96.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.775 0.321 . . . . 1.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.0 -43.72 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.26 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.41 -42.32 99.35 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.659 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.58 -42.38 99.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 1.0 110.446 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.23 -43.35 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.62 -44.88 69.31 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.414 -1.074 . . . . 1.0 110.414 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.05 -38.04 82.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.138 0.494 . . . . 1.0 110.99 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -37.13 -61.77 0.65 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.726 -0.67 . . . . 1.0 112.315 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.0 Cg_endo -62.79 -31.25 78.35 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.764 1.643 . . . . 1.0 113.192 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 712' ' ' LEU . 91.2 mt -65.5 -44.45 86.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.3 -0.56 . . . . 1.0 109.525 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 713' ' ' LEU . 11.2 mp -64.45 -42.84 95.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.099 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.26 -45.09 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 120.297 -0.561 . . . . 1.0 109.872 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.568 ' CD2' HD11 ' A' ' 719' ' ' ILE . 1.5 t90 -65.98 -46.53 77.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.15 -43.4 95.76 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.352 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 721' ' ' ILE . 38.0 mt -63.39 -43.95 96.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.297 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.58 -44.57 90.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.749 -0.78 . . . . 1.0 109.679 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.568 HD11 ' CD2' ' A' ' 715' ' ' TRP . 93.3 mt -66.32 -45.01 90.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.756 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 716' ' ' ALA . 97.3 m -63.84 -44.74 92.28 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.0 mm -64.18 -43.59 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.984 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 9.6 m80 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.545 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.0 mp . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.86 -45.42 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-O 121.42 0.629 . . . . 1.0 109.734 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 699' ' ' SER . 79.3 t -64.29 -43.08 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.001 -1.0 . . . . 1.0 109.382 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 51.9 tp -61.93 -42.47 99.13 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.87 -0.605 . . . . 1.0 112.031 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.19 -42.15 89.22 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.178 0.513 . . . . 1.0 110.926 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 68.8 p -61.73 -39.39 91.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.445 -0.798 . . . . 1.0 111.633 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.27 -40.31 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 119.67 -0.812 . . . . 1.0 109.498 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 56.0 ttp -61.23 -39.5 90.52 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.2 -40.81 98.33 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 110.595 -1.002 . . . . 1.0 110.595 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.52 91.37 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.689 -0.404 . . . . 1.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.96 -44.52 99.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 120.452 -0.499 . . . . 1.0 110.272 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.21 -43.16 99.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.628 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.58 -40.29 96.43 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.75 0.31 . . . . 1.0 111.142 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.455 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 85.2 mt -62.28 -41.54 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.84 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.31 -44.71 64.17 Favored Glycine 0 N--CA 1.471 0.996 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 8.9 mp -69.07 -35.47 76.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.501 -0.35 . . . . 1.0 111.936 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.678 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -50.5 -59.83 6.52 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 119.445 -0.902 . . . . 1.0 111.644 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 38.7 Cg_exo -53.16 -41.04 74.99 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.538 1.492 . . . . 1.0 112.308 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.52 -44.07 88.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.499 -0.556 . . . . 1.0 109.499 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.6 -43.82 92.6 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.475 -0.49 . . . . 1.0 109.876 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . 0.424 ' O ' HD13 ' A' ' 718' ' ' LEU . 95.5 mt -64.53 -44.84 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.483 ' CZ2' HD11 ' A' ' 719' ' ' ILE . 68.9 t-105 -63.76 -45.84 87.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.979 -0.748 . . . . 1.0 108.979 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.52 86.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.999 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.9 mt -63.16 -43.7 97.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.426 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 714' ' ' ILE . 8.8 mp -63.86 -43.93 94.62 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.413 -0.915 . . . . 1.0 109.021 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.483 HD11 ' CZ2' ' A' ' 715' ' ' TRP . 30.1 mm -65.11 -45.24 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.7 m -64.92 -46.61 80.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.953 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 717' ' ' LEU . 82.7 mt -65.52 -44.19 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . 0.453 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 1.7 p-80 . . . . . 0 N--CA 1.467 0.39 0 C-N-CA 119.799 -0.76 . . . . 1.0 110.512 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 694' ' ' LEU . 94.0 mt . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.81 -45.09 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.772 0.796 . . . . 1.0 109.334 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.764 ' O ' HG23 ' A' ' 700' ' ' VAL . 76.2 t -63.32 -43.09 98.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.207 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.26 -43.04 99.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.642 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.04 -43.19 96.29 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.143 0.497 . . . . 1.0 109.724 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 72.8 p -63.4 -34.61 78.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.466 -0.788 . . . . 1.0 109.883 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 696' ' ' VAL . 73.1 t -65.67 -45.27 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 53.4 ttp -61.71 -39.91 93.17 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.345 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.42 -42.42 99.06 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.28 92.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.834 0.826 . . . . 1.0 110.341 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.12 -43.76 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 119.763 -0.775 . . . . 1.0 109.943 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.05 -43.81 98.03 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.94 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.54 -41.2 98.73 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.631 0.253 . . . . 1.0 110.598 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.43 -43.0 98.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.31 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.39 -40.84 94.63 Favored Glycine 0 N--CA 1.468 0.783 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.06 -35.15 76.23 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.715 0.406 . . . . 1.0 111.757 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -48.62 -60.54 4.39 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.201 -0.6 . . . . 1.0 111.862 -177.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 39.3 Cg_exo -53.49 -41.44 73.3 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.235 1.29 . . . . 1.0 112.529 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -64.68 -43.3 94.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.631 -0.428 . . . . 1.0 109.891 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.43 -43.9 92.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.403 -0.519 . . . . 1.0 110.249 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.69 -44.77 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.41 ' O ' HD13 ' A' ' 719' ' ' ILE . 85.6 t90 -64.35 -48.65 74.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.438 -0.579 . . . . 1.0 109.438 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -58.76 -41.74 87.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.987 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 37.2 mt -63.69 -44.17 94.47 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.731 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 718' ' ' LEU . 88.7 mt -64.47 -45.43 87.39 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.796 -0.762 . . . . 1.0 110.034 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.535 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 1.7 mp -66.78 -45.3 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.11 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 716' ' ' ALA . 98.8 m -64.87 -45.95 83.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.11 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.61 -43.97 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.156 0.799 . . . . 1.0 113.156 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 1.9 p-80 . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 119.306 -0.958 . . . . 1.0 110.266 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.73 -44.82 98.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.755 ' O ' HG23 ' A' ' 700' ' ' VAL . 75.6 t -64.06 -43.56 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.643 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.37 -41.89 98.83 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.276 0.472 . . . . 1.0 112.276 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.88 -42.87 97.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.325 0.583 . . . . 1.0 109.728 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.2 p -64.04 -34.05 77.15 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.253 -0.885 . . . . 1.0 109.801 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 696' ' ' VAL . 72.5 t -65.54 -45.55 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.659 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.9 mmm -64.52 -38.48 91.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.629 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.59 -41.2 99.53 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.456 -1.058 . . . . 1.0 110.456 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.78 84.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.806 0.336 . . . . 1.0 110.555 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.7 mt -62.8 -43.92 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.454 -0.499 . . . . 1.0 110.954 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.51 -42.02 99.22 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.185 -0.606 . . . . 1.0 110.743 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.25 -42.44 99.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 1.0 110.551 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.35 -43.27 98.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.229 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.83 -43.81 72.53 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.718 -0.953 . . . . 1.0 110.718 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.41 -37.38 82.97 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 122.79 0.436 . . . . 1.0 111.067 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.645 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.28 -62.2 0.98 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.602 -0.726 . . . . 1.0 112.529 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.2 Cg_endo -63.24 -32.85 73.22 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.672 1.581 . . . . 1.0 112.573 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 712' ' ' LEU . 89.4 mt -66.01 -43.52 87.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.1 -43.89 90.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.087 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.7 mt -64.03 -44.58 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.751 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.514 ' CZ2' HD11 ' A' ' 719' ' ' ILE . 76.0 t-105 -65.26 -46.46 80.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -58.16 -43.89 87.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.125 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 721' ' ' ILE . 80.2 mt -63.85 -42.89 97.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.633 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.1 -44.37 89.04 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.693 -0.803 . . . . 1.0 109.733 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.548 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.5 mm -66.37 -45.39 89.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.881 -0.785 . . . . 1.0 108.881 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 716' ' ' ALA . 38.3 m -64.69 -44.64 89.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.14 -0.936 . . . . 1.0 110.912 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 717' ' ' LEU . 81.0 mt -67.26 -41.73 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 112.991 0.738 . . . . 1.0 112.991 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . 0.548 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 2.6 p-80 . . . . . 0 C--N 1.313 -0.992 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.191 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 694' ' ' LEU . 90.9 mt . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.0 -43.92 96.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.812 ' O ' HG23 ' A' ' 700' ' ' VAL . 76.4 t -63.62 -42.99 97.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.189 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.33 -42.91 99.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.351 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.96 -43.28 96.25 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.294 0.569 . . . . 1.0 109.572 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 76.4 p -63.72 -34.44 77.88 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.352 -0.84 . . . . 1.0 109.893 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.3 t -65.47 -45.06 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.6 ttp -61.76 -39.69 92.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.252 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.74 99.35 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.427 -1.069 . . . . 1.0 110.427 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.74 -36.23 82.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.713 0.292 . . . . 1.0 110.418 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.85 -44.1 99.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.551 -0.459 . . . . 1.0 110.757 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.4 -42.07 98.77 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.653 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 51.7 tp -62.48 -43.99 97.47 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.403 0.52 . . . . 1.0 112.403 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 21.2 tt -67.28 -38.41 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.211 -0.596 . . . . 1.0 111.749 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 712' ' ' LEU . . . -68.2 -44.97 73.69 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.35 -35.28 77.51 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.954 0.502 . . . . 1.0 111.07 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.642 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -41.03 -61.87 1.18 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.925 -0.58 . . . . 1.0 112.559 -177.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 23.1 Cg_endo -62.15 -33.07 82.89 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.756 1.637 . . . . 1.0 112.918 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.36 -43.17 91.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 177.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.76 -44.13 91.07 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.085 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.5 mm -64.85 -44.72 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 80.8 t90 -65.74 -47.03 76.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.25 95.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.255 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.7 mt -63.07 -43.11 99.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.714 -0.395 . . . . 1.0 110.236 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . 0.432 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 85.3 mt -64.17 -44.91 90.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.81 -0.756 . . . . 1.0 109.515 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.37 -45.25 89.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.774 -0.648 . . . . 1.0 109.642 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.7 m -64.29 -44.17 92.52 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.4 mm -64.59 -42.23 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.943 0.878 . . . . 1.0 110.819 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . 0.432 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 11.7 m80 . . . . . 0 CA--C 1.553 1.067 0 CA-C-N 114.995 -1.002 . . . . 1.0 110.487 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.0 mp . . . . . 0 C--O 1.245 0.86 0 CA-C-O 122.09 0.948 . . . . 1.0 109.579 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -44.49 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.31 -0.859 . . . . 1.0 109.229 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.791 ' O ' HG23 ' A' ' 700' ' ' VAL . 73.5 t -63.13 -43.52 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.115 -0.948 . . . . 1.0 109.609 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.31 -42.08 98.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.993 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.05 -43.16 96.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.282 0.563 . . . . 1.0 109.581 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 78.0 p -63.65 -34.82 78.68 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.661 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 696' ' ' VAL . 73.3 t -65.39 -45.35 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.2 ttp -61.86 -39.73 92.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.334 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.69 -42.37 98.69 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.745 -0.942 . . . . 1.0 110.745 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.91 96.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.636 0.255 . . . . 1.0 111.376 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.49 -41.56 92.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 82.0 mt -61.67 -42.05 98.38 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.979 -0.688 . . . . 1.0 110.446 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.82 -41.6 99.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.752 0.311 . . . . 1.0 111.199 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.404 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 31.1 mm -63.46 -43.2 98.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.371 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.55 -42.27 81.53 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 110.956 -0.857 . . . . 1.0 110.956 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.5 mt -68.3 -35.86 78.47 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.974 0.51 . . . . 1.0 111.74 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.699 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -49.59 -60.37 5.08 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.091 -0.644 . . . . 1.0 111.921 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 38.5 Cg_exo -53.76 -40.93 78.13 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.443 1.429 . . . . 1.0 112.399 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.19 -44.16 89.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.0 -43.61 91.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.563 -0.455 . . . . 1.0 109.928 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.7 -44.76 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.837 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -66.51 -46.86 74.84 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.41 -40.07 89.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.843 -0.617 . . . . 1.0 109.703 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 59.2 tp -63.64 -46.21 86.7 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.66 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 718' ' ' LEU . 86.5 mt -64.19 -44.36 92.23 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.248 -0.581 . . . . 1.0 109.935 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.3 mm -65.82 -43.95 93.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 716' ' ' ALA . 95.4 m -62.58 -45.24 93.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.35 -43.32 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 119.742 -0.783 . . . . 1.0 111.754 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.0 m80 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.542 -179.615 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 694' ' ' LEU . 92.1 mt . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 109.219 -0.659 . . . . 1.0 109.219 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 69.5 t -64.45 -45.2 96.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.503 0.668 . . . . 1.0 109.489 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.803 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.3 t -64.32 -43.06 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.955 -1.02 . . . . 1.0 109.336 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.2 -43.16 99.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.802 -0.635 . . . . 1.0 111.594 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.13 -43.0 96.62 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.423 0.63 . . . . 1.0 109.562 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 74.1 p -64.08 -34.38 77.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.231 -0.895 . . . . 1.0 109.782 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 696' ' ' VAL . 74.5 t -65.2 -45.17 94.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 61.3 mtt -63.45 -38.48 91.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.439 -0.8 . . . . 1.0 109.348 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.12 -41.68 99.69 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.232 -1.147 . . . . 1.0 110.232 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.66 94.61 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.636 0.255 . . . . 1.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 707' ' ' ILE . 97.5 mt -62.37 -43.91 98.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.59 0.71 . . . . 1.0 110.053 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.99 -43.34 99.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.601 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.06 -43.17 99.41 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.285 0.476 . . . . 1.0 112.285 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 704' ' ' ILE . 14.6 tt -65.33 -31.93 56.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.045 -0.662 . . . . 1.0 111.176 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.94 -45.75 71.35 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.624 -0.991 . . . . 1.0 110.624 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.68 -36.87 81.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 1.0 111.266 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -37.78 -62.05 0.69 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.982 -0.554 . . . . 1.0 112.311 -177.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 27.2 Cg_endo -62.57 -31.65 79.85 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.924 1.749 . . . . 1.0 112.502 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.8 -43.72 71.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.504 -0.479 . . . . 1.0 109.928 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.17 -45.05 86.48 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.935 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 715' ' ' TRP . 20.4 tt -70.26 -41.96 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 119.873 -0.731 . . . . 1.0 109.704 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . 0.446 ' N ' HG23 ' A' ' 714' ' ' ILE . 78.7 t90 -63.7 -47.28 81.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.887 -0.782 . . . . 1.0 108.887 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.95 85.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.17 -45.44 91.81 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.545 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.16 -44.2 89.3 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 121.298 0.571 . . . . 1.0 109.895 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . 0.56 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.2 mm -65.05 -44.41 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 98.9 m -63.91 -45.9 87.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.443 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 3.7 mm -65.89 -43.99 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 113.826 1.047 . . . . 1.0 113.826 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . 0.56 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 2.2 p-80 . . . . . 0 C--N 1.328 -0.353 0 C-N-CA 119.782 -0.767 . . . . 1.0 110.754 -178.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.6 t -63.72 -45.41 97.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.989 -0.55 . . . . 1.0 109.876 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.422 ' O ' ' OG ' ' A' ' 699' ' ' SER . 74.6 t -64.01 -43.52 97.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.329 -0.85 . . . . 1.0 109.852 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.92 -41.13 99.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.046 -0.525 . . . . 1.0 112.184 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.38 -42.27 88.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.238 0.542 . . . . 1.0 110.852 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.3 p -62.07 -39.63 93.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.68 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 16.2 m -69.82 -41.39 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 119.386 -0.926 . . . . 1.0 109.632 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.22 -39.0 88.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.92 -40.55 99.01 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.66 -36.87 82.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.511 0.196 . . . . 1.0 111.006 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 38.6 mm -60.93 -44.02 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 122.293 1.044 . . . . 1.0 109.547 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 46.4 tp -64.23 -44.21 92.59 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.674 -1.266 . . . . 1.0 112.404 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.06 -41.18 99.41 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 45.2 pt -65.38 -38.69 83.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.482 -0.487 . . . . 1.0 111.62 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.13 -40.98 92.82 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.414 -1.074 . . . . 1.0 110.414 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 97.0 mt -68.58 -35.27 77.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.42 -0.39 . . . . 1.0 111.505 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 710' ' ' ALA . . . . . 0.688 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -48.67 -60.91 3.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.03 -0.668 . . . . 1.0 112.075 -176.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 711' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 39.9 Cg_exo -53.88 -40.63 79.79 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.351 1.367 . . . . 1.0 112.35 178.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.34 -43.85 89.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.78 -43.94 91.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.236 178.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.82 -44.69 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -65.23 -47.77 75.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 716' ' ' ALA . . . . . 0.76 ' O ' HG23 ' A' ' 720' ' ' THR . . . -61.96 -39.43 92.12 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.096 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.412 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 60.8 tp -62.97 -46.47 87.56 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.93 -44.86 88.1 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.133 -0.627 . . . . 1.0 110.282 178.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.5 mm -66.62 -44.4 89.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.426 179.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 716' ' ' ALA . 57.4 p -65.71 -39.79 91.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.412 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.96 -43.29 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 120.015 -0.674 . . . . 1.0 110.986 178.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.624 -0.716 . . . . 1.0 110.294 -179.844 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 CA--C 1.517 -0.332 0 N-CA-C 108.356 -1.44 . . . . 15.1 108.356 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . 0.632 ' O ' ' C ' ' A' ' 687' ' ' SER . 0.0 OUTLIER -80.2 27.86 0.32 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 118.235 -0.888 . . . . 15.289999999999999 111.374 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.632 ' C ' ' O ' ' A' ' 686' ' ' GLU . 2.6 t -37.25 134.52 0.71 Allowed Pre-proline 0 C--N 1.378 1.811 0 N-CA-C 100.882 -3.747 . . . . 12.09 100.882 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . 0.607 ' C ' ' O ' ' A' ' 687' ' ' SER . 80.2 Cg_exo -40.62 118.7 0.64 Allowed 'Trans proline' 0 C--N 1.302 -1.889 0 CA-C-N 123.062 2.129 . . . . 10.02 110.06 -169.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . 0.566 ' NZ ' ' CB ' ' A' ' 689' ' ' LYS . 0.0 OUTLIER -74.17 -2.68 25.74 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 112.153 -2.294 . . . . 9.5199999999999996 106.941 -176.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.508 ' O ' ' C ' ' A' ' 691' ' ' PRO . . . -115.86 62.57 0.36 Allowed Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 105.144 -3.182 . . . . 5.1500000000000004 105.144 172.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.691 ' HG2' HD12 ' A' ' 694' ' ' LEU . 15.0 Cg_exo -51.38 126.17 18.58 Favored 'Trans proline' 0 CA--C 1.485 -1.952 1 N-CA-C 98.717 -5.147 . . . . 4.3200000000000003 98.717 177.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.738 ' O ' HG23 ' A' ' 696' ' ' VAL . 67.4 m-20 -65.56 -22.22 66.68 Favored 'General case' 0 N--CA 1.406 -2.635 0 N-CA-C 106.107 -1.812 . . . . 2.1299999999999999 106.107 -175.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 697' ' ' LEU . 50.2 mt -65.45 -55.21 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 114.95 -1.023 . . . . 1.25 111.662 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.691 HD12 ' HG2' ' A' ' 691' ' ' PRO . 21.0 mt -62.92 -43.83 97.74 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.728 -0.471 . . . . 0.93999999999999995 109.728 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 91.4 t -67.3 -45.31 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 108.448 -0.945 . . . . 0.17999999999999999 108.448 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.8 ' O ' HG23 ' A' ' 700' ' ' VAL . 71.6 t -64.51 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.342 -0.985 . . . . 0.59999999999999998 108.342 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 693' ' ' ILE . 17.7 tp -60.69 -43.61 97.54 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.576 -0.284 . . . . 1.6399999999999999 111.321 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 72.5 mt -66.46 -46.6 75.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.064 -0.717 . . . . 1.1000000000000001 109.064 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 80.0 p -61.4 -36.78 81.24 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.415 -0.587 . . . . 0.17000000000000001 109.415 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 696' ' ' VAL . 41.0 t -65.65 -46.92 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 107.977 -1.12 . . . . 0.81999999999999995 107.977 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 6.3 mtp -59.94 -35.55 75.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.344 -0.984 . . . . 2.4500000000000002 108.344 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -67.79 -44.07 81.63 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.57 -1.012 . . . . 0.14000000000000001 110.57 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.72 96.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.14000000000000001 110.232 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.67 -44.68 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.829 -0.748 . . . . 0.72999999999999998 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.68 -44.49 96.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.89 -0.324 . . . . 1.6799999999999999 110.374 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.99 -42.03 97.61 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.045 0.45 . . . . 1.8200000000000001 110.259 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 89.2 mt -62.77 -41.5 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.804 -0.635 . . . . 1.3700000000000001 111.021 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.29 -40.61 87.31 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.654 -0.978 . . . . 0.17000000000000001 110.654 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 17.8 mt -77.68 -25.18 49.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 117.39 0.595 . . . . 1.3600000000000001 110.693 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -48.44 -60.7 4.06 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.34999999999999998 111.978 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 43.0 Cg_endo -66.73 -30.81 40.97 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.875 1.716 . . . . 0.40000000000000002 112.354 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 716' ' ' ALA . 19.2 mt -68.04 -42.84 79.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 61.0 mt -65.4 -44.52 87.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.839 -0.43 . . . . 0.95999999999999996 109.839 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.65 -46.33 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.376 -0.602 . . . . 1.0900000000000001 109.376 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.815 ' CH2' HD11 ' A' ' 719' ' ' ILE . 8.7 t-105 -63.39 -47.35 82.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.442 -1.318 . . . . 3.4199999999999999 107.442 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -56.24 -43.51 78.71 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.853 -0.612 . . . . 0.20999999999999999 109.904 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.498 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 6.3 mt -64.48 -42.66 95.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.643 -0.253 . . . . 1.5800000000000001 110.54 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 722' ' ' HIS . 80.6 mt -65.18 -45.6 84.21 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.212 -1.033 . . . . 0.88 108.212 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.815 HD11 ' CH2' ' A' ' 715' ' ' TRP . 12.7 mm -65.55 -46.96 88.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 N-CA-C 108.825 -0.806 . . . . 1.3999999999999999 108.825 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 716' ' ' ALA . 31.8 m -60.35 -42.23 95.3 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.393 -1.336 . . . . 1.0900000000000001 107.393 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.498 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 1.3 mm -65.67 -43.58 93.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.83 -0.748 . . . . 1.0700000000000001 111.392 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 718' ' ' LEU . 46.6 m80 -76.1 -41.26 50.88 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 115.334 -0.848 . . . . 2.4900000000000002 109.311 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.723 ' N ' ' O ' ' A' ' 719' ' ' ILE . 11.5 t0 -70.39 -52.65 20.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.979 -1.119 . . . . 2.6000000000000001 107.979 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 720' ' ' THR . 10.8 ttp85 -68.88 148.07 50.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 102.296 -3.224 . . . . 7.6100000000000003 102.296 173.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 726' ' ' GLU . 0.0 OUTLIER -167.63 -4.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.104 -1.438 . . . . 8.4399999999999995 109.74 -175.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . 0.546 ' CB ' ' O ' ' A' ' 725' ' ' LYS . 60.4 tt0 101.66 172.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.673 -1.232 . . . . 8.6300000000000008 107.673 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 726' ' ' GLU . 2.8 m-85 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.09 -0.957 . . . . 11.470000000000001 109.51 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo . . . . . 0 N--CA 1.484 0.927 0 N-CA-C 109.829 -0.874 . . . . 1.0 109.829 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.89 -38.06 87.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.97 0.414 . . . . 1.0 110.333 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.543 ' H ' ' HD2' ' A' ' 688' ' ' PRO . 0.0 OUTLIER -164.78 -48.15 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.674 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . 0.543 ' HD2' ' H ' ' A' ' 687' ' ' SER . 21.8 Cg_exo -62.54 145.67 95.43 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.049 1.832 . . . . 1.0 111.498 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.08 144.9 50.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.672 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.524 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -97.25 -47.78 2.14 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.273 -0.731 . . . . 1.0 111.273 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 52.3 Cg_exo -54.15 -38.06 87.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.669 2.246 . . . . 1.0 112.346 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -81.34 106.09 13.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.617 0.722 . . . . 1.0 110.757 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.04 -43.17 92.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.732 -1.122 . . . . 1.0 110.965 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.13 -38.69 89.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.297 -0.865 . . . . 1.0 109.99 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.17 -44.77 97.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.162 0.506 . . . . 1.0 109.826 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.776 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.7 t -63.81 -43.79 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.375 -0.829 . . . . 1.0 109.583 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.1 -41.93 99.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.939 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.14 -42.96 96.58 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.294 0.569 . . . . 1.0 110.018 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 67.2 p -63.78 -34.9 78.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.33 -0.85 . . . . 1.0 109.94 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 696' ' ' VAL . 77.9 t -65.27 -44.85 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.27 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 60.9 mtt -63.22 -39.16 93.83 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.346 -0.843 . . . . 1.0 109.49 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.27 99.35 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.35 97.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.633 0.254 . . . . 1.0 111.075 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.37 -44.06 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.414 -0.515 . . . . 1.0 110.684 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.52 -42.7 99.21 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.538 -0.301 . . . . 1.0 111.315 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.57 -40.35 96.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.284 0.564 . . . . 1.0 111.162 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.02 -42.84 96.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.941 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.95 -40.12 89.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.01 -35.21 76.4 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 122.707 0.403 . . . . 1.0 111.536 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.683 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -49.61 -60.56 4.75 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 120.233 -0.587 . . . . 1.0 111.926 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 40.4 Cg_exo -53.49 -41.08 76.09 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.122 1.215 . . . . 1.0 112.434 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.23 -44.1 89.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.686 -0.487 . . . . 1.0 109.686 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 713' ' ' LEU . 87.0 mt -65.19 -43.79 90.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.093 0.473 . . . . 1.0 109.906 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.85 -44.8 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.909 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -65.14 -46.56 80.42 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.46 -38.41 87.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.541 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.99 -47.13 84.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.139 -0.319 . . . . 1.0 110.139 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.72 -44.34 90.5 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.13 -0.628 . . . . 1.0 110.111 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.5 mm -65.94 -44.46 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 716' ' ' ALA . 79.3 m -62.95 -44.91 94.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.44 -43.58 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.472 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -60.37 -39.41 87.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.593 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -77.24 141.77 39.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.996 0.427 . . . . 1.0 110.561 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -96.93 136.53 37.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.224 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -102.77 145.56 29.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.508 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.99 -38.97 89.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.496 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.915 -1.04 . . . . 1.0 110.515 -179.935 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.484 0.957 0 N-CA-C 109.528 -0.989 . . . . 1.0 109.528 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.94 -38.87 89.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.446 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 43.7 t -143.58 73.19 17.34 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -61.55 145.23 97.97 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.819 2.346 . . . . 1.0 112.034 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -67.74 133.91 50.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.517 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.441 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . -172.14 -52.7 0.04 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.026 -0.83 . . . . 1.0 111.026 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 22.3 Cg_exo -61.62 145.14 97.86 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.565 2.177 . . . . 1.0 111.922 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -95.29 -6.03 42.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.306 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 47.1 mm -67.93 -43.61 85.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.835 0.826 . . . . 1.0 109.975 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.83 -39.32 93.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.698 -1.137 . . . . 1.0 110.317 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.62 -47.43 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.374 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 700' ' ' VAL . 29.7 m -66.62 -37.61 79.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.033 -0.667 . . . . 1.0 109.535 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 39.6 mt -63.07 -42.6 99.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.422 -0.511 . . . . 1.0 111.766 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.35 -42.76 96.07 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.366 0.603 . . . . 1.0 109.746 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 74.3 p -63.6 -34.33 77.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.21 -0.904 . . . . 1.0 109.943 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 696' ' ' VAL . 72.9 t -65.41 -45.77 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.188 0.518 . . . . 1.0 109.67 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.59 -38.57 91.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.674 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.79 99.61 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.01 85.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.762 0.315 . . . . 1.0 110.643 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.6 mt -62.77 -44.11 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.002 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.74 -42.03 99.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.091 -0.644 . . . . 1.0 110.779 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.76 -42.01 99.48 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.823 -0.351 . . . . 1.0 111.066 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.08 -41.58 93.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.597 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -71.11 -43.79 55.71 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 110.587 -1.005 . . . . 1.0 110.587 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.53 -37.42 84.97 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.873 0.469 . . . . 1.0 110.679 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.54 -62.58 0.92 Allowed Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.502 -0.772 . . . . 1.0 112.374 -177.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 20.2 Cg_endo -61.34 -34.51 87.11 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.802 1.668 . . . . 1.0 113.128 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.71 -43.18 89.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.94 -44.04 90.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.945 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.75 -44.88 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.701 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -65.24 -47.65 76.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.627 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.49 96.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.398 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 38.7 mt -63.6 -43.38 97.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.339 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 718' ' ' LEU . 85.0 mt -63.55 -44.33 94.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.298 -0.961 . . . . 1.0 109.292 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.74 -44.88 89.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.914 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 20.1 m -63.46 -45.8 89.15 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 79.3 mt -64.37 -43.1 97.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.538 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -59.96 -40.39 88.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.6 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -72.51 -29.27 63.46 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.596 0.712 . . . . 1.0 109.934 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -66.22 -44.94 82.39 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 118.917 -1.113 . . . . 1.0 110.188 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -69.25 136.35 51.83 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.591 -0.732 . . . . 1.0 110.503 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.32 -38.76 88.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.704 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.069 -0.967 . . . . 1.0 110.601 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 N--CA 1.484 0.954 0 N-CA-C 109.519 -0.993 . . . . 1.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -118.62 131.89 56.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.363 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 4.9 t -139.07 73.31 38.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.633 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.61 145.46 97.65 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.84 2.36 . . . . 1.0 112.065 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -126.02 144.78 50.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.464 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -115.25 -166.3 14.96 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.045 -0.822 . . . . 1.0 111.045 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -61.66 146.0 97.12 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.983 2.455 . . . . 1.0 112.051 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 696' ' ' VAL . 98.9 m-20 -67.92 144.07 55.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.464 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.29 -43.28 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.278 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 694' ' ' LEU . 90.9 mt -62.14 -40.12 94.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.351 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.73 -43.99 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.3 t -63.48 -42.96 98.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.957 -1.02 . . . . 1.0 109.235 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.4 tp -62.62 -42.74 99.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.379 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.14 -43.07 96.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.331 0.586 . . . . 1.0 109.655 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.6 p -63.48 -34.55 78.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.332 -0.849 . . . . 1.0 109.81 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 696' ' ' VAL . 79.4 t -65.67 -44.76 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.55 -39.0 93.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.243 -0.889 . . . . 1.0 109.42 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.27 -41.75 99.47 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.705 -0.958 . . . . 1.0 110.705 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.72 -38.5 91.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.702 0.287 . . . . 1.0 110.898 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.05 -43.46 99.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.342 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.64 -42.61 99.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.699 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.0 -41.77 98.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.88 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.14 -42.94 98.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.42 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.407 ' O ' HD13 ' A' ' 712' ' ' LEU . . . -65.91 -47.08 77.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.794 -0.922 . . . . 1.0 110.794 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.35 -36.8 79.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.868 0.467 . . . . 1.0 111.418 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.626 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -36.27 -61.39 0.6 Allowed Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.0 Cg_endo -62.79 -30.81 78.28 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.954 1.769 . . . . 1.0 113.322 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.13 -43.87 90.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.107 -0.637 . . . . 1.0 109.54 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 713' ' ' LEU . 11.2 mp -64.35 -42.93 95.99 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.216 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.79 -44.9 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.551 ' CZ2' HD13 ' A' ' 719' ' ' ILE . 66.9 t-105 -65.39 -46.48 79.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 720' ' ' THR . . . -57.89 -47.85 81.56 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.459 -0.791 . . . . 1.0 110.344 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.82 -44.25 93.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.563 -0.455 . . . . 1.0 110.789 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 82.8 mt -65.13 -45.03 86.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.431 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.551 HD13 ' CZ2' ' A' ' 715' ' ' TRP . 5.3 tp -71.4 -42.33 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.094 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 716' ' ' ALA . 67.8 p -66.7 -40.41 88.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.684 -0.807 . . . . 1.0 108.852 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.41 -40.3 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.676 0.751 . . . . 1.0 111.211 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 10.9 m80 -63.07 -35.89 81.74 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.935 -0.706 . . . . 1.0 109.67 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -75.22 -39.31 60.16 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.49 0.662 . . . . 1.0 110.552 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -66.96 134.75 52.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.142 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.61 144.13 49.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.74 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.06 -38.76 89.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.406 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 117.976 -1.012 . . . . 1.0 110.526 179.826 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo . . . . . 0 N--CA 1.484 0.937 0 N-CA-C 109.408 -1.035 . . . . 1.0 109.408 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -65.89 -38.63 89.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.485 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 1.4 m 65.06 59.41 1.31 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.714 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -72.38 154.76 55.97 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.963 2.442 . . . . 1.0 112.557 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.09 144.15 50.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.293 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.479 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . 56.12 52.36 49.83 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.011 -0.835 . . . . 1.0 111.011 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 690' ' ' GLY . 36.5 Cg_endo -65.58 -21.35 59.66 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.954 2.436 . . . . 1.0 111.997 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 696' ' ' VAL . 79.9 m-20 -67.29 143.88 56.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.471 0.653 . . . . 1.0 110.618 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.98 -42.33 79.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.641 0.734 . . . . 1.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.2 mp -62.25 -39.16 91.97 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.077 -0.965 . . . . 1.0 108.713 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.12 -44.28 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.57 0.7 . . . . 1.0 109.229 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.2 t -63.71 -42.92 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.822 -1.081 . . . . 1.0 109.167 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.19 -42.94 99.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.387 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.96 -42.86 97.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.356 0.598 . . . . 1.0 109.755 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 73.4 p -63.61 -33.58 75.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.002 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.9 t -65.64 -45.22 92.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 99.0 mmm -63.57 -37.83 88.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.377 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.08 99.11 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.581 -1.008 . . . . 1.0 110.581 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.88 92.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.769 0.318 . . . . 1.0 110.72 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.56 -43.97 98.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.337 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.31 -42.79 99.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.776 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.2 -41.99 98.87 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.551 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.8 -42.84 97.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.92 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.21 -43.1 81.52 Favored Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.79 -37.31 81.86 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.939 0.496 . . . . 1.0 111.109 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.645 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -41.44 -61.57 1.36 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.592 -0.731 . . . . 1.0 112.623 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 27.6 Cg_endo -63.11 -32.95 74.63 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.766 1.644 . . . . 1.0 112.749 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 712' ' ' LEU . 90.6 mt -66.37 -43.78 84.97 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.14 -43.97 90.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.058 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . 0.48 ' O ' HD13 ' A' ' 718' ' ' LEU . 95.8 mt -64.98 -45.01 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.972 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -63.89 -46.5 84.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.48 -39.75 88.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.779 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.41 -46.33 86.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 714' ' ' ILE . 9.3 mp -64.68 -45.1 88.09 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 120.178 -0.609 . . . . 1.0 110.167 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 31.0 mm -66.28 -44.35 91.19 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 716' ' ' ALA . 78.8 m -62.83 -44.09 97.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.59 -43.59 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.789 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.507 ' O ' ' C ' ' A' ' 723' ' ' ASP . 7.5 m80 -64.1 -35.61 81.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.069 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.507 ' C ' ' O ' ' A' ' 722' ' ' HIS . 99.5 m-20 -8.77 -72.1 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.999 0.812 . . . . 1.0 112.803 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 722' ' ' HIS . 85.6 mtp180 -79.23 144.61 34.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.647 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 727' ' ' PHE . 64.5 mttp -112.49 145.49 40.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.548 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 727' ' ' PHE . 97.3 mt-10 45.67 -89.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.613 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 725' ' ' LYS . 96.5 m-85 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.562 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 N--CA 1.483 0.903 0 N-CA-C 109.605 -0.96 . . . . 1.0 109.605 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.79 137.86 58.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.605 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 10.2 p -155.49 72.49 5.48 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.549 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -61.72 145.85 97.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.799 2.333 . . . . 1.0 111.942 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -106.13 146.32 30.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.263 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 139.43 -67.79 0.5 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.788 -0.925 . . . . 1.0 110.788 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.76 ' O ' HG23 ' A' ' 695' ' ' VAL . 31.8 Cg_endo -65.51 -22.2 59.1 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.378 2.052 . . . . 1.0 112.09 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -68.02 -41.06 82.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.506 ' O ' HD13 ' A' ' 697' ' ' LEU . 97.1 mt -67.48 -42.7 87.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.095 -0.957 . . . . 1.0 110.559 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 694' ' ' LEU . 90.8 mt -62.62 -36.56 83.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.016 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 691' ' ' PRO . 61.4 t -64.08 -43.73 97.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 O-C-N 123.699 0.624 . . . . 1.0 109.616 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.4 t -62.91 -43.47 98.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.614 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 693' ' ' ILE . 9.6 mp -63.23 -40.97 98.95 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.185 -0.606 . . . . 1.0 112.11 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.94 -43.24 96.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.441 0.639 . . . . 1.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 70.9 p -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.327 -0.852 . . . . 1.0 109.443 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.6 t -65.86 -45.72 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.523 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.7 ttp -62.05 -40.02 94.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.154 -0.93 . . . . 1.0 109.718 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.2 -40.67 99.28 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.71 -36.8 84.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.749 0.309 . . . . 1.0 110.479 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.64 -43.73 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.971 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.43 -41.41 98.7 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.906 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.24 -41.72 98.68 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.826 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 30.8 mm -63.43 -43.45 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.72 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.95 -46.81 64.03 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.392 -0.683 . . . . 1.0 111.392 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.39 -35.27 77.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.838 0.352 . . . . 1.0 111.123 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.647 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.47 -62.04 1.04 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 115.882 -0.599 . . . . 1.0 112.421 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.647 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 29.7 Cg_endo -63.53 -32.49 70.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.882 1.721 . . . . 1.0 112.575 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 712' ' ' LEU . 91.0 mt -65.57 -43.36 90.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.5 -43.7 93.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.794 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.71 -44.91 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.059 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.55 ' CD1' HD11 ' A' ' 719' ' ' ILE . 15.3 t-105 -65.02 -46.36 81.67 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.0 -41.91 97.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.287 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.7 mt -63.68 -43.79 95.64 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.723 -0.391 . . . . 1.0 109.991 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 718' ' ' LEU . 85.1 mt -64.38 -44.79 90.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.79 -0.764 . . . . 1.0 109.831 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.55 HD11 ' CD1' ' A' ' 715' ' ' TRP . 93.1 mt -66.27 -44.81 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 716' ' ' ALA . 99.9 m -63.66 -45.09 91.74 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.0 mm -64.23 -43.64 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.199 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -59.84 -39.57 85.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.731 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -167.91 163.98 13.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.42 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 726' ' ' GLU . 99.8 mtt180 -131.93 140.09 48.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.58 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 38.26 23.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.44 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 724' ' ' ARG . 97.0 mt-10 -140.81 148.74 41.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 1.0 110.715 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.611 179.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 N--CA 1.484 0.958 0 N-CA-C 109.569 -0.973 . . . . 1.0 109.569 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.89 -38.81 89.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.581 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 688' ' ' PRO . 0.4 OUTLIER -57.19 179.99 0.12 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.279 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 687' ' ' SER . 22.9 Cg_exo -61.7 145.28 97.56 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.138 1.892 . . . . 1.0 112.087 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.02 142.01 38.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 1.0 109.976 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.549 ' H ' ' CD ' ' A' ' 691' ' ' PRO . . . -108.69 -51.19 0.71 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.549 ' CD ' ' H ' ' A' ' 690' ' ' GLY . 21.7 Cg_exo -61.72 144.85 97.56 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.664 2.242 . . . . 1.0 111.794 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 696' ' ' VAL . 96.9 m-20 -90.02 -19.0 24.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.341 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.72 -43.69 89.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.336 0.588 . . . . 1.0 110.232 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 698' ' ' LEU . 95.1 mt -62.15 -37.57 85.73 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 65.7 t -64.92 -44.39 96.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.608 0.718 . . . . 1.0 109.204 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.753 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.1 t -63.4 -42.77 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.689 -1.141 . . . . 1.0 109.349 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.16 -44.24 97.06 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.147 0.425 . . . . 1.0 112.147 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 694' ' ' LEU . 4.5 mm? -64.38 -42.5 96.11 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -62.36 -35.38 78.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.779 . . . . 1.0 109.779 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 696' ' ' VAL . 66.3 t -66.66 -45.93 87.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.493 0.663 . . . . 1.0 109.331 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 63.4 mtt -62.83 -38.52 91.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.139 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.03 -41.2 99.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.83 84.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.665 0.269 . . . . 1.0 110.471 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 94.6 mt -62.84 -43.99 99.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.905 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.5 -42.1 99.27 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.056 -0.658 . . . . 1.0 110.969 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.65 -42.03 98.33 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.72 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.27 -40.79 90.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.964 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -73.27 -44.55 34.33 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.739 -0.944 . . . . 1.0 110.739 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.25 -36.83 80.05 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.629 0.372 . . . . 1.0 111.936 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.696 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -47.5 -59.79 5.05 Favored Pre-proline 0 N--CA 1.464 0.275 0 C-N-CA 120.057 -0.657 . . . . 1.0 111.405 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 35.5 Cg_exo -53.23 -40.3 77.94 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.43 1.42 . . . . 1.0 112.644 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.24 -44.67 87.45 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.563 -0.455 . . . . 1.0 109.936 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.77 -42.96 94.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.533 -0.467 . . . . 1.0 109.932 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.12 -44.74 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -65.68 -46.82 77.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.751 ' O ' HG23 ' A' ' 720' ' ' THR . . . -60.9 -41.11 95.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.29 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.479 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 35.4 mt -63.16 -44.34 95.78 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.104 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.73 -45.01 88.29 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 119.943 -0.703 . . . . 1.0 109.991 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.8 mm -66.86 -44.82 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.346 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 716' ' ' ALA . 66.5 p -67.45 -39.66 85.38 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 119.217 -0.993 . . . . 1.0 108.706 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.8 mm -64.65 -43.41 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 119.962 -0.695 . . . . 1.0 110.639 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -60.27 -39.38 86.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.333 -0.848 . . . . 1.0 110.647 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -74.01 -19.24 60.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.506 -0.316 . . . . 1.0 110.389 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' A' ' 721' ' ' ILE . 94.9 mtt-85 -102.71 136.83 41.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 1.0 110.59 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.18 -42.04 99.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.537 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 56.62 76.38 0.3 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.205 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.993 -1.003 . . . . 1.0 110.598 -179.796 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 N--CA 1.484 0.922 0 N-CA-C 109.575 -0.971 . . . . 1.0 109.575 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.66 126.21 54.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.616 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 70.1 m -139.95 72.75 34.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.533 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.51 145.19 98.12 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.911 2.407 . . . . 1.0 112.081 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.14 145.62 50.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.355 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.478 ' H ' ' HD2' ' A' ' 691' ' ' PRO . . . -151.13 -56.31 0.01 OUTLIER Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.889 -0.672 . . . . 1.0 111.451 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 690' ' ' GLY . 23.4 Cg_exo -61.34 144.06 98.24 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.309 2.006 . . . . 1.0 112.073 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 696' ' ' VAL . 95.8 m-20 -98.13 -4.45 35.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.412 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 694' ' ' LEU . 20.7 tt -69.9 -41.51 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.994 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.528 ' N ' HG23 ' A' ' 693' ' ' ILE . 90.9 mt -62.93 -40.27 97.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.437 -0.801 . . . . 1.0 109.204 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.0 -45.04 97.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.441 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.807 ' O ' HG23 ' A' ' 700' ' ' VAL . 75.9 t -63.86 -43.11 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.052 -0.977 . . . . 1.0 109.43 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.41 -43.02 99.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.562 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.34 -43.09 95.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.222 0.534 . . . . 1.0 109.56 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 75.7 p -63.96 -34.09 77.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.793 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 696' ' ' VAL . 73.6 t -65.77 -44.69 93.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 93.8 mtp -63.61 -38.97 93.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.297 -0.865 . . . . 1.0 109.619 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.78 -41.85 98.74 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.12 93.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.655 0.264 . . . . 1.0 110.844 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.26 -43.83 98.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.494 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 705' ' ' LEU . 93.7 mt -62.16 -42.18 99.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.654 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.94 -42.28 99.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.875 0.369 . . . . 1.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.427 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 96.0 mt -62.23 -40.85 89.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.55 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -72.83 -42.27 46.43 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.63 -37.34 84.64 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 122.921 0.488 . . . . 1.0 111.588 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -51.17 -59.91 6.74 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 120.285 -0.566 . . . . 1.0 112.172 -176.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 43.5 Cg_exo -53.02 -41.04 74.5 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.542 1.495 . . . . 1.0 112.18 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.27 -43.93 89.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.73 -43.45 93.36 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.834 -0.432 . . . . 1.0 109.834 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.42 -44.89 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.601 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 79.5 t90 -65.72 -47.01 76.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.748 ' O ' HG23 ' A' ' 720' ' ' THR . . . -61.75 -39.13 90.54 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.933 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 60.0 tp -63.03 -45.98 89.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.534 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 87.6 mt -65.13 -46.02 82.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.283 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.8 -44.46 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.284 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 716' ' ' ALA . 61.6 p -66.13 -36.13 82.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.307 -0.957 . . . . 1.0 108.605 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 2.3 mm -66.56 -39.48 84.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.976 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 725' ' ' LYS . 40.5 m80 -66.88 -34.64 78.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.36 -0.837 . . . . 1.0 111.225 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 722' ' ' HIS . 98.2 m-20 -8.89 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 124.336 1.023 . . . . 1.0 113.231 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -63.08 -43.33 98.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.039 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 722' ' ' HIS . 87.2 tttt -68.29 132.9 47.92 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.98 -41.94 90.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.336 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 727' ' ' PHE . 52.0 p90 . . . . . 0 C--O 1.221 -0.395 0 CA-C-O 117.974 -1.012 . . . . 1.0 110.475 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.483 0.907 0 N-CA-C 109.609 -0.958 . . . . 1.0 109.609 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.0 -38.93 89.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.416 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.49 161.8 70.96 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.414 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.82 152.47 63.83 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.929 2.419 . . . . 1.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -141.26 151.19 43.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.793 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 167.02 -173.04 42.28 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.8 -38.68 85.5 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.782 2.321 . . . . 1.0 111.975 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 66.1 t0 67.6 -48.22 0.51 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.664 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.03 -43.85 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.018 0.437 . . . . 1.0 110.472 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 694' ' ' LEU . 94.4 mt -62.94 -38.74 92.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.723 -0.672 . . . . 1.0 109.447 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.54 -45.39 98.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.63 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.732 ' O ' HG23 ' A' ' 700' ' ' VAL . 74.7 t -63.85 -43.67 97.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.446 -0.797 . . . . 1.0 109.392 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.25 -42.05 99.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.267 0.469 . . . . 1.0 112.267 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.04 -42.76 96.96 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.256 0.55 . . . . 1.0 109.806 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.9 p -63.25 -34.08 76.88 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.002 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 696' ' ' VAL . 75.7 t -65.61 -45.21 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.643 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.27 -38.1 89.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.485 -0.779 . . . . 1.0 109.775 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.3 -42.24 99.3 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.561 -1.016 . . . . 1.0 110.561 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.93 96.15 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.673 0.237 . . . . 1.0 110.675 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.74 -42.93 98.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 121.867 0.841 . . . . 1.0 110.008 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.16 -41.56 98.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.985 -0.686 . . . . 1.0 110.876 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.98 -40.52 97.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.773 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.27 -43.16 98.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.578 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.76 -46.08 62.5 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.716 -0.954 . . . . 1.0 110.716 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.29 -35.75 78.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.163 0.506 . . . . 1.0 111.185 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.06 -61.95 1.01 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.757 -0.656 . . . . 1.0 112.429 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.7 Cg_endo -63.04 -32.33 75.76 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.811 1.674 . . . . 1.0 112.73 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 712' ' ' LEU . 90.7 mt -66.06 -43.57 87.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.04 -43.66 91.63 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.965 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.7 -44.82 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.96 -0.564 . . . . 1.0 109.748 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.437 ' CZ2' HD11 ' A' ' 719' ' ' ILE . 76.9 t-105 -65.5 -46.56 79.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -59.73 -42.06 92.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.111 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.444 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 37.7 mt -63.63 -44.09 94.92 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.238 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.74 -45.35 86.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.956 -0.698 . . . . 1.0 110.024 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.437 HD11 ' CZ2' ' A' ' 715' ' ' TRP . 30.7 mm -66.42 -44.61 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 716' ' ' ALA . 97.6 m -63.51 -44.9 92.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.536 -0.913 . . . . 1.0 108.536 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.444 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.5 -43.13 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.666 -0.697 . . . . 1.0 111.3 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -61.93 -36.33 81.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.755 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -86.64 112.45 21.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 1.0 110.91 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -124.41 133.68 53.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.042 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.53 133.41 50.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.607 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -115.54 126.91 54.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.377 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.553 -179.835 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 N--CA 1.483 0.896 0 N-CA-C 109.612 -0.957 . . . . 1.0 109.612 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -96.79 -7.99 32.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.816 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.562 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 0.0 OUTLIER -62.4 -43.55 85.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.123 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 687' ' ' SER . 22.7 Cg_exo -61.38 144.72 98.49 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.555 2.17 . . . . 1.0 112.027 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.39 -41.89 98.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.768 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -151.95 84.89 0.15 Allowed Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.08 153.11 46.46 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.073 1.849 . . . . 1.0 112.501 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 696' ' ' VAL . 95.7 m-20 -97.33 -4.48 38.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.559 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.4 mt -65.4 -43.65 94.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-O 121.296 0.57 . . . . 1.0 110.164 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.87 -40.0 96.16 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.315 -0.857 . . . . 1.0 109.333 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.05 -45.15 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.382 0.611 . . . . 1.0 109.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 700' ' ' VAL . 76.4 t -64.11 -42.99 97.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.995 -1.002 . . . . 1.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 51.7 tp -62.61 -43.03 99.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.71 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.99 -43.02 96.94 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.259 0.552 . . . . 1.0 109.748 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.6 p -63.23 -34.32 77.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.856 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.4 t -65.44 -45.3 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.638 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.9 mmm -63.93 -37.98 89.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.441 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.49 -42.38 98.98 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.546 -1.022 . . . . 1.0 110.546 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.3 90.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.713 0.292 . . . . 1.0 110.866 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.94 -43.55 99.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.472 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.33 -42.19 99.18 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.784 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 89.0 mt -62.89 -41.51 99.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.354 . . . . 1.0 110.705 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.3 -43.25 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.291 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.86 -43.57 73.44 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.49 -37.14 82.41 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 122.879 0.472 . . . . 1.0 110.954 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -41.45 -61.96 1.23 Allowed Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.782 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.4 Cg_endo -63.27 -33.09 72.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.782 1.654 . . . . 1.0 112.672 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.19 -43.95 85.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.45 -44.21 87.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.155 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.18 -44.68 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.282 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.577 ' NE1' HD11 ' A' ' 719' ' ' ILE . 58.3 t-105 -66.08 -46.54 77.34 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -61.54 -37.98 85.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.848 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 721' ' ' ILE . 58.6 tp -63.54 -44.15 95.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.557 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 84.4 mt -64.63 -43.62 93.13 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.577 HD11 ' NE1' ' A' ' 715' ' ' TRP . 97.9 mt -65.25 -41.74 92.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 CA-C-O 123.64 1.686 . . . . 1.0 107.962 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 716' ' ' ALA . 99.0 m -68.29 -41.23 81.28 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 117.978 -1.489 . . . . 1.0 108.629 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.2 mm -64.71 -44.13 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 119.802 -0.759 . . . . 1.0 111.339 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 43.1 m80 -63.17 -40.62 98.08 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.274 -0.876 . . . . 1.0 110.442 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -67.92 -41.26 82.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.781 0.324 . . . . 1.0 110.256 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -62.76 -43.03 99.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.423 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -71.26 136.61 48.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.238 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.63 -39.22 93.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.911 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 727' ' ' PHE . 81.8 t80 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 N--CA 1.483 0.897 0 N-CA-C 109.584 -0.968 . . . . 1.0 109.584 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -114.19 125.71 54.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.301 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 9.5 p -177.23 73.05 0.23 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.59 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.62 145.6 97.5 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.932 2.421 . . . . 1.0 111.97 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -110.86 146.07 37.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.389 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 145.26 -160.53 28.08 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.16 145.42 98.75 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.538 2.158 . . . . 1.0 111.671 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -98.75 -3.18 36.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.573 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.82 -43.76 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.426 0.631 . . . . 1.0 109.886 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 698' ' ' LEU . 11.0 mp -63.04 -39.91 96.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.099 -0.955 . . . . 1.0 109.503 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.73 -45.47 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.798 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.3 t -64.04 -43.38 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.165 -0.925 . . . . 1.0 109.156 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.65 -43.71 98.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.841 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 694' ' ' LEU . 9.9 mp -64.44 -42.56 95.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.136 0.493 . . . . 1.0 109.7 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 78.0 p -63.21 -34.8 78.42 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.883 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 696' ' ' VAL . 74.2 t -65.63 -45.43 92.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.2 ttp -62.05 -39.56 92.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.587 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.96 -42.43 98.29 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.898 -0.881 . . . . 1.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.92 95.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.586 0.231 . . . . 1.0 110.716 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.37 -44.04 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.399 -0.521 . . . . 1.0 110.36 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.25 -43.09 99.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.714 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.8 -41.19 99.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.153 0.502 . . . . 1.0 111.855 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.7 -39.98 87.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.351 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.41 -42.88 63.7 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.612 -0.995 . . . . 1.0 110.612 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . 0.411 HD23 HD12 ' A' ' 712' ' ' LEU . 96.7 mt -67.47 -37.88 83.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.278 0.561 . . . . 1.0 110.631 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.622 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -36.55 -62.31 0.54 Allowed Pre-proline 0 C--N 1.333 -0.118 0 CA-C-N 115.618 -0.719 . . . . 1.0 112.096 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.622 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.0 Cg_endo -62.03 -31.19 83.78 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.654 1.569 . . . . 1.0 113.256 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . 0.411 HD12 HD23 ' A' ' 709' ' ' LEU . 90.1 mt -65.72 -44.11 87.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.48 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 713' ' ' LEU . 11.2 mp -64.29 -42.84 96.21 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.293 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.95 -44.9 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -65.91 -45.91 80.23 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.273 -0.639 . . . . 1.0 109.273 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 720' ' ' THR . . . -57.96 -47.65 82.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.372 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.462 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 83.1 mt -64.26 -43.73 93.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.75 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.06 -44.89 87.52 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.139 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 5.1 tp -71.4 -41.88 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 108.925 -0.769 . . . . 1.0 108.925 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 716' ' ' ALA . 96.9 m -63.6 -44.86 92.78 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.42 -43.33 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.021 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -60.73 -38.34 84.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -77.34 143.33 38.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.466 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -138.85 152.24 47.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.607 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -127.28 144.63 51.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.565 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -116.86 127.41 54.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.519 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.03 -0.986 . . . . 1.0 110.562 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 N--CA 1.483 0.907 0 N-CA-C 109.569 -0.973 . . . . 1.0 109.569 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -114.12 125.94 54.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.398 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 2.7 m 176.4 73.93 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.538 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.49 145.27 98.09 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.842 2.361 . . . . 1.0 111.962 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -127.05 145.01 50.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.618 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 167.43 71.54 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.939 -0.865 . . . . 1.0 110.939 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.73 145.36 97.41 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.744 2.296 . . . . 1.0 111.943 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 696' ' ' VAL . 95.9 m-20 -95.58 -7.58 37.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.131 0.491 . . . . 1.0 110.039 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 32.3 mm -65.66 -43.47 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.665 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 698' ' ' LEU . 89.9 mt -62.63 -40.23 96.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.463 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 68.9 t -63.23 -45.2 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.322 0.582 . . . . 1.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.4 t -63.9 -43.17 97.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.48 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 40.4 mt -62.84 -42.48 99.76 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.497 -0.481 . . . . 1.0 112.057 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 694' ' ' LEU . 9.8 mp -64.26 -42.61 96.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.25 0.548 . . . . 1.0 109.805 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -63.28 -34.61 78.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.893 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 696' ' ' VAL . 71.6 t -65.44 -45.65 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.695 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 99.0 mmm -64.94 -37.51 87.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.644 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.38 -43.14 99.49 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.86 77.69 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.092 -0.643 . . . . 1.0 110.823 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.96 -43.11 98.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.062 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.83 -42.08 99.58 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.088 -0.645 . . . . 1.0 111.892 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.79 -40.27 96.25 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.648 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.425 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 36.8 mm -64.55 -34.14 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.858 0.361 . . . . 1.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -77.5 -43.94 14.22 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.021 -1.085 . . . . 1.0 111.024 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.26 -36.56 81.84 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.76 0.424 . . . . 1.0 111.969 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.716 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -50.72 -60.04 6.23 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.079 -0.649 . . . . 1.0 111.768 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 42.8 Cg_exo -53.07 -41.29 72.83 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.296 1.331 . . . . 1.0 112.113 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.31 -44.12 88.89 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.59 -43.46 93.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.607 -0.437 . . . . 1.0 110.007 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.58 -44.79 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.7 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.565 ' CE2' HD11 ' A' ' 719' ' ' ILE . 12.7 t90 -66.33 -46.12 77.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.862 ' O ' HG23 ' A' ' 720' ' ' THR . . . -61.82 -38.59 88.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.661 -0.7 . . . . 1.0 109.655 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.09 -45.56 91.54 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.533 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 86.7 mt -63.59 -43.36 97.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.23 -0.588 . . . . 1.0 109.499 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.565 HD11 ' CE2' ' A' ' 715' ' ' TRP . 92.2 mt -64.63 -44.26 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.862 HG23 ' O ' ' A' ' 716' ' ' ALA . 74.3 p -64.12 -41.21 97.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.042 -1.063 . . . . 1.0 108.404 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 81.7 mt -64.46 -43.4 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 119.57 -0.852 . . . . 1.0 111.706 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 718' ' ' LEU . 52.0 m80 -65.18 -37.73 88.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.547 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -85.23 114.54 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 1.0 110.784 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -73.48 146.05 45.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.555 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.93 -41.92 99.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 727' ' ' PHE . 83.9 tt0 -109.75 117.26 33.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.435 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . 0.443 ' C ' ' O ' ' A' ' 726' ' ' GLU . 88.0 m-85 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.961 -1.019 . . . . 1.0 111.567 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.484 0.957 0 N-CA-C 109.659 -0.939 . . . . 1.0 109.659 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -65.98 -38.51 88.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.409 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 62.1 m -131.89 78.05 70.76 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.53 145.0 98.21 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.593 2.195 . . . . 1.0 112.004 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . 0.41 ' O ' ' CD1' ' A' ' 694' ' ' LEU . 88.7 tttt -62.21 -44.21 97.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.537 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 43.98 69.5 0.68 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 695' ' ' VAL . 50.4 Cg_exo -54.71 -38.02 91.51 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.966 2.444 . . . . 1.0 112.294 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 696' ' ' VAL . 54.8 m-20 -65.89 -42.41 90.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.367 0.603 . . . . 1.0 110.046 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 94.8 mt -65.55 -43.27 94.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.353 -0.839 . . . . 1.0 110.031 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 689' ' ' LYS . 88.8 mt -62.65 -39.96 95.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.996 -1.002 . . . . 1.0 109.53 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 691' ' ' PRO . 68.8 t -63.75 -45.1 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.298 -0.63 . . . . 1.0 109.298 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 700' ' ' VAL . 77.0 t -64.05 -43.15 97.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.961 -1.018 . . . . 1.0 109.282 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.49 -42.99 99.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.598 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.32 -43.17 95.52 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.183 0.516 . . . . 1.0 109.671 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.7 p -63.28 -34.95 78.79 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.405 -0.816 . . . . 1.0 109.825 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 696' ' ' VAL . 74.7 t -65.81 -45.39 91.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.0 ttp -61.92 -39.42 91.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.136 -0.938 . . . . 1.0 109.571 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.53 -40.78 99.56 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.713 -0.955 . . . . 1.0 110.713 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.41 87.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.497 0.189 . . . . 1.0 111.016 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 31.6 mm -62.95 -44.12 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.434 -0.507 . . . . 1.0 110.771 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.71 -41.98 99.42 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.932 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.29 -42.53 99.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.811 0.339 . . . . 1.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.43 -43.25 98.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.197 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 712' ' ' LEU . . . -68.52 -43.9 75.02 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.42 -36.88 82.14 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.869 0.468 . . . . 1.0 111.115 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.64 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.12 -62.19 0.96 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.83 -0.623 . . . . 1.0 112.435 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 22.4 Cg_endo -62.02 -33.65 82.5 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.657 1.571 . . . . 1.0 113.036 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.66 -42.94 90.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 177.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.45 -43.69 93.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.883 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.78 -44.9 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.888 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -65.96 -45.96 79.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -55.46 -47.65 75.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.275 -0.875 . . . . 1.0 109.857 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 40.3 mt -63.69 -43.3 97.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.539 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.44 -44.89 89.72 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 120.171 -0.611 . . . . 1.0 111.243 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 719' ' ' ILE . 14.1 pt -73.17 -41.85 58.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 94.8 m -64.14 -43.55 94.88 Favored 'General case' 0 C--O 1.265 1.876 0 CA-C-O 122.346 1.07 . . . . 1.0 108.616 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.0 -44.43 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 117.802 -1.559 . . . . 1.0 111.702 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -59.38 -39.64 84.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.083 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -66.75 -39.09 87.77 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.78 0.324 . . . . 1.0 110.255 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -62.65 -42.9 99.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.395 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -62.41 -44.35 96.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.454 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 56.23 76.23 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.269 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . 0.491 ' CD2' ' OXT' ' A' ' 727' ' ' PHE . 55.2 p90 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.997 -1.002 . . . . 1.0 110.517 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 N--CA 1.484 0.956 0 N-CA-C 109.521 -0.992 . . . . 1.0 109.521 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.04 -38.92 89.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.579 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 74.9 m 44.11 59.47 12.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.785 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.2 153.74 56.75 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.937 2.425 . . . . 1.0 112.41 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -110.78 130.16 55.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.338 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 103.59 75.53 1.06 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.827 -0.909 . . . . 1.0 110.827 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.76 145.49 97.26 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.858 2.372 . . . . 1.0 111.606 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -94.84 -8.66 36.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.299 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.63 -43.19 93.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.633 0.73 . . . . 1.0 110.071 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.04 -37.17 86.73 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.788 -1.096 . . . . 1.0 109.737 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.89 -43.29 93.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.806 0.812 . . . . 1.0 109.571 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.795 ' O ' HG23 ' A' ' 700' ' ' VAL . 71.1 t -66.05 -39.74 85.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.48 -1.236 . . . . 1.0 109.693 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.98 -43.05 96.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.833 -0.621 . . . . 1.0 111.684 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -65.36 -42.23 92.98 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.319 -0.622 . . . . 1.0 109.319 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . . . . . . . . . 59.3 p -62.98 -35.05 78.91 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.678 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 696' ' ' VAL . 75.5 t -66.44 -44.53 90.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.333 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 5.7 ttp -61.89 -39.26 91.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.29 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.92 -41.67 98.62 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.13 96.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.775 0.321 . . . . 1.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.0 -43.72 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.26 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.41 -42.32 99.35 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.659 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.58 -42.38 99.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 1.0 110.446 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.23 -43.35 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.62 -44.88 69.31 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.414 -1.074 . . . . 1.0 110.414 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.05 -38.04 82.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.138 0.494 . . . . 1.0 110.99 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -37.13 -61.77 0.65 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.726 -0.67 . . . . 1.0 112.315 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.0 Cg_endo -62.79 -31.25 78.35 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.764 1.643 . . . . 1.0 113.192 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 712' ' ' LEU . 91.2 mt -65.5 -44.45 86.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.3 -0.56 . . . . 1.0 109.525 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 713' ' ' LEU . 11.2 mp -64.45 -42.84 95.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.099 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.26 -45.09 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 120.297 -0.561 . . . . 1.0 109.872 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.568 ' CD2' HD11 ' A' ' 719' ' ' ILE . 1.5 t90 -65.98 -46.53 77.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.15 -43.4 95.76 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.352 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 721' ' ' ILE . 38.0 mt -63.39 -43.95 96.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.297 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.58 -44.57 90.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.749 -0.78 . . . . 1.0 109.679 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.568 HD11 ' CD2' ' A' ' 715' ' ' TRP . 93.3 mt -66.32 -45.01 90.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.756 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 716' ' ' ALA . 97.3 m -63.84 -44.74 92.28 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 724' ' ' ARG . 3.0 mm -64.18 -43.59 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.984 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -60.28 -40.09 89.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.545 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.95 -42.99 69.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.789 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 721' ' ' ILE . 99.9 mtt180 -130.36 140.6 50.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.842 0.353 . . . . 1.0 110.991 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.32 -42.08 98.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.634 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -135.63 148.25 48.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.702 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.987 -1.006 . . . . 1.0 110.613 -179.921 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.483 0.885 0 N-CA-C 109.576 -0.971 . . . . 1.0 109.576 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -65.98 -38.9 89.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.027 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 70.1 m -144.01 74.74 16.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.48 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.57 145.05 98.07 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.748 2.299 . . . . 1.0 112.004 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -68.75 133.68 48.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.683 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -144.83 -172.73 15.53 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -61.65 144.16 97.23 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.508 2.139 . . . . 1.0 111.888 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 696' ' ' VAL . 95.8 m-20 -97.73 -5.23 35.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.413 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.51 -43.74 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.408 0.623 . . . . 1.0 110.26 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.0 mp -62.81 -40.06 96.19 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.274 -0.875 . . . . 1.0 109.563 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.86 -45.42 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-O 121.42 0.629 . . . . 1.0 109.734 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 699' ' ' SER . 79.3 t -64.29 -43.08 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.001 -1.0 . . . . 1.0 109.382 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 51.9 tp -61.93 -42.47 99.13 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.87 -0.605 . . . . 1.0 112.031 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.19 -42.15 89.22 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.178 0.513 . . . . 1.0 110.926 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 68.8 p -61.73 -39.39 91.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.445 -0.798 . . . . 1.0 111.633 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.27 -40.31 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 119.67 -0.812 . . . . 1.0 109.498 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 56.0 ttp -61.23 -39.5 90.52 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.2 -40.81 98.33 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 110.595 -1.002 . . . . 1.0 110.595 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.52 91.37 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.689 -0.404 . . . . 1.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.96 -44.52 99.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 120.452 -0.499 . . . . 1.0 110.272 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.21 -43.16 99.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.628 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.58 -40.29 96.43 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.75 0.31 . . . . 1.0 111.142 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.455 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 85.2 mt -62.28 -41.54 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.84 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.31 -44.71 64.17 Favored Glycine 0 N--CA 1.471 0.996 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 8.9 mp -69.07 -35.47 76.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.501 -0.35 . . . . 1.0 111.936 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.678 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -50.5 -59.83 6.52 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 119.445 -0.902 . . . . 1.0 111.644 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 38.7 Cg_exo -53.16 -41.04 74.99 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.538 1.492 . . . . 1.0 112.308 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.52 -44.07 88.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.499 -0.556 . . . . 1.0 109.499 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.6 -43.82 92.6 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.475 -0.49 . . . . 1.0 109.876 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . 0.424 ' O ' HD13 ' A' ' 718' ' ' LEU . 95.5 mt -64.53 -44.84 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.483 ' CZ2' HD11 ' A' ' 719' ' ' ILE . 68.9 t-105 -63.76 -45.84 87.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.979 -0.748 . . . . 1.0 108.979 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.52 86.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.999 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.9 mt -63.16 -43.7 97.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.426 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 714' ' ' ILE . 8.8 mp -63.86 -43.93 94.62 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.413 -0.915 . . . . 1.0 109.021 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.483 HD11 ' CZ2' ' A' ' 715' ' ' TRP . 30.1 mm -65.11 -45.24 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.7 m -64.92 -46.61 80.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.953 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 717' ' ' LEU . 82.7 mt -65.52 -44.19 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.488 ' O ' ' C ' ' A' ' 723' ' ' ASP . 1.7 p-80 -67.69 -30.03 69.44 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 119.799 -0.76 . . . . 1.0 110.512 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.488 ' C ' ' O ' ' A' ' 722' ' ' HIS . 51.6 p-10 -7.05 126.27 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.154 0.908 . . . . 1.0 113.392 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -62.51 -42.87 99.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.348 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.5 146.61 48.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.637 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -109.21 124.11 50.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.521 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.554 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo . . . . . 0 N--CA 1.484 0.945 0 N-CA-C 109.56 -0.977 . . . . 1.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -64.97 138.35 58.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.98 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 32.1 m 54.48 73.01 0.96 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.59 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -61.69 145.25 97.6 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.747 2.298 . . . . 1.0 112.072 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.56 144.54 50.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.572 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -177.61 -70.14 0.06 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.797 ' O ' HG23 ' A' ' 695' ' ' VAL . 29.7 Cg_endo -64.77 -23.06 63.25 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.756 2.304 . . . . 1.0 112.144 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 693' ' ' ILE . 38.2 p-10 -71.83 -40.98 68.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.8 -0.637 . . . . 1.0 109.836 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.548 ' N ' ' OD1' ' A' ' 692' ' ' ASP . 97.9 mt -65.44 -43.66 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.039 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 694' ' ' LEU . 94.0 mt -62.33 -37.05 84.13 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.307 -0.861 . . . . 1.0 109.129 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 691' ' ' PRO . 78.5 t -65.81 -45.09 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.772 0.796 . . . . 1.0 109.334 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.764 ' O ' HG23 ' A' ' 700' ' ' VAL . 76.2 t -63.32 -43.09 98.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.207 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.26 -43.04 99.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.642 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.04 -43.19 96.29 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.143 0.497 . . . . 1.0 109.724 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 72.8 p -63.4 -34.61 78.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.466 -0.788 . . . . 1.0 109.883 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 696' ' ' VAL . 73.1 t -65.67 -45.27 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 53.4 ttp -61.71 -39.91 93.17 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.345 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.42 -42.42 99.06 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.28 92.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.834 0.826 . . . . 1.0 110.341 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.12 -43.76 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 119.763 -0.775 . . . . 1.0 109.943 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.05 -43.81 98.03 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.94 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.54 -41.2 98.73 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.631 0.253 . . . . 1.0 110.598 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.43 -43.0 98.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.31 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.39 -40.84 94.63 Favored Glycine 0 N--CA 1.468 0.783 0 N-CA-C 110.78 -0.928 . . . . 1.0 110.78 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.06 -35.15 76.23 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.715 0.406 . . . . 1.0 111.757 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -48.62 -60.54 4.39 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.201 -0.6 . . . . 1.0 111.862 -177.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 39.3 Cg_exo -53.49 -41.44 73.3 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.235 1.29 . . . . 1.0 112.529 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -64.68 -43.3 94.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.631 -0.428 . . . . 1.0 109.891 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.43 -43.9 92.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.403 -0.519 . . . . 1.0 110.249 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.69 -44.77 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.41 ' O ' HD13 ' A' ' 719' ' ' ILE . 85.6 t90 -64.35 -48.65 74.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.438 -0.579 . . . . 1.0 109.438 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -58.76 -41.74 87.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.987 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 37.2 mt -63.69 -44.17 94.47 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.731 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 718' ' ' LEU . 88.7 mt -64.47 -45.43 87.39 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.796 -0.762 . . . . 1.0 110.034 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.535 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 1.7 mp -66.78 -45.3 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.11 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 716' ' ' ALA . 98.8 m -64.87 -45.95 83.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.11 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.61 -43.97 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.156 0.799 . . . . 1.0 113.156 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 1.9 p-80 -65.64 -35.52 81.02 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.306 -0.958 . . . . 1.0 110.266 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 722' ' ' HIS . 64.6 t0 -66.83 -40.01 87.84 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.058 -0.349 . . . . 1.0 110.058 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -67.45 134.43 51.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.288 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 727' ' ' PHE . 98.8 mttt -63.04 -41.96 99.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.593 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 45.38 -88.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.671 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 725' ' ' LYS . 89.0 t80 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.047 -0.978 . . . . 1.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.482 0.829 0 N-CA-C 109.463 -1.014 . . . . 1.0 109.463 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -114.41 125.96 54.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.6 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 10.6 t -166.82 73.52 1.09 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.697 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.9 145.14 97.1 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.852 2.368 . . . . 1.0 111.964 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.35 -44.11 97.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.591 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.475 ' O ' HG22 ' A' ' 693' ' ' ILE . . . 97.97 55.87 1.11 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.648 ' O ' HG23 ' A' ' 695' ' ' VAL . 41.4 Cg_endo -69.37 -11.8 32.17 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.77 2.313 . . . . 1.0 112.314 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -65.7 -40.54 92.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.17 0.509 . . . . 1.0 110.315 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 690' ' ' GLY . 10.9 tp -70.18 -39.25 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.268 0.556 . . . . 1.0 109.968 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.34 -39.27 92.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.269 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 691' ' ' PRO . 66.7 t -63.73 -44.82 98.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.755 ' O ' HG23 ' A' ' 700' ' ' VAL . 75.6 t -64.06 -43.56 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.643 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.37 -41.89 98.83 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.276 0.472 . . . . 1.0 112.276 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.88 -42.87 97.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.325 0.583 . . . . 1.0 109.728 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.2 p -64.04 -34.05 77.15 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.253 -0.885 . . . . 1.0 109.801 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 696' ' ' VAL . 72.5 t -65.54 -45.55 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.659 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 98.9 mmm -64.52 -38.48 91.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.629 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.59 -41.2 99.53 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.456 -1.058 . . . . 1.0 110.456 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.78 84.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.806 0.336 . . . . 1.0 110.555 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.7 mt -62.8 -43.92 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.454 -0.499 . . . . 1.0 110.954 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.51 -42.02 99.22 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.185 -0.606 . . . . 1.0 110.743 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.25 -42.44 99.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 1.0 110.551 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.35 -43.27 98.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.229 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.83 -43.81 72.53 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.718 -0.953 . . . . 1.0 110.718 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.41 -37.38 82.97 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 122.79 0.436 . . . . 1.0 111.067 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.645 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -40.28 -62.2 0.98 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.602 -0.726 . . . . 1.0 112.529 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 28.2 Cg_endo -63.24 -32.85 73.22 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.672 1.581 . . . . 1.0 112.573 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 712' ' ' LEU . 89.4 mt -66.01 -43.52 87.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.1 -43.89 90.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.087 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 93.7 mt -64.03 -44.58 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.751 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.514 ' CZ2' HD11 ' A' ' 719' ' ' ILE . 76.0 t-105 -65.26 -46.46 80.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -58.16 -43.89 87.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.125 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 721' ' ' ILE . 80.2 mt -63.85 -42.89 97.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.633 178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.1 -44.37 89.04 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.693 -0.803 . . . . 1.0 109.733 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.548 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.5 mm -66.37 -45.39 89.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.881 -0.785 . . . . 1.0 108.881 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.428 ' O ' ' OD2' ' A' ' 723' ' ' ASP . 38.3 m -64.69 -44.64 89.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.14 -0.936 . . . . 1.0 110.912 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 717' ' ' LEU . 81.0 mt -67.26 -41.73 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 112.991 0.738 . . . . 1.0 112.991 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.548 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 2.6 p-80 -69.95 -26.67 64.23 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.191 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 722' ' ' HIS . 98.5 m-20 -9.76 -73.99 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.908 0.755 . . . . 1.0 113.02 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -126.45 132.78 51.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.188 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.03 142.37 41.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.376 -0.374 . . . . 1.0 110.505 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -89.96 139.36 30.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.535 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.061 -0.971 . . . . 1.0 110.661 179.91 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 N--CA 1.484 0.928 0 N-CA-C 109.538 -0.985 . . . . 1.0 109.538 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.01 137.96 58.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.61 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.435 ' CB ' ' CD ' ' A' ' 688' ' ' PRO . 0.1 OUTLIER -141.33 179.47 1.22 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.263 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 687' ' ' SER . 22.6 Cg_exo -61.75 144.94 97.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.137 1.892 . . . . 1.0 112.04 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.35 134.51 36.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.27 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -170.43 -167.16 30.45 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.84 146.98 96.19 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.105 2.536 . . . . 1.0 112.195 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.555 ' O ' HG23 ' A' ' 696' ' ' VAL . 83.7 m-20 -66.66 142.69 57.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.134 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.27 -43.36 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.386 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 694' ' ' LEU . 90.9 mt -62.1 -40.26 95.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.188 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.0 -43.92 96.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.812 ' O ' HG23 ' A' ' 700' ' ' VAL . 76.4 t -63.62 -42.99 97.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.189 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.33 -42.91 99.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.351 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.96 -43.28 96.25 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.294 0.569 . . . . 1.0 109.572 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 76.4 p -63.72 -34.44 77.88 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.352 -0.84 . . . . 1.0 109.893 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 696' ' ' VAL . 76.3 t -65.47 -45.06 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.6 ttp -61.76 -39.69 92.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.252 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.74 99.35 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.427 -1.069 . . . . 1.0 110.427 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.74 -36.23 82.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.713 0.292 . . . . 1.0 110.418 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.85 -44.1 99.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.551 -0.459 . . . . 1.0 110.757 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.4 -42.07 98.77 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.653 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 51.7 tp -62.48 -43.99 97.47 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.403 0.52 . . . . 1.0 112.403 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 21.2 tt -67.28 -38.41 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.211 -0.596 . . . . 1.0 111.749 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 712' ' ' LEU . . . -68.2 -44.97 73.69 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.35 -35.28 77.51 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.954 0.502 . . . . 1.0 111.07 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.642 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -41.03 -61.87 1.18 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.925 -0.58 . . . . 1.0 112.559 -177.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 23.1 Cg_endo -62.15 -33.07 82.89 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.756 1.637 . . . . 1.0 112.918 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 712' ' ' LEU . 11.0 mp -65.36 -43.17 91.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 177.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.76 -44.13 91.07 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.085 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.5 mm -64.85 -44.72 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 80.8 t90 -65.74 -47.03 76.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.25 95.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.255 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 721' ' ' ILE . 36.7 mt -63.07 -43.11 99.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.714 -0.395 . . . . 1.0 110.236 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.432 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 85.3 mt -64.17 -44.91 90.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.81 -0.756 . . . . 1.0 109.515 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.37 -45.25 89.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.774 -0.648 . . . . 1.0 109.642 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.7 m -64.29 -44.17 92.52 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 717' ' ' LEU . 3.4 mm -64.59 -42.23 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.943 0.878 . . . . 1.0 110.819 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.557 ' O ' ' CB ' ' A' ' 723' ' ' ASP . 11.7 m80 -61.47 -29.72 70.14 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.995 -1.002 . . . . 1.0 110.487 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 722' ' ' HIS . 48.1 t0 108.46 46.63 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.454 1.121 . . . . 1.0 109.296 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . 0.51 ' O ' ' CE1' ' A' ' 727' ' ' PHE . 99.8 mtt180 41.81 81.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.287 -0.965 . . . . 1.0 111.159 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -62.16 -43.86 97.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.318 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.38 -37.41 83.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.856 0.36 . . . . 1.0 111.079 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . 0.51 ' CE1' ' O ' ' A' ' 724' ' ' ARG . 73.3 m-85 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.433 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 687' ' ' SER . 12.3 Cg_exo . . . . . 0 N--CA 1.483 0.864 0 N-CA-C 109.608 -0.959 . . . . 1.0 109.608 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 46.82 -89.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.264 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 685' ' ' PRO . 0.0 OUTLIER -73.97 161.86 76.6 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.484 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.51 152.96 60.5 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.016 2.477 . . . . 1.0 112.392 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -63.09 -42.08 99.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.589 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.44 ' N ' ' CD ' ' A' ' 691' ' ' PRO . . . 86.0 53.99 2.86 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.517 ' O ' HG23 ' A' ' 695' ' ' VAL . 33.8 Cg_endo -65.7 -19.81 59.52 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.765 2.31 . . . . 1.0 111.362 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -67.41 -39.8 85.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.52 -42.29 89.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 122.173 0.987 . . . . 1.0 109.548 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 694' ' ' LEU . 11.0 mp -63.64 -38.0 89.45 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 122.09 0.948 . . . . 1.0 109.579 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 691' ' ' PRO . 62.1 t -64.3 -44.49 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.31 -0.859 . . . . 1.0 109.229 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.791 ' O ' HG23 ' A' ' 700' ' ' VAL . 73.5 t -63.13 -43.52 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.115 -0.948 . . . . 1.0 109.609 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.31 -42.08 98.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.993 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.05 -43.16 96.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.282 0.563 . . . . 1.0 109.581 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 78.0 p -63.65 -34.82 78.68 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.661 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 696' ' ' VAL . 73.3 t -65.39 -45.35 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 65.2 ttp -61.86 -39.73 92.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.334 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.69 -42.37 98.69 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.745 -0.942 . . . . 1.0 110.745 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.91 96.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.636 0.255 . . . . 1.0 111.376 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.49 -41.56 92.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 82.0 mt -61.67 -42.05 98.38 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.979 -0.688 . . . . 1.0 110.446 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.82 -41.6 99.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.752 0.311 . . . . 1.0 111.199 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.404 ' O ' ' CD ' ' A' ' 711' ' ' PRO . 31.1 mm -63.46 -43.2 98.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.371 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.55 -42.27 81.53 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 110.956 -0.857 . . . . 1.0 110.956 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 89.5 mt -68.3 -35.86 78.47 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.974 0.51 . . . . 1.0 111.74 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.699 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -49.59 -60.37 5.08 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.091 -0.644 . . . . 1.0 111.921 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 38.5 Cg_exo -53.76 -40.93 78.13 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.443 1.429 . . . . 1.0 112.399 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.19 -44.16 89.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.0 -43.61 91.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.563 -0.455 . . . . 1.0 109.928 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.7 -44.76 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.837 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -66.51 -46.86 74.84 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 720' ' ' THR . . . -60.41 -40.07 89.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.843 -0.617 . . . . 1.0 109.703 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 59.2 tp -63.64 -46.21 86.7 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.66 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 718' ' ' LEU . 86.5 mt -64.19 -44.36 92.23 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 120.248 -0.581 . . . . 1.0 109.935 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.3 mm -65.82 -43.95 93.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 716' ' ' ALA . 95.4 m -62.58 -45.24 93.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.35 -43.32 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 119.742 -0.783 . . . . 1.0 111.754 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.545 ' O ' ' CB ' ' A' ' 723' ' ' ASP . 7.0 m80 -60.15 -38.86 84.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.542 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 722' ' ' HIS . 67.0 t0 117.54 117.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.72 1.263 . . . . 1.0 109.989 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -68.19 134.15 50.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -108.28 145.77 33.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 1.0 109.905 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.12 138.03 58.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.525 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 55.2 p90 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.412 -179.941 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.484 0.919 0 N-CA-C 109.606 -0.959 . . . . 1.0 109.606 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.87 148.05 50.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.289 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . . . . . . . . . 6.3 m -126.07 81.7 66.14 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.634 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -61.32 144.91 98.76 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.36 2.04 . . . . 1.0 111.96 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 18.1 tttm 48.06 27.56 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.807 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -170.0 71.2 0.13 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.999 -0.84 . . . . 1.0 110.999 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.38 144.51 98.37 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.68 2.254 . . . . 1.0 112.042 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . 0.444 ' O ' HG23 ' A' ' 696' ' ' VAL . 96.4 m-20 -96.74 -6.62 35.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.307 179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.11 -43.62 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.163 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 694' ' ' LEU . 92.1 mt -62.94 -39.48 94.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.244 -0.889 . . . . 1.0 109.219 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 69.5 t -64.45 -45.2 96.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.503 0.668 . . . . 1.0 109.489 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.803 ' O ' HG23 ' A' ' 700' ' ' VAL . 78.3 t -64.32 -43.06 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.955 -1.02 . . . . 1.0 109.336 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.2 -43.16 99.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.802 -0.635 . . . . 1.0 111.594 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.13 -43.0 96.62 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.423 0.63 . . . . 1.0 109.562 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 74.1 p -64.08 -34.38 77.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.231 -0.895 . . . . 1.0 109.782 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 696' ' ' VAL . 74.5 t -65.2 -45.17 94.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 61.3 mtt -63.45 -38.48 91.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.439 -0.8 . . . . 1.0 109.348 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.12 -41.68 99.69 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.232 -1.147 . . . . 1.0 110.232 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.66 94.61 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.636 0.255 . . . . 1.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 707' ' ' ILE . 97.5 mt -62.37 -43.91 98.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.59 0.71 . . . . 1.0 110.053 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.99 -43.34 99.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.601 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.06 -43.17 99.41 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.285 0.476 . . . . 1.0 112.285 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 704' ' ' ILE . 14.6 tt -65.33 -31.93 56.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.045 -0.662 . . . . 1.0 111.176 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.94 -45.75 71.35 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.624 -0.991 . . . . 1.0 110.624 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.68 -36.87 81.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 1.0 111.266 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -37.78 -62.05 0.69 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.982 -0.554 . . . . 1.0 112.311 -177.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 27.2 Cg_endo -62.57 -31.65 79.85 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.924 1.749 . . . . 1.0 112.502 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.8 -43.72 71.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.504 -0.479 . . . . 1.0 109.928 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.17 -45.05 86.48 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.935 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 715' ' ' TRP . 20.4 tt -70.26 -41.96 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 119.873 -0.731 . . . . 1.0 109.704 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . 0.446 ' N ' HG23 ' A' ' 714' ' ' ILE . 78.7 t90 -63.7 -47.28 81.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.887 -0.782 . . . . 1.0 108.887 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.95 85.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.17 -45.44 91.81 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.545 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.16 -44.2 89.3 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 121.298 0.571 . . . . 1.0 109.895 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . 0.56 ' O ' ' ND1' ' A' ' 722' ' ' HIS . 30.2 mm -65.05 -44.41 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 98.9 m -63.91 -45.9 87.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.443 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 3.7 mm -65.89 -43.99 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 113.826 1.047 . . . . 1.0 113.826 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . 0.56 ' ND1' ' O ' ' A' ' 719' ' ' ILE . 2.2 p-80 -64.68 -30.41 71.42 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.782 -0.767 . . . . 1.0 110.754 -178.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -87.92 110.5 20.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.918 0.39 . . . . 1.0 110.625 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -103.28 137.85 40.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.507 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.71 144.27 50.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.574 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -116.27 127.28 54.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.342 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.963 -1.018 . . . . 1.0 110.542 179.98 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 N--CA 1.484 0.95 0 N-CA-C 109.641 -0.946 . . . . 1.0 109.641 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.88 138.28 58.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.352 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 687' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 688' ' ' PRO . 0.1 OUTLIER -99.7 -43.21 0.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.903 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 688' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 687' ' ' SER . 22.5 Cg_exo -61.56 145.16 98.0 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.521 2.148 . . . . 1.0 111.957 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.25 -41.93 99.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.548 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 693' ' ' ILE . . . 160.88 177.6 34.13 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 691' ' ' PRO . . . . . 0.66 ' O ' HG23 ' A' ' 695' ' ' VAL . 53.4 Cg_endo -72.55 -11.61 26.4 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 123.318 2.679 . . . . 1.0 112.746 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 692' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.06 -42.17 94.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.49 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 690' ' ' GLY . 20.1 tt -70.33 -39.38 76.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.207 0.527 . . . . 1.0 110.183 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 694' ' ' LEU . . . . . 0.416 ' N ' HG23 ' A' ' 693' ' ' ILE . 91.5 mt -62.19 -39.59 93.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.211 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 691' ' ' PRO . 68.6 t -63.72 -45.41 97.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.989 -0.55 . . . . 1.0 109.876 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.422 ' O ' ' OG ' ' A' ' 699' ' ' SER . 74.6 t -64.01 -43.52 97.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.329 -0.85 . . . . 1.0 109.852 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.92 -41.13 99.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.046 -0.525 . . . . 1.0 112.184 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 698' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.38 -42.27 88.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.238 0.542 . . . . 1.0 110.852 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 696' ' ' VAL . 77.3 p -62.07 -39.63 93.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.68 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 16.2 m -69.82 -41.39 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 119.386 -0.926 . . . . 1.0 109.632 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 701' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.22 -39.0 88.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 702' ' ' GLY . . . . . . . . . . . . . . . -61.92 -40.55 99.01 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.66 -36.87 82.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.511 0.196 . . . . 1.0 111.006 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 38.6 mm -60.93 -44.02 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 122.293 1.044 . . . . 1.0 109.547 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 46.4 tp -64.23 -44.21 92.59 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.674 -1.266 . . . . 1.0 112.404 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.06 -41.18 99.41 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 707' ' ' ILE . . . . . . . . . . . . . 45.2 pt -65.38 -38.69 83.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.482 -0.487 . . . . 1.0 111.62 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.13 -40.98 92.82 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.414 -1.074 . . . . 1.0 110.414 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 709' ' ' LEU . . . . . . . . . . . . . 97.0 mt -68.58 -35.27 77.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.42 -0.39 . . . . 1.0 111.505 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 710' ' ' ALA . . . . . 0.688 ' HB3' ' HD3' ' A' ' 711' ' ' PRO . . . -48.67 -60.91 3.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.03 -0.668 . . . . 1.0 112.075 -176.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 711' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 710' ' ' ALA . 39.9 Cg_exo -53.88 -40.63 79.79 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.351 1.367 . . . . 1.0 112.35 178.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 712' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.34 -43.85 89.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 713' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.78 -43.94 91.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.236 178.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 714' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.82 -44.69 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 715' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -65.23 -47.77 75.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 716' ' ' ALA . . . . . 0.76 ' O ' HG23 ' A' ' 720' ' ' THR . . . -61.96 -39.43 92.12 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.096 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.412 ' O ' ' CG1' ' A' ' 721' ' ' ILE . 60.8 tp -62.97 -46.47 87.56 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 718' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.93 -44.86 88.1 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.133 -0.627 . . . . 1.0 110.282 178.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 719' ' ' ILE . . . . . . . . . . . . . 30.5 mm -66.62 -44.4 89.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.426 179.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 716' ' ' ALA . 57.4 p -65.71 -39.79 91.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.412 ' CG1' ' O ' ' A' ' 717' ' ' LEU . 2.9 mm -64.96 -43.29 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 120.015 -0.674 . . . . 1.0 110.986 178.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 722' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -59.82 -41.11 90.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.624 -0.716 . . . . 1.0 110.294 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 723' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 725' ' ' LYS . 64.7 t0 -67.38 -40.81 85.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.095 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 61.76 -42.41 0.14 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.27 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 723' ' ' ASP . 27.2 tttt 46.97 32.68 1.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.681 0.277 . . . . 1.0 110.472 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 726' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 725' ' ' LYS . 97.4 mt-10 55.53 158.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.858 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.026 -0.988 . . . . 1.0 110.552 -179.935 . . . . . . . . 0 0 . 1 stop_ save_